0001062993-12-002934.txt : 20120814 0001062993-12-002934.hdr.sgml : 20120814 20120814141337 ACCESSION NUMBER: 0001062993-12-002934 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20120630 FILED AS OF DATE: 20120814 DATE AS OF CHANGE: 20120814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cybrdi, Inc. CENTRAL INDEX KEY: 0000019002 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 952461404 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-09081 FILM NUMBER: 121031723 BUSINESS ADDRESS: STREET 1: 401 ROSEMONT AVENUE STREET 2: - CITY: FREDERICK STATE: MD ZIP: 21701 BUSINESS PHONE: 301-644-3901 MAIL ADDRESS: STREET 1: 401 ROSEMONT AVENUE STREET 2: - CITY: FREDERICK STATE: MD ZIP: 21701 FORMER COMPANY: FORMER CONFORMED NAME: CERTRON CORP DATE OF NAME CHANGE: 19920703 10-Q 1 form10q.htm FORM 10-Q Cybrdi, Inc.: Form 10-Q - Filed by newsfilecorp.com

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2012

OR

[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File No: 09081

CYBRDI, INC.
(Exact name of registrant as specified in its charter)

CALIFORNIA
(State or other jurisdiction of incorporation or organization)

95-2461404
(I.R.S. Employer ID No)

No 29 Chang'An South Road Xi'an Shaanxi P.R. China 71006 1
(Address of principal executive office) (Zip Code)

Registrant's telephone number: (011) 86-29-8237-3068

N/A
Former name, former address and former fiscal year, (if changed since last report)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X]        No [  ]


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [X]     No [  ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer", "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company
[  ] [  ] [  ] [X]
    (Do not check if a smaller  
    reporting company)  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [  ]       No [X]

The number of shares of common stock, no par value per share, outstanding as of August 14, 2012 was 120,225,323.

2


 
 FORM 10-Q 
 QUARTERLY PERIOD ENDED JUNE 30, 2012 
 INDEX 
     
 TABLE OF CONTENTS 
     
    Page
 PART I – FINANCIAL INFORMATION 
Item 1: Financial Statements 4
Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations 5
Item 3: Quantitative and Qualitative Disclosures About Market Risk 13
Item 4T: Controls and Procedures 13
 PART II – OTHER INFORMATION 
Item 1: Legal Proceedings 14
Item 1A: Risk Factors 14
Item 2: Unregistered Sales of Equity Securities and Use of Proceeds 15
Item 3: Defaults Upon Senior Securities 15
Item 4: Mine Safety Disclosures 15
Item 5: Other Information 15
Item 6: Exhibits 15


3


PART I. FINANCIAL INFORMATION

Item 1 Financial Statements

 


4


CYBRDI, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
 

    June 30, 2012     December 31, 2011  
ASSETS   (Unaudited)     (Audited)  
             
CURRENT ASSETS            
     Cash and equivalents $  495,492   $  781,048  
     Accounts receivable, net   3,125     -  
     Inventories   921,606     1,053,038  
     Due from related companies   90,331     79,442  
     Other receivables, net and prepaid expenses   72,456     75,089  
     Advance to suppliers   630     832  
TOTAL CURRENT ASSETS   1,583,640     1,989,449  
PROPERTY, PLANT AND EQUIPMENT, NET   1,233,391     1,310,529  
CONSTRUCTION IN PROGRESS   6,781,274     6,829,329  
INTANGIBLE ASSETS, NET   715,647     782,215  
             
TOTAL ASSETS $  10,313,952   $  10,911,522  
             
LIABILITIES AND EQUITY            
             
CURRENT LIABILITIES            
     Short-term loan $  1,652,762   $  1,668,282  
     Accounts payable   3,318     4,942  
     Accrued expenses   746,757     693,436  
     Deferred revenue   123,370     139,284  
     Customers deposits   86,080     188,186  
     Due to related parties   1,745,801     1,850,181  
     Deferred tax liabilities   10,197     10,293  
     Other payables   426,870     366,020  
TOTAL CURRENT LIABILITIES   4,795,155     4,920,624  
CONSTRUCTION PAYABLE   840,150     894,750  
TOTAL LIABILITIES   5,635,305     5,815,374  
             
EQUITY            
     Preferred Stock, $1.00 per value, 500,000 shares authorized, no shares issued and outstanding   -     -  
     Common Stock, no par value, 150,000,000 shares authorized, and 120,225,323
     and 120,225,323 shares issued and outstanding, respectively
  4,313,614     4,313,614  
     Additional paid-in capital   172,308     172,308  
     Reserve funds   336,885     336,885  
     Accumulated deficit   (2,740,390 )   (2,447,643 )
     Accumulated other comprehensive income   1,483,900     1,540,329  
TOTAL STOCKHOLDERS’ EQUITY   3,566,317     3,915,493  
NONCONTROLLING INTEREST   1,112,330     1,180,655  
TOTAL EQUITY   4,678,647     5,096,148  
             
TOTAL LIABILITIES AND EQUITY $  10,313,952   $  10,911,522  

See notes to consolidated financial statements.

F-1


CYBRDI, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)

    Three Months Ended     Three Months Ended     Six Months Ended     Six Months Ended  
    June 30, 2012     June 30, 2011     June 30, 2012     June 30, 2011  
Revenue                        
     Housing $ -   $  -   $  142,200   $  -  
     Commercial rental   -     -     -     -  
     Tissue array products   112,407     123,419     212,317     237,230  
        Total revenue   112,407     123,419     354,517     237,230  
Cost of Sales                        
     Housing   -     -     123,306     -  
     Commercial rental   16,414     17,125     32,880     31,752  
     Tissue array products   65,120     102,176     144,434     189,324  
       Total cost of sales   81,534     119,301     300,620     221,076  
                         
Gross Profit   30,873     4,118     53,897     16,154  
                         
Operating Expenses:                        
     Salaries and wages   50,316     41,093     102,560     81,576  
     Depreciation and amortization   36,561     36,721     75,008     72,993  
     Professional fees   19,026     10,783     37,735     57,108  
     Operating tax expenses   10,985     54     27,214     125  
     Selling and distribution expenses   1,374     3,786     2,753     10,211  
     Other general and administrative expenses   24,541     25,352     54,854     51,637  
     Bad debt expense   -     23,226     -     68,830  
Total Operating Expenses   142,803     141,015     300,124     342,480  
                         
Loss from Operations   (111,930 )   (136,897 )   (246,227 )   (326,326 )
                         
Other Income                        
     Net interest expense   (46,132 )   (1,085 )   (92,122 )   (598 )
     Other (expense) income, net   3,496     (14 )   (22,561 )   229  
Total Other Expense, Net   (42,636 )   (1,099 )   (114,683 )   (369 )
                         
Loss before Income Taxes   (154,566 )   (137,996 )   (360,910 )   (326,695 )
Income Tax Expense   (162 )   -     (162 )   -  
Net loss   (154,728 )   (137,996 )   (361,072 )   (326,695 )
Net loss attributable to the noncontrolling interest   (29,860 )   (28,160 )   (68,325 )   (53,169 )
Net loss attributable to CYBRDI, INC. AND SUBSIDIARIES $  (124,868 ) $  (109,836 ) $  (292,747 ) $  (273,526 )
                         
Net Loss Per Common Share                        
     Basic and Diluted $  (0.00 ) $  (0.00 ) $  (0.00 ) $  (0.00 )
                         
Weighted Average Number of Shares Outstanding                        
     Basic and Diluted   120,225,323     65,756,567     120,225,323     65,756,567  

See notes to consolidated financial statements.

F-2


CYBRDI INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)

    Six Months Ended     Six Months Ended  
    June 30, 2012     June 30, 2011  
             
CASH FLOWS FROM OPERATING ACTIVITIES            
     Net Loss $  (292,747 ) $  (273,526 )
     Adjustments to Reconcile Net Loss to Net Cash            
       Provided by Operating Activities:            
             Depreciation and amortization   125,081     135,345  
             Bad debt expense   -     68,830  
             Minority interest   (68,325 )   (53,169 )
     Changes in Operating Assets and Liabilities:            
             Accounts receivable   (3,142 )   -  
             Inventories   122,276     (15,636 )
             Other receivable and prepaid expenses   1,189     (3,365 )
             Accounts payable and other current liabilities   93,345     81,043  
             Deferred revenue   10,378     -  
             Customer deposits   (100,883 )   906  
     Net Cash Used in Operating Activities   (112,828 )   (59,572 )
             
CASH FLOWS FROM INVESTING ACTIVITIES            
             Advance for loan to affiliated companies   (5,845 )   (38,480 )
             Purchase of property, plant, and equipment   (190 )   (46,523 )
             Payments for construction in progress   (62,077 )   (87,100 )
     Net Cash Used in Investing Activities   (68,112 )   (172,103 )
             
CASH FLOWS FROM FINANCING ACTIVITIES            
             Proceeds from loans from related companies   50,635     36,710  
             Proceeds from shareholders/officers   104,273     122,469  
             Repayments of loan from shareholders/officers   (253,173 )   -  
     Net Cash (Used in) Provided by Financing Activities   (98,265 )   159,179  
             
NET DECREASE IN CASH & CASH EQUIVALENTS   (279,205 )   (72,496 )
EFFECT OF EXCHANGE RATE CHANGE ON CASH & CASH EQUIVALENTS   (6,351 )   11,684  
CASH & CASH EQUIVALENTS, BEGINNING BALANCE   781,048     585,020  
             
CASH & CASH EQUIVALENTS, ENDING BALANCE $  495,492     524,208  
             
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION            
             Interest paid $  75,031     86,084  
             Income taxes paid $  -     -  

See notes to consolidated financial statements.

F-3


CYBRDI, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE A - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

1. Interim Financial Statements

The unaudited consolidated financial statements of Cybrdi Inc. and subsidiaries have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and pursuant to the requirements for reporting on Form 10-Q. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. However, the information included in these interim financial statements reflects all adjustments (consisting solely of normal recurring adjustments) which are, in the opinion of management, necessary for the fair presentation of the consolidated financial position and the consolidated results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full year. The consolidated balance sheet information as of December 31, 2011 was derived from the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K. These interim financial statements should be read in conjunction with that report. Certain comparative amounts have been reclassified to conform to the current period's presentation.

The consolidated financial statements include the accounts of Cybrdi, Inc. and its wholly-owned subsidiaries and joint ventures. All material intercompany balances and transactions have been eliminated.

2. Description of Business

Cybrdi, Inc. (f/k/a Certron Corporation) (the “Company” or “Cybrdi”) was incorporated on August 1, 1966, under the laws of the State of California. Until around June 2004, the Company’s business consisted of the distribution of magnetic media products, primarily blank audio and video cassettes. Due to continuing intense price competition and technological changes in the marketplace for its products, the Company lost its remaining significant customers and disposed of or wrote off its remaining inventory. As a result of these occurrences, the Company concluded that its audio and videotape businesses were no longer viable and some of its product lines were obsolete.

On February 10, 2005, the Company, through a wholly-owned subsidiary, acquired all the ownership interest in Cybrdi, Inc., a privately held company incorporated in the State of Maryland ("Cybrdi Maryland"). As a result of the ownership interests of the former shareholders of Cybrdi Maryland, for financial statement reporting purposes, the transaction was treated as a reverse acquisition, with Cybrdi Maryland deemed the accounting acquirer and Certron Corporation deemed the accounting acquiree. Historical information of the surviving company is that of Cybrdi Maryland.

Cybrdi Maryland was established in 2001 to acquire an interest in biogenetic products commercialization and related services entities in Asia. On March 5, 2003, Cybrdi Maryland acquired an 80% interest in Shaanxi Chao Ying Biotechnology Co., Ltd. (“Chaoying Biotech”), a sino-foreign equity joint venture established in July 2000 in the People's Republic of China (“PRC”), through the exchange of 99% of the Company’s shares to the existing shareholders of Chaoying Biotech. For financial statement reporting purposes, the merger was treated as a reverse acquisition, with Chaoying Biotech deemed the accounting acquirer and Cybrdi Maryland deemed the accounting acquiree.

F-4
 


Chaoying Biotech is a sino-foreign equity joint venture between Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd. (the “Chinese Partner”, a PRC corporation) and Immuno-Onco Genomics Inc. (the “Foreign Partner”, a USA corporation). The joint venture agreement has a 15 year operating period starting from its formation in July 2000 and it may be extended upon mutual consent. The principal activities of Chaoying Biotech are research, manufacture and sale of various high-quality tissue arrays and the related services in the PRC.

Most of the Company’s activities are conducted through Chaoying Biotech. Chaoying Biotech, with its principal operations located in China, aims to take advantage of China's abundant scientific talent, low wage rates, less stringent biogenetic regulation, and the huge genetic population as it introduces its growing list of tissue micro array products.

On February 10, 2005, the Company completed the merger with Cybrdi Maryland and changed its name to Cybrdi, Inc.

On July 26 , 2007, Chaoying Biotech entered into an acquisition agreement with its Chinese partner, which is a principal shareholder of the company, Mr. Bai, the Company’s chief executive officer and a director is also a principal of its Chinese partner.

On July 28,2007, Chaoying Biotech invested RMB15 millions (equivalent to US$1,983,078) to acquire an 83.33% equity ownership of Shandong Chaoying Culture and Entertainment Co., Ltd. (“SD Chaoying”) from its Chinese partner, SD Chaoying is a corporation organized in Shandong Province P.R.China. On September 5, 2007, Shandong Commercial government had approved this acquisition and the ownership title of SD Chaoying had been transferred to Chaoying Biotech from its Chinese partner. The future business of SD Chaoying will primarily focus on culture and entertainment, including spa activities, cosmetic and personal care, body building, gambling, catering, and lodging, etc. SD Chaoying will have a specific emphasis on casino gambling, which has been approved by Shandong Administration for Civil Affairs. As of December 31, 2009, SD Chaoying had substantially completed the construction of two residential buildings and had recognized revenue from sales of housing for 2009. The main structure of the commercial entertainment center has also been completed, except for the exterior, rooftop, the surrounding supporting projects and the community landscaping, which are expected to be completed in 2012 prior to the commencement of operations by merchant tenants if we can obtain an estimated $2.8 million to complete construction.

On March 10, 2007 the Company entered into a Sales Agency Agreement with BioMax, Ltd., a reseller located in the United States.

On April 29, 2011, Chaoying Biotech invested $154,732 (equivalent to RMB 1 million) to restore the operation of the Institute of Shaanxi Chaoying Clinical Pathology (“IOSCCP”), a wholly-owned subsidiary established on July 31, 2003, whose main business includes pathology research and consulting, consulting and diagnostic clinical pathology and pathology-related research and development of new technologies, and basic training in pathology. Its sole shareholder has been Chaoying Biotech. However, Chaoying Biotech withdrew the original investment from IOSCCP in September 2007 as we believed that both internal and external conditions of IOSCCP were not mature at that time. In light of foreseeable benefits and new business opportunities for this entity, we resumed its business and re-invested $154,732 (equivalent to RMB 1 million) in it in April 2011.

F-5
 


3. Going Concern

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred significant losses and has not demonstrated the ability to generate sufficient cash flows from operations to satisfy its liabilities and sustain operations. The Company had an accumulated deficit of $2,740,390 and $2,447,643 as of June 30, 2012 and December 31, 2011, including net losses of $292,747 and $273,526 for the six months ended June 30, 2012 and 2011, respectively. In addition, current liabilities exceeded current assets by $3,211,515 and $2,931,175 at June 30, 2012 and December 31, 2011, respectively. These matters raise substantial doubt about the Company’s ability to continue as a going concern.

The Company finances its operations primarily through short-term bank borrowings and advances from related parties and/or officers/shareholders. In order to complete the construction of SD Chaoying cultural and entertainment center, approximately $3.0 million (equivalent to RMB 19 million) of capital is expected to be needed. The Company, taking into account the available banking facilities, internal financial resource, and supports from related companies, believes it has sufficient working capital to meet its present obligation for at least the next twelve months. Management is taking actions to address the company's financial condition and deteriorating liquidity position. The following sets forth management’s plans for dealing with the adverse effects of the conditions:

(a) Sale of housing inventories: Proceeds to be received from the sale of the remaining housing of the two completed residential buildings are expected to amount to approximately $693,000.

(b) Rental and management fee revenue from the cultural and entertainment center: Annual rental revenue is estimated to be approximately $650,000 per year. Management fee revenue will be charged to commercial tenants at 3% of annual gross revenue. As of June 30, 2012, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.

(c) Additional advances from related companies and affiliates: Mr. Bai, our Chief Executive Officer, advanced $55,974 to the Company in the current period to finance operations and the costs to maintain the Company’s public status in the U.S. In addition, Shaanxi Chaoying Beauty & Cosmetics Group, which is also an affiliate, is anticipated to provide up to approximately $791,000 (equivalent to RMB 5 million) of capital to support operations. Shaanxi Chaoying Beauty & Cosmetics Group advanced $12,660 for the current quarter period to the Company to finance its operations.

The Company may require additional funds and may seek to raise such funds though public and private financings or from other sources. There is no assurance that management’s plans will be realized or the additional financing will be available at all or that, if available, such financing will be obtainable on terms favorable to the Company or that any additional financing will not be dilutive. The consolidated financial statements do not include any adjustments that might result from the outcome of those uncertainties.

F-6
 


4. Use of Estimates:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

5. Revenue Recognition

Revenue represents the invoiced value of goods sold recognized upon the delivery of goods to customers and service income is recognized when services are provided. Deferred revenue represents the undelivered portion of invoiced value of goods sold to customers. Sales transactions not meeting all the conditions of the full accrual method are accounted for using the deposit method of accounting. Under the deposit method, all costs are capitalized as incurred, and payments received from the buyer are recorded as customer deposits.

6. Reverse Merger

On February 10, 2005, (the "Closing Date") the Company closed on an Agreement and Plan of Merger (the "Agreement") among Certron Corporation (“Certron”), a California corporation, Certron Acquisition Corp., a Maryland corporation and a wholly-owned subsidiary of Certron ("Acquisition Sub"), and Cybrdi, Inc., a Maryland corporation (“Cybrdi – Maryland”) relating to the acquisition by Certron of all of the issued and outstanding capital stock of Cybrdi -Maryland in exchange for shares of common stock of Certron that will aggregate approximately 93.8% of the issued and outstanding common stock of Certron. Pursuant to the terms of the Agreement, at the Closing Date (a) Acquisition Sub has been merged with and into Cybrdi - Maryland, with Cybrdi - Maryland being the surviving corporation, (b) the common stock of Cybrdi-Maryland has been cancelled and converted into the right to receive shares of the common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of the Certron’s common stock, and (c) each share of the common stock of Acquisition Sub has been converted in to and become one share of the common stock of Cybrdi-Maryland. The share exchange has been accounted for as a reverse merger under the purchase method of accounting. Accordingly, Cybrdi, Inc. will be treated as the continuing entity for accounting purposes and the historical financial statements presented will be those of Cybrdi, Inc.

In connection with the Agreement, on February 10, 2005, the Company amended its articles of incorporation to authorize the issuance of 150 million shares of common stock no par value and 500,000 shares of preferred stock, $1.00 par value per share, none of which are issued or outstanding.

Concurrent with the filing of the Articles of Merger, all of the Company then existing officers and directors tendered their resignation and Yanbiao Bai was appointed as its Chairman of the Board of Directors. Mr. Bai then nominated the balance of the Board of Directors.

F-7


7. Income Taxes

Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to the differences between the basis of assets and liabilities for financial and income tax reporting. The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes also are recognized for operating losses that are available to offset future income taxes.

8. Contingencies

Currently we are involved in disputes, litigation and other legal proceedings. We prosecute and defend these matters aggressively. However, there are many uncertainties associated with any litigation, and we cannot assure you that these actions or other third party claims against us will be resolved without costly litigation and/or substantial settlement charges. We record a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements and (ii) the range of loss can be reasonably estimated. However, the actual liability in any such disputes or litigation may be materially different from our estimates, which could result in the need to record additional costs.

9. Recent Accounting Pronouncements

The Company has adopted all recently issued accounting pronouncements. The adoption of the accounting pronouncements, including those not yet effective, is not anticipated to have a material effect on the financial position or results of operations of the Company.

NOTE B – ASSETS

The June 30, 2012 consolidated balance sheet included total current assets of $1,583,640 and non-current assets of $8,730,312. Of these amounts, $495,492 in cash and equivalents is planned for funding current operations and for future business expansion.

Other current assets also included accounts receivable, inventories, due from related companies, other receivables and prepaid expenses, and advance to suppliers. Inventories are mainly finished goods. Other components of inventories include raw materials, finished goods, and housing inventories. Inventories are stated at the lower of cost or market. Cost of raw materials is determined on the basis of first in first out method (“FIFO”). Finished goods are determined on the weighted average basis and are comprised of direct materials, direct labor, and an appropriate proportion of overhead.

F-8
 


The other primary assets included in current assets are loans to an unaffiliated company, QuanYe Security Co., Ltd (“QuanYe”), an unrelated People’s Republic of China (“PRC”) registered company located in Xian PRC. QuanYe is engaged in the pawnshop business and their primary business is offering alternative financing to small, local companies. According to the loan agreement, QuanYe had received loans from Chaoying Biotech for a total amount of RMB 29.3Million (equivalent to $4,652,640) since January 2006. A remaining balance of RMB 7.3 million (equivalent to $1,159,190) was extended to and expired on March 24, 2008. As of June 30, 2012 and December 31, 2011, the principal balance and interest receivable for this loan had been reduced to $0, net of allowance of $94,444 and $180,258 for doubtful principal balance and interest receivable, respectively. The interest rate for these loans initially was initially 8% per year, and subsequently reduced to 5% since October 9, 2006.

Included in non-current assets are property, plant and equipment, construction-in-progress and intangible assets. Property, plant and equipment mainly consist of building, office equipments, motor vehicles, leasehold improvement, software-website, and machinery used for product manufacturing located in the People’s Republic of China (“PRC”). Depreciation on property, plant and equipment is computed using the straight-line method over the estimated useful life of the assets. The majority of the assets have estimated useful lives of 10 years. Building and office equipment have estimated useful lives of 20 and 5 years, respectively. The “construction in progress” in the amount of $6,781,274 mainly consisted of land under development and construction of the entertainment, culture, and casino facility in Shandong Province, which will be transferred to fixed assets in SD Chaoying when construction is completed. As of June 30, 2012, construction-in-progress of $4.32 million and land use rights of $3.15 million of SD Chaoying were collateralized under a short-term loan from Changle Rural Credit Union. For the $3.15 million land use rights, $2.49 million was classified under construction-in-progress for the commercial property and the remaining $0.66 million was classified under intangible assets subject to amortization. Intangible assets included a tissue chip patent at Chaoying Biotech and $0.66 million of land use rights being put in operation for the partial completed commercial property at SD Chaoying. Effective January 1, 2002, with the adoption of the accounting guidance for Goodwill and Other Intangible Assets, intangible assets with a definite life are amortized on a straight-line basis. The patent is being amortized over its estimated life of 10 years. The land use rights classified in intangible asset is being amortized over its estimated life of 36.9 years through the maturity of the land use rights for commercial use on November 6, 2047.

F-9


NOTE C - LIABILITIES

As of June 30, 2012, the balance sheet included total liabilities of $5,635,305, which consisted of current liabilities of $4,795,155 and construction payable of $840,150. Included in the current liabilities was a short-term loan of $1,495,357 (equivalent to RMB 9.5 million) from Changle Rural Credit Union, which is a bank located in Shandong Province of the PRC. The original term of the loan was from August 25, 2009 to August 24, 2010 with an interest rate of 7.965% per annum. In August 2011, the Company renewed this short-term loan with the same amount of $1,495,357 (equivalent to RMB 9.5 million) with Changle Rural Credit Union. The term of the renewal loan started from August 31, 2011 with a maturity date of August 20, 2012. The adjustable interest rate is a rate per annum equal to the Prime Rate plus 50% of prime rate. The prime rate is based on six-month-to-one-year loan interest rate released by The People's Bank of China. The interest rate for the short-term loan was 9.465% as of June 30, 2012. This short-term loan had been secured by the Company’s land use right and construction-in-progress of SD Chaoying with a book value of $3.15 million (equivalent to RMB 20.03 million) and $4.32 million (equivalent to RMB 27.45 million) as of June 30, 2012, respectively. For the $3.15 million land use rights, $2.49 million was classified under construction-in-progress for the commercial property and the remaining $0.66 million was classified under intangible assets subject to amortization. The Company currently is in process of negotiating with Changle Rural Credit Union to renew the bank loan upon the maturity date on August 20, 2012. Additionally, there is another short-term loan of $157,406 (equivalent to RMB 1.0 million) from Mr. Fengguo Liu, an unrelated party. Also included in the current liabilities was $1,745,801 of loans from related companies, including Xi’an Yanfeng Biotechnology Co., Ltd., Shaanxi Yanfeng Real Estate Co. Ltd, Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd and the stockholders who are also the Company’s officers. These entities were related to the Company through common ownership and principal officers. These loans are non-interest bearing and have no set repayment terms.

NOTE D – STOCKHOLDERS’ EQUITY

As a result of the reverse merger (see Note A item 6), the common stock of Cybrdi-Maryland has been cancelled and converted into shares of common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of Certron’s common stock to the Cybrdi shareholders. As of June 30, 2012 and December 31, 2011, the Company had 120,225,323 and 120,225,323 shares issued and outstanding, respectively.

As of June 30, 2012, the balance sheet included total equity of $4,678,647, of which $1,112,330 was for non-controlling interest, representing 20% minority interest in Chaoying Biotech and 16.67% minority interest in SD Chaoying.

On January 15, 2010, the Board of Directors adopted resolutions that authorized incentive compensation to key management of the Company for services it has provided to the Company. As set forth in the Board of Directors’ resolution dated January 15, 2010, the incentive compensation shall be paid by the issuance of 12,000,000 shares of common stock of the Company to Mr. Yanbiao Bai, Chief Executive Officer and President of the Company, and 3,300,000 shares of common stock of the Company to Ms. Xue Bu, the former Chief Financial and Operating Officer of the Company. Compensation cost of $306,000 was recorded during the first quarter of 2010 at $0.02 per share, the market price of the Company’s common stock on January 15, 2010, the grant date.

F-10
 


On June 30, 2011, the Company entered into a written Debt Conversion Agreement with Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd. (a related party), Shaanxi NuoQi Healthfood Co., Ltd. (a related party), and Mr. Yanbiao Bai, Chairman and CEO of the Company. In the Agreement, the Company agreed to repay a total of $605,723 (RMB 3,920,000) debt due to Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd. by issuing the Company’s common stock. Simultaneously upon the execution of the repayment, Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd. agreed to transfer to Mr. Yanbiao Bai the number of shares to be issued through the debt repayment. The number of shares transferred to Mr. Yanbiao Bai was further offset by a number of shares equivalent to $169,973 (RMB 1,100,000) due by Shaanxi NuoQi Health Food Co., Ltd., a company wholly-controlled by Ms. Xue Bu, the spouse of Mr. Yanbiao Bai and former COO and Director of the Company, to offset its debt due to the Company. The Agreement was approved by the Company’s Board of Directors on June 30, 2011. As a result of the debt conversion and offset, the number of shares of common stock issued to Mr. Yanbiao Bai was 54,468,756 shares, which was determined based on the closing price of $0.008 per share on June 30, 2011. The share issuance for repayment of debt as agreed upon and approved was executed on August 17, 2011.

NOTE E – INCOME TAXES

Under the Enterprise Income Tax (“EIT”) of the PRC, prior to 2007, Chinese enterprises are generally subject to an income tax at an effective rate of 33% (30% statutory income taxes plus 3% local income taxes) on income reported in the statutory financial statements after appropriate tax adjustments, unless the enterprise is located in a specially designated region for which more favorable effective tax rates are applicable. Beginning on January 1, 2008, the new EIT law has replaced the existing laws for Domestic Enterprises (“DEs”) and Foreign Invested Enterprises (“FIEs”). The new standard EIT rate of 25% will replace the 33% rate previously applicable to both DES and FIEs. The two year tax exemption, six year 50% tax reduction and tax holiday for production-oriented FIEs will be eliminated. According to the Western Developing Plan implemented by the PRC Government, Chaoying Biotech is entitled to a 50% reduction in EIT of preferential policy, but not less than 15%. As a result, Chaoying Biotech’s effective EIT tax rate has been 15% since 2008.

The Company’s income tax expense includes U.S. and PRC income taxes. There were no U.S. current taxes for the six months ended June 30, 2012 according to net loss incurred in the U.S. entity, which will not be anticipated to have any tax benefit in the future since no revenue is expected to be generated in the U.S as a result of discontinuing the U.S. operating company in Maryland in October 2007. There was $162 of PRC current income taxes accrued for the six months ended June 30, 2012 in SD Chaoying.

NOTE F – CONTINGENCIES AND LITIGATION LIABILITIES

On June 7, 2011, Weifang Shili Hesin Engineering Equipment Co., Ltd. (the “Plaintiff”) filed a complaint against SD Chaoying at the Basic People's Court of Changle County in Shandong Province, China, for alleged damages caused by SD Chaoying for not performing appropriately and completely the obligations in accordance with the agreement signed by both parties on April 28, 2011. Pursuant to the agreement, SD Chaoying agreed to transfer: (1) the rights of development, construction, and land of the #1 and #2 residential buildings for RMB 7.6 million, or $1,207,518, and (2) the 12 unsold residential units in the #3 and #4 residential buildings at a price as agreed upon. As of June 30, 2012, the Plaintiff paid $94,444 (equivalent to RMB 600,000) deposit as agreed upon, and prepaid $184,183 (equivalent to RMB 1,170,114), both of which were recorded as Other Payables under current liabilities. Plaintiff was seeking for the discharge of the original agreement signed, the return of prepayment of $184,183 (equivalent to RMB 1,170,114), repayment of the deposit plus 100% penalty, totaling $188,888 (equivalent to RMB 1,200,000), and for attorneys’ fees and costs. The Company disputed Plaintiff’s claim for a land use right certificate of underlying construction base of the #1 and #2 residential buildings, which certificate was inseparable from other part of the land and was not specifically stated in the agreement. The Company also disputed Plaintiff’s entitlement to the amounts claimed and instructed the Company’s legal counsel to contest the action, while concurrently pursuing opportunities for reasonable settlement. The case went to trial on July 7, 2011. On November 15, 2011, the Basic People's Court of Changle County pronounced its judgment against Plaintiff and that SD Chaoying had no liability. However, the plaintiff still has a right to appeal the judgment to the Intermediate Court in Weifang City, Shandong Province, China within 15 days after receiving verdict from the court. The verdict was released by the court on March 23, 2012. An appeal was filed on April 6, 2012 by the Plaintiff after the verdict was released. The court session for the appeal was held on May 16, 2012 at Intermediate Court in Weifang City, Shandong Province, China. As of the date of this report on Form 10-Q, the verdict of the appeal has not yet released by the intermediate court in Weifang City. As of June 30, 2012, the Company has recorded an estimate of loss contingencies of $37,700 under accrued expenses, which was estimated by the Company’s legal counsel to be reasonable. The Company recorded the estimated liability and loss contingencies according to FASB ASC 450-20-25-2 under Topic 450, “Contingencies Loss Contingencies Recognition”.

F-11
 


Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operation

The following discussion and analysis should be read in conjunction with the company’s Financial Statements and Notes there to appearing elsewhere in this Report on Form 10-Q as well as the company’s other SEC filings, including our annual report on Form 10-K for the year ended December 31, 2011.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements in this quarterly report on Form 10-Q contain or may contain forward-looking statements that are subject to known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements were based on various factors and were derived utilizing numerous assumptions and other factors that could cause its actual results to differ materially from those in the forward-looking statements. These factors include, but are not limited to, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk, U.S. and global competition, and other factors. Most of these factors are difficult to predict accurately and are generally beyond its control. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. Readers should carefully review this quarterly report in its entirety, including but not limited to its financial statements and the notes thereto. Except for its ongoing obligations to disclose material information under the Federal securities laws, the Company undertakes no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events. For any forward-looking statements contained in any document, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. This report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws. These include statements about our expectations, beliefs, intentions or strategies for the future, which we indicate by words or phrases such as "anticipate," "expect," "intend," "plan," "will," "we believe," "Cybrdi believes," "management believes" and similar language. The forward-looking statements are based on the current expectations of Cybrdi and are subject to certain risks, uncertainties and assumptions, including those set forth in the discussion under "Description of Business" and "Management's Discussion and Analysis." The actual results may differ materially from results anticipated in these forward-looking statements. We base the forward-looking statements on information currently available to us, and we assume no obligation to update them.

5


PLAN OF OPERATIONS

The Company focuses on biogenetics commercialization and healthcare product applications. The Company’s primary business includes sales of tissue microarray products and services. Tissue chips, also called micro tissue arrays, provide high-throughput molecular profiling and parallel analysis of biological and molecular characteristics for hundreds of pathologically controlled tissue specimens. Tissue arrays can provide rapid and cost-effective localization and evaluation of proteins, RNA, or DNA molecules, which is particularly useful for functioning genomic studies. Cybrdi manufactures both human and animal tissue microarray for a wide variety of scientific uses, including drug discovery and development purposes.

The Company’s business strategy and focus in the near future include

  • Enhancing R&D in TMAs and technical service

  • Expanding its product portfolio and virtual tissue array data bank (vTMAB)

  • Launching the health diagnosis kit for obesity and skin disease

  • Participating in the culture and entertainment field

With its sophisticated research in genes, the Company can provide the professional health diagnostic service for its customers. The Company can check the reasons for obesity and other skin diseases like freckles by its genetic analysis, which offers more accurate and specialized diagnosis than other similar services in the current market. Such information can be utilized to guide customers to set up the right health or fitness program. At present, the Company provide genetic tests for the mechanism of obesity or skin diseases.

The Company will also explore other business development opportunities that can leverage its sales platform and relationship with affiliated companies. Until such time as the Company can identify attractive marketing opportunities, the Company will loan available cash on a short term unsecured basis to non-affiliated third parties in order to generate interest income.

Commencing in the third quarter of 2007, the Company developed a new gene detective tissue array, called New Kits, and began to offer them to its customers.

On July 28, 2007, the Company acquired an 83.33% equity ownership of SD Chaoying from its Chinese partner, which will be primarily engaged in developing and operating culture and entertainment business. The culture and entertainment business will consist primarily of a spa activities, cosmetic personal care, hotel and casino. Its Chinese partner is a principal shareholder of the Company and Mr. Bai, its chief executive officer and a director is also a principal of its Chinese partner. SD Chaoying began constructing the facility in September 2007. The total useable land and net building area for the project consists of approximately 50,000 and 33,000 square meters, respectively of which 52% will constitute property for business use and 48% for residential use. As of June 30, 2012, SD Chaoying had substantially completed the construction of two residential buildings and had recognized revenue from sales of housing units from these buildings. The project includes four multi-family residential buildings (about 14,188 square meters). Approximately 20.88% of the cultural and entertainment part of the facility opened in January 2011 and the balance remains under construction, but is expected to be completed in 2012 prior to the commencement of operations by merchant tenants. SD Chaoying intends to focus on Spa activities, cosmetic personal care, hotel and casino gambling, which has been approved by Shandong Administration for Civil Affairs. In January 2011, SD Chaoying entered into a verbal agreement with Dongshan Victoria Spring Hotel (“Victoria”) allowing Victoria to manage and operate the SPA business at the completed section of the cultural and entertainment facility. SD Chaoying agreed not to charge fees from Victoria during the first year of operation as the trial period. SD Chaoiying and Weifang Shili Hesin Engineering Equipment Co., Ltd. executed an agreement on April 28, 2011, pursuant to which agreement, SD Chaoying agreed to transfer: (1) the rights of development, construction, and land of the #1 and #2 residential buildings for RMB 7.6 million, or approximately $1,206,800, and (2) the 12 unsold residential units in the #3 and #4 residential buildings at a price as agreed upon. As of June 30, 2012, the land use right and construction-in-progress with total book value of $7.47 million (equivalent to RMB 47.5 million) of SD Chaoying were collateralized under the short-term loan of $1,495,357 (equivalent to RMB 9.5 million) from Changle Rural Credit Union.

6


RESULTS OF OPERATIONS

FOR THE THREE MONTHS ENDED JUNE 30, 2012 COMPARED TO THREE MONTHS ENDED JUNE 30, 2011

CONSOLIDATED STATEMENTS OF OPERATIONS                    
                         
                         
    Three Months Ended     Three Months Ended              
    June 30, 2012     June 30, 2011   $ Change     % Change  
Revenue                        
     Housing $ -   $  -     -     0.0%  
     Commercial rental   -     -     -     0.0%  
     Tissue array products   112,407     123,419     (11,012 )   -8.9%  
          Total revenue   112,407     123,419     (11,012 )   -8.9%  
Cost of Sales                        
     Housing   -     -           0.0%  
     Commercial rental   16,414     17,125     (711 )   -4.2%  
     Tissue array products   65,120     102,176     (37,056 )   -36.3%  
          Total cost of sales   81,534     119,301     (37,767 )   -31.7%  
                         
Gross Profit   30,873     4,118     26,755     649.7%  
                         
Operating Expenses:                        
     Salaries and wages   50,316     41,093     9,223     22.4%  
     Depreciation and amortization   36,561     36,721     (160 )   -0.4%  
     Professional fees   19,026     10,783     8,243     76.4%  
     Operating tax expenses   10,985     54     10,931     20242.6%  
     Selling and distribution expenses   1,374     3,786     (2,412 )   -63.7%  
     Other general and administrative expenses   24,541     25,352     (811 )   -3.2%  
     Bad debt expense   -     23,226     (23,226 )   -100.0%  
Total Operating Expenses   142,803     141,015     1,788     1.3%  
                         
Loss from Operations   (111,930 )   (136,897 )   24,967     -18.2%  
                         
Other Income                        
     Net interest expense   (46,132 )   (1,085 )   (45,047 )   4151.8%  
     Other (expense) income, net   3,496     (14 )   3,510     -25071.4%  
Total Other Expense, Net   (42,636 )   (1,099 )   (41,537 )   3779.5%  
                         
Loss before Income Taxes   (154,566 )   (137,996 )   (16,570 )   12.0%  
Income Tax Expense   (162 )   -     (162 )   100.0%  
Net loss   (154,728 )   (137,996 )   (16,732 )   12.1%  
Net loss attributable to the noncontrolling interest   (29,860 )   (28,160 )   (1,700 )   6.0%  
Net loss attributable to CYBRDI, INC. AND SUBSIDIARIES $  (124,868 ) $  (109,836 )   (15,032 )   13.7%  
                         

Net Sales

Cybrdi mainly generates two categories of revenues, including sales of tissue chip & kits products and residential housing. The net sales decreased $11,012 to $112,407 for the three months ended June 30, 2012 from $123,419 for the three months ended June 30, 2011, a decrease of 8.9% .

Tissue Chip & Kit Products: The net sales decreased $11,012 to $112,407 for the three months ended June 30, 2012 as compared to $123,419 for the three months ended June 30, 2011, a decrease of 8.9% . The decrease in net sales of tissue chip & kit product was primarily due to the decrease in the export sales revenues which accounted for approximately 83.0% of total tissue product sales revenues for the current period. Export sales revenues decreased $21,119 to $93,306 for the three months ended June 30, 2012 , as compared to $114,425 for the three months ended June 30, 2011, a decrease of 18.5% . The sales revenues generated from export sales now are subject to value added tax (VAT) according to PRC tax regulation, whereas the VAT imposed by PRC tax bureau was absorbed by the Company without charging to the customers. Currently, our sole domestic sales representative in China is Xi’an AiLiNa Biotechnology Co., Ltd., and the only overseas sales representative is Biomax. We mainly distribute our products through these two sales representatives.

Housing: SD Chaoying completed the construction of the two six-story multi-family residential buildings with a total of 72 housing units in 2009, 9 and 37 of which units qualified as being recognized as sales revenue aggregating $296,521 and $1,010,632 for the years ended December 31, 2010 and 2009. An additional two residential units were sold in 2011. Another five residential units were qualified as being recognized as sales revenues during the first quarter of 2012. There was no sales from housing in the quarter ended June 30, 2012. Since SD Chaoying is required to continue its involvement with the property after the sale, including installations of utility systems, improvements and amenities, and community landscaping, profit from the sale was recognized using the percentage of completion method as required by ASC Topic 360-20, “Property, Plant, and Equipment – Real Estate Sales”.

7


Gross Margin

Gross margin as a percentage of sales increased to 27.5% for the three months ended June 30, 2012 from 3.3% for the three months ended June 30, 2011.

Tissue Chip & Kit Products: The gross margin of the Tissue Chip & Kit Products division increased to 42.1% for the second quarter of 2012 compared to 17.2% for the same period in 2011. The increase in gross margin for the three months ended June 30, 2012 was mainly because more technical services were rendered to customers in the domestic market and the service incomes were charged to the selling price of products.

Housing: There was no gross profit of the Housing division for the three months ended June 30, 2012 and for the three months ended June 30, 2011, mainly because no housing unit was sold and qualified as being recognized as sales revenues during these quarters.

In addition, the commencement of the business in the commercial property segment has not generated revenue but has incurred costs directly associated with the business.

Operating Expenses

The Company’s operating expenses increased slightly by $1,788 to $142,803 for the three months ended June 30, 2012 from $141,015 for the three months ended June 30, 2011, an increase of 1.3% . The increase was primarily due to the increase in operating tax expense, salaries and wages, and professional fees, partially offset by the decrease of bad debt expense for the three months ended June 30, 2012. Operating tax expense increased from $54 for the second quarter in 2011 to $10,985 for the second quarter of 2012. Salaries and wages also increased from $41,093 for the second quarter in 2011 to $50,316 for the second quarter of 2012. Also professional fees increased by $8,243 from $10,783 for the second quarter in 2011 to $19,026 for the same period this year. There was no bad debt expense assessed for the three months ended June 30, 2012, whereas the bad debt expense was $23,226 for the same period last year.

Other Income (Expense)

Other income decreased by $41,537 to $(42,636) for the three months ended June 30, 2012 as compared to $(1,099) for the three months ended June 30, 2011, a decrease of 3779.5% . The decrease was primarily due to the interest expense of $47,410 for the three months ended June 30, 2012 that was not subject to capitalization due to suspension of the construction of the entertainment center, whereas interest expense was capitalized and recorded as construction-in-progress in the second quarter of 2011.

Income Taxes

The Company did not record U.S. current income tax for the three months ended June 30, 2012, and 2011, since there was no taxable income during these periods. There was $162 of PRC current income taxes accrued for the three months ended June 30, 2012 in SD Chaoying.

Net Loss

As a result of the above factors, our net loss before minority interests increased $16,732, or 12.1%, from $137,996 for the three months ended June 30, 2011 to $154,728 for the three months ended June 30, 2012.

8


FOR THE SIX MONTHS ENDED JUNE 30, 2012 COMPARED TO SIX MONTHS ENDED JUNE 30, 2011

CONSOLIDATED STATEMENTS OF OPERATIONS

    Six Months Ended     Six Months Ended              
    June 30, 2012     June 30, 2011   $ Change     % Change  
Revenue                        
   Housing $  142,200   $  -     142,200     100.0%  
   Commercial rental   -     -     -     0.0%  
   Tissue array products   212,317     237,230     (24,913 )   -10.5%  
          Total revenue   354,517     237,230     117,287     49.4%  
Cost of Sales                        
   Housing   123,306     -     123,306     100.0%  
   Commercial rental   32,880     31,752     1,128     3.6%  
   Tissue array products   144,434     189,324     (44,890 )   -23.7%  
          Total cost of sales   300,620     221,076     79,544     36.0%  
                         
Gross Profit   53,897     16,154     37,743     233.6%  
                         
Operating Expenses:                        
   Salaries and wages   102,560     81,576     20,984     25.7%  
   Depreciation and amortization   75,008     72,993     2,015     2.8%  
   Professional fees   37,735     57,108     (19,373 )   -33.9%  
   Operating tax expenses   27,214     125     27,089     21671.2%  
   Selling and distribution expenses   2,753     10,211     (7,458 )   -73.0%  
   Other general and administrative expenses   54,854     51,637     3,217     6.2%  
   Bad debt expense   -     68,830     (68,830 )   -100.0%  
Total Operating Expenses   300,124     342,480     (42,356 )   -12.4%  
                         
Loss from Operations   (246,227 )   (326,326 )   80,099     -24.5%  
                         
Other Income                        
   Net interest expense   (92,122 )   (598 )   (91,524 )   15305.0%  
   Other (expense) income, net   (22,561 )   229     (22,790 )   -9952.0%  
Total Other Expense, Net   (114,683 )   (369 )   (114,314 )   30979.4%  
                         
Loss before Income Taxes   (360,910 )   (326,695 )   (34,215 )   10.5%  
Income Tax Expense   (162 )   -     (162 )   100.0%  
Net loss   (361,072 )   (326,695 )   (34,377 )   10.5%  
Net loss attributable to the noncontrolling interest   (68,325 )   (53,169 )   (15,156 )   28.5%  
Net loss attributable to CYBRDI, INC. AND SUBSIDIARIES $  (292,747 ) $  (273,526 )   (19,221 )   7.0%  

Net Sales

Cybrdi mainly generates two categories of revenues, including sales of tissue chip & kits products and residential housing. The net sales increased $117,287 to $354,517 for the six months ended June 30, 2012 from $237,230 for the six months ended June 30, 2011, an increase of 49.4 %.

Tissue Chip & Kit Products: The net sales decreased $24,913 to $212,317 for the six months ended June 30, 2012 as compared to $237,230 for the six months ended June 30, 2011, a decrease of 10.5% . The decrease in net sales of tissue chip & kit product was primarily due to the decrease in the export sales revenues which accounted for approximately 85.5% of total tissue product sales revenues for the current period. Export sales revenues decreased $34,953 to $181,463 for the six months ended June 30, 2012 , as compared to $216,416 for the six months ended June 30, 2011, a decrease of 16.2% . The sales revenues generated from export sales now are subject to value added tax (VAT) according to PRC tax regulation, whereas the VAT imposed by PRC tax bureau was absorbed by the Company without charging to the customers. Currently, our sole domestic sales representative in China is Xi’an AiLiNa Biotechnology Co., Ltd., and the only overseas sales representative is Biomax. We mainly distribute our products through these two sales representatives.

9


Housing: SD Chaoying completed the construction of the two six-story multi-family residential buildings with a total of 72 housing units in 2009, 9 and 37 of which units qualified as being recognized as sales revenue aggregating $296,521 and $1,010,632 for the years ended December 31, 2010 and 2009. An additional two residential units were sold in 2011. Another five residential units were qualified as being recognized as sales revenues during the first quarter of 2012. There was no sales from housing in the quarter ended June 30, 2012. Since SD Chaoying is required to continue its involvement with the property after the sale, including installations of utility systems, improvements and amenities, and community landscaping, profit from the sale was recognized using the percentage of completion method as required by ASC Topic 360-20, “Property, Plant, and Equipment – Real Estate Sales”.

Gross Margin

Gross margin as a percentage of sales increased to 15.2% for the six months ended June 30, 2012 from 6.8% for the six months ended June 30, 2011.

Tissue Chip & Kit Products: The gross margin of the Tissue Chip & Kit Products division increased to 32.0% for the six months ended June 30, 2012 compared to 20.2% for the same period in 2011. The increase in gross margin for the six months ended June 30, 2012 was mainly because more technical services were rendered to customers in the domestic market and the service incomes were charged to the selling price of products.

Housing: The gross margin of the housing division increased to 13.3% for the six months ended June 30, 2012 compared to 0% for the same period in 2011. The increase was mainly due to five housing units being sold and qualified as being recognized as sales revenues during the six-month period in 2012.

In addition, the commencement of the business in the commercial property segment has not generated revenue but has incurred costs directly associated with the business.

Operating Expenses

The Company’s operating expenses decreased by $42,356 to $300,124 for the six months ended June 30, 2012 from $342,480 for the six months ended June 30, 2011, a decrease of 12.4% . The decrease in operating expenses was primarily because there was no bad debt expense assessed for the six months ended June 30, 2012. Also professional fees decreased from $57,108 for the six months ended June 30, 2011 to $37,735 for the same period in 2012. The decrease of operating expense for the six-month period this year was partially offset by an increase of $27,089 in operating tax expenses from $125 for the six months ended June 30, 2011 to $27,214 for the six months ended June 30, 2012, and an increase of salaries and wages of $20,984 to $102,560 for the six months ended June 30, 2012 from $81,576 for the same period last year.

Other Income (Expense)

Other income decreased by $114,314 to $(114,683) for the six months ended June 30, 2012 as compared to $(369) for the six months ended June 30, 2011, a decrease of 30979.4% . The decrease was primarily due to the interest expense of $94,020 for the six months ended June 30, 2012 that was not subject to capitalization due to suspension of the construction of the entertainment center, whereas interest expense was capitalized and recorded as construction-in-progress for the same period in 2011.

Income Taxes

The Company did not record U.S. current income tax for the six months ended June 30, 2012, and 2011, since there was no taxable income during these periods. There was $162 of PRC current income taxes accrued for the six months ended June 30, 2012 in SD Chaoying.

Net Loss

As a result of the above factors, our net loss before minority interests increased $34,377, or 10.5%, from $326,695 for the six months ended June 30, 2011 to $361,072 for the six months ended June 30, 2012.

10


LIQUIDITY AND CAPITAL RESOURCES

Operating working capital deficit (total current asset deduct total current liabilities) decreased by $280,340 from $(2,931,175) as of December 31, 2011 to $(3,211,515) as of June 30, 2012. The decrease was primarily due to a decrease of $131,432 in inventories from $1,053,038 as of December 31, 2011 to $921,606 as of June 30, 2012 , an increase of $53,321 in accrued expense from $693,436 as of December 31, 2011 to $746,757 as of June 30, 2012, and an increase of $60,850 in other payables from $366,020 as of December 31, 2011 to $426,870 as of June 30, 2012.

For investing activities, the Company incurred net cash outflow during the six months ended June 30, 2012. The primary reason was due to $62,077 used in the construction in progress of the SD Chaoying project during the six months ended June 30, 2012.

For financing activities, the Company obtained net proceeds of $50,635 and $104,273 from related parties and shareholders/officers of the Company, respectively for the six months ended June 30, 2012, partially offset by the repayments of loan from the Company’s shareholders/officers of $253,173 for the six months ended June 30, 2012.

The Company has a short-term loan in the principal amount of $1,495,357 (equivalent to RMB 9.5 million) with Changle Rural Credit Union. The loan has a maturity date of August 20, 2012. The adjustable interest rate is a rate per annum equal to the prime rate plus 50% of the prime rate. The prime rate is based on six-month-to-one-year loan interest rate released by the People's Bank of China. The interest rate for the short-term loan was 9.465% as of June 30, 2012. This short-term loan had been secured by the Company’s land use right and construction-in-progress of SD Chaoying with a book value of $3.15 million (equivalent to RMB 20.03 million) and $4.32 million (equivalent to RMB 27.45 million) as of June 30, 2012, respectively.  The Company currently is in process of negotiating with Changle Rural Credit Union to renew the bank loan upon the maturity date on August 20, 2012.

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred significant losses and has not demonstrated the ability to generate sufficient cash flows from operations to satisfy its liabilities and sustain operations. The Company had an accumulated deficit of $2,740,390 and $2,447,643 as of June 30, 2012 and December 31, 2011, including net losses of $292,747 and $273,526 for the six months ended June 30, 2012 and 2011, respectively. In addition, current liabilities exceeded current assets by $3,211 515 and $2,931,175 as of June 30, 2012 and December 31, 2011, respectively. These matters raise substantial doubt about the Company’s ability to continue as a going concern.

11


The Company finances its operations primarily through short-term bank borrowings and advances from related parties and/or officers/shareholders. In order to complete the construction of SD Chaoying cultural and entertainment center, approximately $3.0 million (equivalent to RMB 19 million) of capital is expected to be needed. The Company, taking into accounts the available banking facilities, internal financial resource, and supports from related companies, believes it has sufficient working capital to meet its present obligation for at least the next twelve months. Management is taking actions to address the company's financial condition and deteriorating liquidity position. The following sets forth management’s plans for dealing with the adverse effects of the conditions:

(a) Sale of housing inventories: Proceeds to be received from the sale of the remaining housing of the two completed residential buildings are expected to amount to approximately $693,000.

(b) Rental and management fee revenue from the cultural and entertainment center: Annual rental revenue is estimated to be approximately $650,000 per year. Management fee revenue will be charged to commercial tenants at 3% of annual gross revenue. As of June 30, 2012, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.

(c) Additional advances from related companies and affiliates: Mr. Bai, our Chief Executive Officer, advanced $55,974 to the Company in the current period to finance operations and the costs to maintain the Company’s public status in the U.S. In addition, Shaanxi Chaoying Beauty & Cosmetics Group, which is also an affiliate, is anticipated to provide up to approximately $791,000 (equivalent to RMB 5 million) of capital to support operations.

Shaanxi Chaoying Beauty & Cosmetics Group advanced $12,660 for the three months ended June 30, 2012 to the Company to finance its operations.

The Company may require additional funds and may seek to raise such funds though public and private financings or from other sources. There is no assurance that management’s plans will be realized or the additional financing will be available at all or that, if available, such financing will be obtainable on terms favorable to the Company or that any additional financing will not be dilutive. The consolidated financial statements do not include any adjustments that might result from the outcome of those uncertainties.

INFLATION

Inflation has not had a material impact on our business.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements in this quarterly report on Form 10-Q contain or may contain forward-looking statements that are subject to known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements were based on various factors and were derived utilizing numerous assumptions and other factors that could cause its actual results to differ materially from those in the forward-looking statements. These factors include, but are not limited to, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk, U.S. and global competition, and other factors. Most of these factors are difficult to predict accurately and are generally beyond its control. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. Readers should carefully review this quarterly report in its entirety, including but not limited to its financial statements and the notes thereto. Except for its ongoing obligations to disclose material information under the Federal securities laws, the Company undertakes no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events. For any forward-looking statements contained in any document, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.

12


Item 3. Quantitative and Qualitative Disclosures about Market Risk

A smaller reporting company is not required to provide the information required by this Item .

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures. The term “disclosure controls and procedures” (defined in SEC Rule 13a-15(e)) refers to the controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported within required time periods. Under the supervision and with the participation of our management, including our Chief Executive Officer, Yanbiao Bai, and Principal Financial Officer, Yonghong Ren, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report were effective such that the information required to be disclosed by us in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and (ii) accumulated and communicated to our management to allow timely decisions regarding disclosure. A controls system cannot provide absolute assurance, however, that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

Changes in Internal Control Over Financial Reporting. The term “internal control over financial reporting” (defined in SEC Rule 13a-15(f)) refers to the process of a company that is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. During the most recent quarter ended June 30, 2012, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

13


PART II. OTHER INFORMATION

Item 1. Legal Proceedings

On June 6, 2000, we received a notice to inform us that we may have a potential liability from waste disposal in the Casmalia Disposal Site at Santa Barbara County, California. We were given a choice of either signing an agreement that would toll the statute of limitations for eighteen (18) months in order to allow us to resolve any liability with the government without incurring costs associated with being named a defendant in a lawsuit, or becoming an immediate defendant in a lawsuit. We signed the tolling agreement. On November 20, 2001, the tolling agreement was extended for an additional 18 months. On May 20, 2003 the tolling agreement was again extended for an additional 18 months and on November 24, 2004 the tolling agreement was again extended for additional 18 months. On June 29, 2004, we received a proposed settlement from the EPA in the amount of $21,131, which had been accrued as other payable. We are waiting for communication from the government concerning payment of the final settlement. As of June 30, 2012, the Company had not received further correspondences from the EPA regarding this matter.

On June 7, 2011, Weifang Shili Hesin Engineering Equipment Co., Ltd. (the “Plaintiff”) filed a complaint against SD Chaoying at the Basic People's Court of Changle County in Shandong Province, China, for alleged damages caused by SD Chaoying for not performing appropriately and completely the obligations in accordance with the agreement signed by both parties on April 28, 2011. Pursuant to the agreement, SD Chaoying agreed to transfer: (1) the rights of development, construction, and land of the #1 and #2 residential buildings for RMB 7.6 million, or $1,207,518, and (2) the 12 unsold residential units in the #3 and #4 residential buildings at a price as agreed upon. As of June 30, 2012, the Plaintiff paid $94,444 (equivalent to RMB 600,000) deposit as agreed upon, and prepaid $184,183 (equivalent to RMB 1,170,114), both of which were recorded as Other Payables under current liabilities. Plaintiff was seeking for the discharge of the original agreement signed, the return of prepayment of $184,183 (equivalent to RMB 1,170,114), repayment of the deposit plus 100% penalty, totaling $188,888 (equivalent to RMB 1,200,000), and for attorneys’ fees and costs. The Company disputed Plaintiff’s claim for a land use right certificate of underlying construction base of the #1 and #2 residential buildings, which certificate was inseparable from other part of the land and was not specifically stated in the agreement. The Company also disputed Plaintiff’s entitlement to the amounts claimed and instructed the Company’s legal counsel to contest the action, while concurrently pursuing opportunities for reasonable settlement. The case went to trial on July 7, 2011. On November 15, 2011, the Basic People's Court of Changle County pronounced its judgment against Plaintiff and that SD Chaoying had no liability. However, the plaintiff still has a right to appeal the judgment to the Intermediate Court in Weifang City, Shandong Province, China within 15 days after receiving verdict from the court. The verdict was released by the court on March 23, 2012. An appeal was filed on April 6, 2012 by the Plaintiff after the verdict was released. The court session for the appeal was held on May 16, 2012 at Intermediate Court in Weifang City, Shandong Province, China. As of the date of this report on Form 10-Q, the verdict of the appeal has not yet been released by the intermediate court in Weifang City. As of June 30, 2012, the Company has recorded an estimate of loss contingencies of $37,700 under accrued expenses, which was estimated by the Company’s legal counsel to be reasonable. The Company recorded the estimated liability and loss contingencies according to FASB ASC 450-20-25-2 under Topic 450, “Contingencies Loss Contingencies Recognition”.

Other than stated above, there are no material pending legal proceedings to which the Registrant is a party or as to which any of its property is subject, and no such proceedings are known to the Registrant to be threatened or contemplated against it.

Item 1A. Risk Factors

A smaller reporting company is not required to provide the information required by this Item.

14


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures

Not Applicable

Item 5. Other Information

None

Item 6. Exhibits

Exhibit Number

Description
31.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

XBRL Exhibit

101.

INS† XBRL Instance Document.

101.

SCH† XBRL Taxonomy Extension Schema Document.

101.

CAL† XBRL Taxonomy Extension Calculation Linkbase Document.

101.

DEF† XBRL Taxonomy Extension Definition Linkbase Document.

101.

LAB† XBRL Taxonomy Extension Label Linkbase Document.

101.

PRE† XBRL Taxonomy Extension Presentation Linkbase Document.


15


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

   CYBRDI, INC.
   
DATE: August 14, 2012  By /s/ Yanbiao Bai                                                         
 Yanbiao Bai, Chief Executive Officer and president
   
   By /s/ Yonghong Ren                                                                    
   Yonghong Ren, Principal Financial Officer
   
   
 

16


EX-31.1 2 exhibit31-1.htm EXHIBIT 31.1 Cybrdi, Inc.: Exhibit 31.1 - Filed by newsfilecorp.com

Exhibit 31.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Yanbiao Bai, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Cybrdi, Inc.

     
2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances made, not misleading with respect to the period covered by this quarterly report;

     
3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

     
4.

The Company's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and the internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f) for the Company and have:

     
a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

     
b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;

     
c.

Evaluated the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions after the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

     
d.

Disclosed in this report any change in the Company's internal control over financial reporting that occurred during the Company's most recent fiscal quarter (the Company's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting; and

     
5.

The Company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company's auditors and the audit committee of the Company's board of directors (or persons performing the equivalent functions):

     
a.

All significant deficiencies in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information; and

     
b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

Date: August 14 , 2012

By: /s/ YanBiao Bai                                    
Yanbiao Bai,
Chief Executive Officer and President


EX-31.2 3 exhibit31-2.htm EXHIBIT 31.2 Cybrdi, Inc.: Exhibit 31.2 - Filed by newsfilecorp.com

Exhibit 31.2

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Yonghong Ren, certifies that:

1.

I have reviewed this quarterly report on Form 10-Q of Cybrdi, Inc.

     
2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances made, not misleading with respect to the period covered by this quarterly report;

     
3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

     
4.

The Company's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and the internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f) for the Company and have:

     
a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

     
b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals;

     
c.

Evaluated the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions after the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

     
d.

Disclosed in this report any change in the Company's internal control over financial reporting that occurred during the Company's most recent fiscal quarter (the Company's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting; and

     
5.

The Company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company's auditors and the audit committee of the Company's board of directors (or persons performing the equivalent functions):

     
a.

All significant deficiencies in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information; and

     
b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

Date: August 14, 2012

By: /s/ Yonghong Ren                
Yonghong Ren,
Principal Financial Officer


EX-32.1 4 exhibit32-1.htm EXHIBIT 32.1 Cybrdi, Inc.: Exhibit 32.1 - Filed by newsfilecorp.com

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906
OF THE SARBANES OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Cybrdi Inc. for the period ended June 30, 2012 as filed with the Securities and Exchange Commission as of the date hereof (the "Report"), I, Yanbiao Bai, the chief executive officer of us, hereby certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

  (1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange 1934; and

   
  (2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of us.

Date: August 14, 2012

/s/ Yanbiao Bai                                        
Yanbiao Bai, CEO and President


EX-32.2 5 exhibit32-2.htm EXHIBIT 32.2 Cybrdi, Inc.: Exhibit 32.2 - Filed by newsfilecorp.com

Exhibit 32.2

CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 906
OF THE SARBANES OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Cybrdi Inc. for the period ended June 30, 2012 as filed with the Securities and Exchange Commission as of the date hereof (the "Report"), I, Yonghong Ren, the principal financial officer of us, hereby certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

  (1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange 1934; and

   
  (2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of us.

Date: August 14, 2012

/s/ Yonghong Ren                  
Name: Yonghong Ren
Principal Financial Officer


EX-101.INS 6 cydi-20120630.xml XBRL INSTANCE DOCUMENT --12-31 cydi Cybrdi, Inc. 2012-06-30 0000019002 No Smaller Reporting Company No 10-Q false 120225323 Yes 2012 Q2 0000019002 2012-08-14 0000019002 2012-01-01 2012-06-30 0000019002 2012-06-30 0000019002 2011-12-31 0000019002 2012-04-01 2012-06-30 0000019002 2011-04-01 2011-06-30 0000019002 2011-01-01 2011-06-30 0000019002 2010-12-31 0000019002 2011-06-30 shares iso4217:USD iso4217:USD shares pure cydi:years iso4217:CNY pure cydi:years cydi:days 495492 781048 3125 0 921606 1053038 90331 79442 72456 75089 630 832 1583640 1989449 1233391 1310529 6781274 6829329 715647 782215 10313952 10911522 1652762 1668282 3318 4942 746757 693436 123370 139284 86080 188186 1745801 1850181 10197 10293 426870 366020 4795155 4920624 840150 894750 5635305 5815374 0 0 4313614 4313614 172308 172308 336885 336885 -2740390 -2447643 1483900 1540329 3566317 3915493 1112330 1180655 4678647 5096148 10313952 10911522 1.00 1.00 500000 500000 150000000 150000000 120225323 120225323 120225323 120225323 0 0 142200 0 0 0 0 0 112407 123419 212317 237230 112407 123419 354517 237230 0 0 123306 0 16414 17125 32880 31752 65120 102176 144434 189324 81534 119301 300620 221076 30873 4118 53897 16154 50316 41093 102560 81576 36561 36721 75008 72993 19026 10783 37735 57108 10985 54 27214 125 1374 3786 2753 10211 24541 25352 54854 51637 0 23226 0 68830 142803 141015 300124 342480 -111930 -136897 -246227 -326326 -46132 -1085 -92122 -598 3496 -14 -22561 229 -42636 -1099 -114683 -369 -154566 -137996 -360910 -326695 162 0 162 0 -154728 -137996 -361072 -326695 -29860 -28160 -68325 -53169 -124868 -109836 -292747 -273526 0.00 0.00 0.00 0.00 120225323 65756567 120225323 65756567 125081 135345 3142 0 -122276 15636 -1189 3365 93345 81043 10378 0 -100883 906 -112828 -59572 5845 38480 190 46523 62077 87100 -68112 -172103 50635 36710 104273 122469 253173 0 -98265 159179 -279205 -72496 -6351 11684 585020 524208 75031 86084 0 0 <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>NOTE A - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>1. Interim Financial Statements</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">The unaudited consolidated financial statements of Cybrdi Inc. and subsidiaries have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and pursuant to the requirements for reporting on Form 10-Q. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. However, the information included in these interim financial statements reflects all adjustments (consisting solely of normal recurring adjustments) which are, in the opinion of management, necessary for the fair presentation of the consolidated financial position and the consolidated results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full year. The consolidated balance sheet information as of December 31, 2011 was derived from the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K. These interim financial statements should be read in conjunction with that report. Certain comparative amounts have been reclassified to conform to the current period's presentation.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">The consolidated financial statements include the accounts of Cybrdi, Inc. and its wholly-owned subsidiaries and joint ventures. All material intercompany balances and transactions have been eliminated.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>2. Description of Business</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Cybrdi, Inc. (f/k/a Certron Corporation) (the &#8220;Company&#8221; or &#8220;Cybrdi&#8221;) was incorporated on August 1, 1966, under the laws of the State of California. Until around June 2004, the Company&#8217;s business consisted of the distribution of magnetic media products, primarily blank audio and video cassettes. Due to continuing intense price competition and technological changes in the marketplace for its products, the Company lost its remaining significant customers and disposed of or wrote off its remaining inventory. As a result of these occurrences, the Company concluded that its audio and videotape businesses were no longer viable and some of its product lines were obsolete.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">On February 10, 2005, the Company, through a wholly-owned subsidiary, acquired all the ownership interest in Cybrdi, Inc., a privately held company incorporated in the State of Maryland ("Cybrdi Maryland"). As a result of the ownership interests of the former shareholders of Cybrdi Maryland, for financial statement reporting purposes, the transaction was treated as a reverse acquisition, with Cybrdi Maryland deemed the accounting acquirer and Certron Corporation deemed the accounting acquiree. Historical information of the surviving company is that of Cybrdi Maryland.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Cybrdi Maryland was established in 2001 to acquire an interest in biogenetic products commercialization and related services entities in Asia. On March 5, 2003, Cybrdi Maryland acquired an 80% interest in Shaanxi Chao Ying Biotechnology Co., Ltd. (&#8220;Chaoying Biotech&#8221;), a sino-foreign equity joint venture established in July 2000 in the People's Republic of China (&#8220;PRC&#8221;), through the exchange of 99% of the Company&#8217;s shares to the existing shareholders of Chaoying Biotech. For financial statement reporting purposes, the merger was treated as a reverse acquisition, with Chaoying Biotech deemed the accounting acquirer and Cybrdi Maryland deemed the accounting acquiree. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Chaoying Biotech is a sino-foreign equity joint venture between Shaanxi Chaoying Beauty &amp; Cosmetics Group Co., Ltd. (the &#8220;Chinese Partner&#8221;, a PRC corporation) and Immuno-Onco Genomics Inc. (the &#8220;Foreign Partner&#8221;, a USA corporation). The joint venture agreement has a 15 year operating period starting from its formation in July 2000 and it may be extended upon mutual consent. The principal activities of Chaoying Biotech are research, manufacture and sale of various high-quality tissue arrays and the related services in the PRC. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Most of the Company&#8217;s activities are conducted through Chaoying Biotech. Chaoying Biotech, with its principal operations located in China, aims to take advantage of China's abundant scientific talent, low wage rates, less stringent biogenetic regulation, and the huge genetic population as it introduces its growing list of tissue micro array products.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">On February 10, 2005, the Company completed the merger with Cybrdi Maryland and changed its name to Cybrdi, Inc.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">On July 26 , 2007, Chaoying Biotech entered into an acquisition agreement with its Chinese partner, which is a principal shareholder of the company, Mr. Bai, the Company&#8217;s chief executive officer and a director is also a principal of its Chinese partner.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> On July 28,2007, Chaoying Biotech invested RMB15 millions (equivalent to US$1,983,078) to acquire an 83.33% equity ownership of Shandong Chaoying Culture and Entertainment Co., Ltd. (&#8220;SD Chaoying&#8221;) from its Chinese partner, SD Chaoying is a corporation organized in Shandong Province P.R.China. On September 5, 2007, Shandong Commercial government had approved this acquisition and the ownership title of SD Chaoying had been transferred to Chaoying Biotech from its Chinese partner. The future business of SD Chaoying will primarily focus on culture and entertainment, including spa activities, cosmetic and personal care, body building, gambling, catering, and lodging, etc. SD Chaoying will have a specific emphasis on casino gambling, which has been approved by Shandong Administration for Civil Affairs. As of December 31, 2009, SD Chaoying had substantially completed the construction of two residential buildings and had recognized revenue from sales of housing for 2009. The main structure of the commercial entertainment center has also been completed, except for the exterior, rooftop, the surrounding supporting projects and the community landscaping, which are expected to be completed in 2012 prior to the commencement of operations by merchant tenants if we can obtain an estimated $2.8 million to complete construction. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">On March 10, 2007 the Company entered into a Sales Agency Agreement with BioMax, Ltd., a reseller located in the United States.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> On April 29, 2011, Chaoying Biotech invested $154,732 (equivalent to RMB1 million) to restore the operation of the Institute of Shaanxi Chaoying Clinical Pathology (&#8220;IOSCCP&#8221;), a wholly-owned subsidiary established on July 31, 2003, whose main business includes pathology research and consulting, consulting and diagnostic clinical pathology and pathology-related research and development of new technologies, and basic training in pathology. Its sole shareholder has been Chaoying Biotech. However, Chaoying Biotech withdrew the original investment from IOSCCP in September 2007 as we believed that both internal and external conditions of IOSCCP were not mature at that time. In light of foreseeable benefits and new business opportunities for this entity, we resumed its business and re-invested $154,732 (equivalent to RMB1 million) in it in April 2011. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>3. Going Concern</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred significant losses and has not demonstrated the ability to generate sufficient cash flows from operations to satisfy its liabilities and sustain operations. The Company had an accumulated deficit of $2,740,390 and $2,447,643 as of June 30, 2012 and December 31, 2011, including net losses of $292,747 and $273,526 for the six months ended June 30, 2012 and 2011, respectively. In addition, current liabilities exceeded current assets by $3,211,515 and $2,931,175 at June 30, 2012 and December 31, 2011, respectively. These matters raise substantial doubt about the Company&#8217;s ability to continue as a going concern. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The Company finances its operations primarily through short-term bank borrowings and advances from related parties and/or officers/shareholders. In order to complete the construction of SD Chaoying cultural and entertainment center, approximately $3.0 million (equivalent to RMB19 million) of capital is expected to be needed. The Company, taking into account the available banking facilities, internal financial resource, and supports from related companies, believes it has sufficient working capital to meet its present obligation for at least the next twelve months. Management is taking actions to address the company's financial condition and deteriorating liquidity position. The following sets forth management&#8217;s plans for dealing with the adverse effects of the conditions: </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> (a) Sale of housing inventories: Proceeds to be received from the sale of the remaining housing of the two completed residential buildings are expected to amount to approximately $693,000. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> (b) Rental and management fee revenue from the cultural and entertainment center: Annual rental revenue is estimated to be approximately $650,000 per year. Management fee revenue will be charged to commercial tenants at 3% of annual gross revenue.&#160; As of June 30, 2012, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> (c) Additional advances from related companies and affiliates: Mr. Bai, our Chief Executive Officer, advanced $55,974 to the Company in the current period to finance operations and the costs to maintain the Company&#8217;s public status in the U.S. In addition, Shaanxi Chaoying Beauty &amp; Cosmetics Group, which is also an affiliate, is anticipated to provide up to approximately $791,000 (equivalent to RMB5 million) of capital to support operations. Shaanxi Chaoying Beauty &amp; Cosmetics Group advanced $12,660 for the current quarter period to the Company to finance its operations. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">The Company may require additional funds and may seek to raise such funds though public and private financings or from other sources. There is no assurance that management&#8217;s plans will be realized or the additional financing will be available at all or that, if available, such financing will be obtainable on terms favorable to the Company or that any additional financing will not be dilutive. The consolidated financial statements do not include any adjustments that might result from the outcome of those uncertainties.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>4. Use of Estimates:</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>5. Revenue Recognition</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Revenue represents the invoiced value of goods sold recognized upon the delivery of goods to customers and service income is recognized when services are provided. Deferred revenue represents the undelivered portion of invoiced value of goods sold to customers. Sales transactions not meeting all the conditions of the full accrual method are accounted for using the deposit method of accounting. Under the deposit method, all costs are capitalized as incurred, and payments received from the buyer are recorded as customer deposits.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>6. Reverse Merger</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> On February 10, 2005, (the "Closing Date") the Company closed on an Agreement and Plan of Merger (the "Agreement") among Certron Corporation (&#8220;Certron&#8221;), a California corporation, Certron Acquisition Corp., a Maryland corporation and a wholly-owned subsidiary of Certron ("Acquisition Sub"), and Cybrdi, Inc., a Maryland corporation (&#8220;Cybrdi &#8211; Maryland&#8221;) relating to the acquisition by Certron of all of the issued and outstanding capital stock of Cybrdi -Maryland in exchange for shares of common stock of Certron that will aggregate approximately 93.8% of the issued and outstanding common stock of Certron. Pursuant to the terms of the Agreement, at the Closing Date (a) Acquisition Sub has been merged with and into Cybrdi - Maryland, with Cybrdi - Maryland being the surviving corporation, (b) the common stock of Cybrdi-Maryland has been cancelled and converted into the right to receive shares of the common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of the Certron&#8217;s common stock, and (c) each share of the common stock of Acquisition Sub has been converted in to and become one share of the common stock of Cybrdi-Maryland. The share exchange has been accounted for as a reverse merger under the purchase method of accounting. Accordingly, Cybrdi, Inc. will be treated as the continuing entity for accounting purposes and the historical financial statements presented will be those of Cybrdi, Inc. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> In connection with the Agreement, on February 10, 2005, the Company amended its articles of incorporation to authorize the issuance of 150 million shares of common stock no par value and 500,000 shares of preferred stock, $1.00 par value per share, none of which are issued or outstanding. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Concurrent with the filing of the Articles of Merger, all of the Company then existing officers and directors tendered their resignation and Yanbiao Bai was appointed as its Chairman of the Board of Directors. Mr. Bai then nominated the balance of the Board of Directors.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>7. Income Taxes</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to the differences between the basis of assets and liabilities for financial and income tax reporting. The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes also are recognized for operating losses that are available to offset future income taxes.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>8. Contingencies</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Currently we are involved in disputes, litigation and other legal proceedings. We prosecute and defend these matters aggressively. However, there are many uncertainties associated with any litigation, and we cannot assure you that these actions or other third party claims against us will be resolved without costly litigation and/or substantial settlement charges. We record a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements and (ii) the range of loss can be reasonably estimated. However, the actual liability in any such disputes or litigation may be materially different from our estimates, which could result in the need to record additional costs.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>9. Recent Accounting Pronouncements</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">The Company has adopted all recently issued accounting pronouncements. The adoption of the accounting pronouncements, including those not yet effective, is not anticipated to have a material effect on the financial position or results of operations of the Company.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>1. Interim Financial Statements</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">The unaudited consolidated financial statements of Cybrdi Inc. and subsidiaries have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and pursuant to the requirements for reporting on Form 10-Q. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. However, the information included in these interim financial statements reflects all adjustments (consisting solely of normal recurring adjustments) which are, in the opinion of management, necessary for the fair presentation of the consolidated financial position and the consolidated results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full year. The consolidated balance sheet information as of December 31, 2011 was derived from the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K. These interim financial statements should be read in conjunction with that report. Certain comparative amounts have been reclassified to conform to the current period's presentation.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">The consolidated financial statements include the accounts of Cybrdi, Inc. and its wholly-owned subsidiaries and joint ventures. All material intercompany balances and transactions have been eliminated.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>2. Description of Business</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Cybrdi, Inc. (f/k/a Certron Corporation) (the &#8220;Company&#8221; or &#8220;Cybrdi&#8221;) was incorporated on August 1, 1966, under the laws of the State of California. Until around June 2004, the Company&#8217;s business consisted of the distribution of magnetic media products, primarily blank audio and video cassettes. Due to continuing intense price competition and technological changes in the marketplace for its products, the Company lost its remaining significant customers and disposed of or wrote off its remaining inventory. As a result of these occurrences, the Company concluded that its audio and videotape businesses were no longer viable and some of its product lines were obsolete.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">On February 10, 2005, the Company, through a wholly-owned subsidiary, acquired all the ownership interest in Cybrdi, Inc., a privately held company incorporated in the State of Maryland ("Cybrdi Maryland"). As a result of the ownership interests of the former shareholders of Cybrdi Maryland, for financial statement reporting purposes, the transaction was treated as a reverse acquisition, with Cybrdi Maryland deemed the accounting acquirer and Certron Corporation deemed the accounting acquiree. Historical information of the surviving company is that of Cybrdi Maryland.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Cybrdi Maryland was established in 2001 to acquire an interest in biogenetic products commercialization and related services entities in Asia. On March 5, 2003, Cybrdi Maryland acquired an 80% interest in Shaanxi Chao Ying Biotechnology Co., Ltd. (&#8220;Chaoying Biotech&#8221;), a sino-foreign equity joint venture established in July 2000 in the People's Republic of China (&#8220;PRC&#8221;), through the exchange of 99% of the Company&#8217;s shares to the existing shareholders of Chaoying Biotech. For financial statement reporting purposes, the merger was treated as a reverse acquisition, with Chaoying Biotech deemed the accounting acquirer and Cybrdi Maryland deemed the accounting acquiree. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Chaoying Biotech is a sino-foreign equity joint venture between Shaanxi Chaoying Beauty &amp; Cosmetics Group Co., Ltd. (the &#8220;Chinese Partner&#8221;, a PRC corporation) and Immuno-Onco Genomics Inc. (the &#8220;Foreign Partner&#8221;, a USA corporation). The joint venture agreement has a 15 year operating period starting from its formation in July 2000 and it may be extended upon mutual consent. The principal activities of Chaoying Biotech are research, manufacture and sale of various high-quality tissue arrays and the related services in the PRC. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Most of the Company&#8217;s activities are conducted through Chaoying Biotech. Chaoying Biotech, with its principal operations located in China, aims to take advantage of China's abundant scientific talent, low wage rates, less stringent biogenetic regulation, and the huge genetic population as it introduces its growing list of tissue micro array products.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">On February 10, 2005, the Company completed the merger with Cybrdi Maryland and changed its name to Cybrdi, Inc.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">On July 26 , 2007, Chaoying Biotech entered into an acquisition agreement with its Chinese partner, which is a principal shareholder of the company, Mr. Bai, the Company&#8217;s chief executive officer and a director is also a principal of its Chinese partner.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> On July 28,2007, Chaoying Biotech invested RMB15 millions (equivalent to US$1,983,078) to acquire an 83.33% equity ownership of Shandong Chaoying Culture and Entertainment Co., Ltd. (&#8220;SD Chaoying&#8221;) from its Chinese partner, SD Chaoying is a corporation organized in Shandong Province P.R.China. On September 5, 2007, Shandong Commercial government had approved this acquisition and the ownership title of SD Chaoying had been transferred to Chaoying Biotech from its Chinese partner. The future business of SD Chaoying will primarily focus on culture and entertainment, including spa activities, cosmetic and personal care, body building, gambling, catering, and lodging, etc. SD Chaoying will have a specific emphasis on casino gambling, which has been approved by Shandong Administration for Civil Affairs. As of December 31, 2009, SD Chaoying had substantially completed the construction of two residential buildings and had recognized revenue from sales of housing for 2009. The main structure of the commercial entertainment center has also been completed, except for the exterior, rooftop, the surrounding supporting projects and the community landscaping, which are expected to be completed in 2012 prior to the commencement of operations by merchant tenants if we can obtain an estimated $2.8 million to complete construction. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">On March 10, 2007 the Company entered into a Sales Agency Agreement with BioMax, Ltd., a reseller located in the United States.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> On April 29, 2011, Chaoying Biotech invested $154,732 (equivalent to RMB1 million) to restore the operation of the Institute of Shaanxi Chaoying Clinical Pathology (&#8220;IOSCCP&#8221;), a wholly-owned subsidiary established on July 31, 2003, whose main business includes pathology research and consulting, consulting and diagnostic clinical pathology and pathology-related research and development of new technologies, and basic training in pathology. Its sole shareholder has been Chaoying Biotech. However, Chaoying Biotech withdrew the original investment from IOSCCP in September 2007 as we believed that both internal and external conditions of IOSCCP were not mature at that time. In light of foreseeable benefits and new business opportunities for this entity, we resumed its business and re-invested $154,732 (equivalent to RMB1 million) in it in April 2011. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>3. Going Concern</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred significant losses and has not demonstrated the ability to generate sufficient cash flows from operations to satisfy its liabilities and sustain operations. The Company had an accumulated deficit of $2,740,390 and $2,447,643 as of June 30, 2012 and December 31, 2011, including net losses of $292,747 and $273,526 for the six months ended June 30, 2012 and 2011, respectively. In addition, current liabilities exceeded current assets by $3,211,515 and $2,931,175 at June 30, 2012 and December 31, 2011, respectively. These matters raise substantial doubt about the Company&#8217;s ability to continue as a going concern. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The Company finances its operations primarily through short-term bank borrowings and advances from related parties and/or officers/shareholders. In order to complete the construction of SD Chaoying cultural and entertainment center, approximately $3.0 million (equivalent to RMB19 million) of capital is expected to be needed. The Company, taking into account the available banking facilities, internal financial resource, and supports from related companies, believes it has sufficient working capital to meet its present obligation for at least the next twelve months. Management is taking actions to address the company's financial condition and deteriorating liquidity position. The following sets forth management&#8217;s plans for dealing with the adverse effects of the conditions: </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> (a) Sale of housing inventories: Proceeds to be received from the sale of the remaining housing of the two completed residential buildings are expected to amount to approximately $693,000. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> (b) Rental and management fee revenue from the cultural and entertainment center: Annual rental revenue is estimated to be approximately $650,000 per year. Management fee revenue will be charged to commercial tenants at 3% of annual gross revenue.&#160; As of June 30, 2012, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> (c) Additional advances from related companies and affiliates: Mr. Bai, our Chief Executive Officer, advanced $55,974 to the Company in the current period to finance operations and the costs to maintain the Company&#8217;s public status in the U.S. In addition, Shaanxi Chaoying Beauty &amp; Cosmetics Group, which is also an affiliate, is anticipated to provide up to approximately $791,000 (equivalent to RMB5 million) of capital to support operations. Shaanxi Chaoying Beauty &amp; Cosmetics Group advanced $12,660 for the current quarter period to the Company to finance its operations. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">The Company may require additional funds and may seek to raise such funds though public and private financings or from other sources. There is no assurance that management&#8217;s plans will be realized or the additional financing will be available at all or that, if available, such financing will be obtainable on terms favorable to the Company or that any additional financing will not be dilutive. The consolidated financial statements do not include any adjustments that might result from the outcome of those uncertainties.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>4. Use of Estimates:</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>5. Revenue Recognition</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Revenue represents the invoiced value of goods sold recognized upon the delivery of goods to customers and service income is recognized when services are provided. Deferred revenue represents the undelivered portion of invoiced value of goods sold to customers. Sales transactions not meeting all the conditions of the full accrual method are accounted for using the deposit method of accounting. Under the deposit method, all costs are capitalized as incurred, and payments received from the buyer are recorded as customer deposits.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>6. Reverse Merger</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> On February 10, 2005, (the "Closing Date") the Company closed on an Agreement and Plan of Merger (the "Agreement") among Certron Corporation (&#8220;Certron&#8221;), a California corporation, Certron Acquisition Corp., a Maryland corporation and a wholly-owned subsidiary of Certron ("Acquisition Sub"), and Cybrdi, Inc., a Maryland corporation (&#8220;Cybrdi &#8211; Maryland&#8221;) relating to the acquisition by Certron of all of the issued and outstanding capital stock of Cybrdi -Maryland in exchange for shares of common stock of Certron that will aggregate approximately 93.8% of the issued and outstanding common stock of Certron. Pursuant to the terms of the Agreement, at the Closing Date (a) Acquisition Sub has been merged with and into Cybrdi - Maryland, with Cybrdi - Maryland being the surviving corporation, (b) the common stock of Cybrdi-Maryland has been cancelled and converted into the right to receive shares of the common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of the Certron&#8217;s common stock, and (c) each share of the common stock of Acquisition Sub has been converted in to and become one share of the common stock of Cybrdi-Maryland. The share exchange has been accounted for as a reverse merger under the purchase method of accounting. Accordingly, Cybrdi, Inc. will be treated as the continuing entity for accounting purposes and the historical financial statements presented will be those of Cybrdi, Inc. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> In connection with the Agreement, on February 10, 2005, the Company amended its articles of incorporation to authorize the issuance of 150 million shares of common stock no par value and 500,000 shares of preferred stock, $1.00 par value per share, none of which are issued or outstanding. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Concurrent with the filing of the Articles of Merger, all of the Company then existing officers and directors tendered their resignation and Yanbiao Bai was appointed as its Chairman of the Board of Directors. Mr. Bai then nominated the balance of the Board of Directors.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>7. Income Taxes</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to the differences between the basis of assets and liabilities for financial and income tax reporting. The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes also are recognized for operating losses that are available to offset future income taxes.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>8. Contingencies</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">Currently we are involved in disputes, litigation and other legal proceedings. We prosecute and defend these matters aggressively. However, there are many uncertainties associated with any litigation, and we cannot assure you that these actions or other third party claims against us will be resolved without costly litigation and/or substantial settlement charges. We record a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements and (ii) the range of loss can be reasonably estimated. However, the actual liability in any such disputes or litigation may be materially different from our estimates, which could result in the need to record additional costs.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>9. Recent Accounting Pronouncements</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;">The Company has adopted all recently issued accounting pronouncements. The adoption of the accounting pronouncements, including those not yet effective, is not anticipated to have a material effect on the financial position or results of operations of the Company.</p> 0.8 0.99 15 15000000 1983078 0.8332 2800000 154732 1000000 154732 1000000 2740390 2447643 292747 273526 3211515 2931175 3000000 19000000 693000 650000 0.03 55974 791000 5000000 12660 0.938 1.566641609 47328263 150000000 500000 1 <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>NOTE B &#8211; ASSETS</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The June 30, 2012 consolidated balance sheet included total current assets of $1,583,640 and non-current assets of $8,730,312. Of these amounts, $495,492 in cash and equivalents is planned for funding current operations and for future business expansion. </p> <p style="font-family: times new roman,times,serif; font-size: 10pt;">Other current assets also included accounts receivable, inventories, due from related companies, other receivables and prepaid expenses, and advance to suppliers. Inventories are mainly finished goods. Other components of inventories include raw materials, finished goods, and housing inventories. Inventories are stated at the lower of cost or market. Cost of raw materials is determined on the basis of first in first out method (&#8220;FIFO&#8221;). Finished goods are determined on the weighted average basis and are comprised of direct materials, direct labor, and an appropriate proportion of overhead.</p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The other primary assets included in current assets are loans to an unaffiliated company, QuanYe Security Co., Ltd (&#8220;QuanYe&#8221;), an unrelated People&#8217;s Republic of China (&#8220;PRC&#8221;) registered company located in Xian PRC. QuanYe is engaged in the pawnshop business and their primary business is offering alternative financing to small, local companies. According to the loan agreement, QuanYe had received loans from Chaoying Biotech for a total amount of RMB29.3Mill ion (equivalent to $4,652,640) since January 2006. A remaining balance of RMB7.3 million (equivalent to $1,159,190) was extended to and expired on March 24, 2008. As of June 30, 2012 and December 31, 2011, the principal balance and interest receivable for this loan had been reduced to $0, net of allowance of $94,444 and $180,258 for doubtful principal balance and interest receivable, respectively. The interest rate for these loans initially was initially 8% per year, and subsequently reduced to 5% since October 9, 2006. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Included in non-current assets are property, plant and equipment, construction-in-progress and intangible assets. Property, plant and equipment mainly consist of building, office equipments, motor vehicles, leasehold improvement, software-website, and machinery used for product manufacturing located in the People&#8217;s Republic of China (&#8220;PRC&#8221;). Depreciation on property, plant and equipment is computed using the straight-line method over the estimated useful life of the assets. The majority of the assets have estimated useful lives of 10 years. Building and office equipment have estimated useful lives of 20 and 5 years, respectively. The &#8220;construction in progress&#8221; in the amount of $6,781,274 mainly consisted of land under development and construction of the entertainment, culture, and casino facility in Shandong Province, which will be transferred to fixed assets in SD Chaoying when construction is completed. As of June 30, 2012, construction-in-progress of $4.32 million and land use rights of $3.15 million of SD Chaoying were collateralized under a short-term loan from Changle Rural Credit Union. For the $3.15 million land use rights, $2.49 million was classified under construction-in-progress for the commercial property and the remaining $0.66 million was classified under intangible assets subject to amortization. Intangible assets included a tissue chip patent at Chaoying Biotech and $0.66 million of land use rights being put in operation for the partial completed commercial property at SD Chaoying. Effective January 1, 2002, with the adoption of the accounting guidance for Goodwill and Other Intangible Assets, intangible assets with a definite life are amortized on a straight-line basis. The patent is being amortized over its estimated life of 10 years. The land use rights classified in intangible asset is being amortized over its estimated life of 36.9 years through the maturity of the land use rights for commercial use on November 6, 2047. </p> 1583640 8730312 495492 29300000 4652640 7300000 1159190 0 94444 180258 0.08 0.05 10 20 5 6781274 4320000 3150000 3150000 2490000 660000 660000 10 36.9 <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>NOTE C - LIABILITIES</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> As of June 30, 2012, the balance sheet included total liabilities of $5,635,305, which consisted of current liabilities of $4,795,155 and construction payable of $840,150. Included in the current liabilities was a short-term loan of $1,495,357 (equivalent to RMB9.5 million) from Changle Rural Credit Union, which is a bank located in Shandong Province of the PRC. The original term of the loan was from August 25, 2009 to August 24, 2010 with an interest rate of 7.965% per annum. In August 2011, the Company renewed this short-term loan with the same amount of $1,495,357 (equivalent to RMB9.5 million) with Changle Rural Credit Union. The term of the renewal loan started from August 31, 2011 with a maturity date of August 20, 2012. The adjustable interest rate is a rate per annum equal to the Prime Rate plus 50% of prime rate. The prime rate is based on six-month-to-one-year loan interest rate released by The People's Bank of China. The interest rate for the short-term loan was 9.465% as of June 30, 2012. This short-term loan had been secured by the Company&#8217;s land use right and construction-in-progress of SD Chaoying with a book value of $3.15 million (equivalent to RMB20.03 million) and $4.32 million (equivalent to RMB27.45 million) as of June 30, 2012, respectively. For the $3.15 million land use rights, $2.49 million was classified under construction-in-progress for the commercial property and the remaining $0.66 million was classified under intangible assets subject to amortization. The Company currently is in process of negotiating with Changle Rural Credit Union to renew the bank loan upon maturity date on August 20, 2012.&#160; Additionally, there is another short-term loan of $157,406 (equivalent to RMB1.0 million) from Mr. Fengguo Liu, an unrelated party. Also included in the current liabilities was $1,745,801 of loans from related companies, including Xi&#8217;an Yanfeng Biotechnology Co., Ltd., Shaanxi Yanfeng Real Estate Co. Ltd, Shaanxi Chaoying Beauty &amp; Cosmetics Group Co., Ltd and the stockholders who are also the Company&#8217;s officers. These entities were related to the Company through common ownership and principal officers. These loans are non-interest bearing and have no set repayment terms. </p> 5635305 4795155 840150 1495357 9500000 0.0796 1495357 9500000 0.5 0.0946 3150000 20030000 4320000 27450000 3150000 2490000 660000 157406 1000000 1745801 <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>NOTE D &#8211; STOCKHOLDERS&#8217; EQUITY</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> As a result of the reverse merger (see Note A item 6), the common stock of Cybrdi-Maryland has been cancelled and converted into shares of common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of Certron&#8217;s common stock to the Cybrdi shareholders. As of June 30, 2012 and December 31, 2011, the Company had 120,225,323 and 120,225,323 shares issued and outstanding, respectively. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> As of June 30, 2012, the balance sheet included total equity of $4,678,647, of which $1,112,330 was for non-controlling interest, representing 20% minority interest in Chaoying Biotech and 16.67% minority interest in SD Chaoying. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> On January 15, 2010, the Board of Directors adopted resolutions that authorized incentive compensation to key management of the Company for services it has provided to the Company. As set forth in the Board of Directors&#8217; resolution dated January 15, 2010, the incentive compensation shall be paid by the issuance of 12,000,000 shares of common stock of the Company to Mr. Yanbiao Bai, Chief Executive Officer and President of the Company, and 3,300,000 shares of common stock of the Company to Ms. Xue Bu, the former Chief Financial and Operating Officer of the Company. Compensation cost of $306,000 was recorded during the first quarter of 2010 at $0.02 per share, the market price of the Company&#8217;s common stock on January 15, 2010, the grant date. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> On June 30, 2011, the Company entered into a written Debt Conversion Agreement with Shaanxi Chaoying Beauty &amp; Cosmetics Group Co., Ltd. (a related party), Shaanxi NuoQi Healthfood Co., Ltd. (a related party), and Mr. Yanbiao Bai, Chairman and CEO of the Company. In the Agreement, the Company agreed to repay a total of $605,723 (RMB3,920,000) debt due to Shaanxi Chaoying Beauty &amp; Cosmetics Group Co., Ltd. by issuing the Company's common stock. Simultaneously upon the execution of the repayment, Shaanxi Chaoying Beauty &amp; Cosmetics Group Co., Ltd. agreed to transfer to Mr. Yanbiao Bai the number of shares to be issued through the debt repayment. The number of shares transferred to Mr. Yanbiao Bai was further offset by a number of shares equivalent to $169,973 (RMB1,100,000) due by Shaanxi NuoQi Health Food Co., Ltd., a company wholly-controlled by Ms. Xue Bu, the spouse of Mr. Yanbiao Bai and former COO and Director of the Company, to offset its debt due to the Company. The Agreement was approved by the Company&#8217;s Board of Directors on June 30, 2011. As a result of the debt conversion and offset, the number of shares of common stock issued to Mr. Yanbiao Bai was 54,468,756 shares, which was determined based on the closing price of $0.008 per share on June 30, 2011. The share issuance for repayment of debt as agreed upon and approved was executed on August 17, 2011. </p> 1.566641609 47328263 120225323 120225323 4678647 1112330 0.2 0.1667 12000000 3300000 306000 0.02 605723 3920000 169973 1100000 54468756 0.008 <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>NOTE E &#8211; INCOME TAXES</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> Under the Enterprise Income Tax (&#8220;EIT&#8221;) of the PRC, prior to 2007, Chinese enterprises are generally subject to an income tax at an effective rate of 33% ( 30% statutory income taxes plus 3% local income taxes) on income reported in the statutory financial statements after appropriate tax adjustments, unless the enterprise is located in a specially designated region for which more favorable effective tax rates are applicable. Beginning on January 1, 2008, the new EIT law has replaced the existing laws for Domestic Enterprises (&#8220;DEs&#8221;) and Foreign Invested Enterprises (&#8220;FIEs&#8221;). The new standard EIT rate of 25% will replace the 33% rate previously applicable to both DES and FIEs. The two year tax exemption, six year 50% tax reduction and tax holiday for production-oriented FIEs will be eliminated. According to the Western Developing Plan implemented by the PRC Government, Chaoying Biotech is entitled to a 50% reduction in EIT of preferential policy, but not less than 15%. As a result, Chaoying Biotech&#8217;s effective EIT tax rate has been 15% since 2008. </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> The Company&#8217;s income tax expense includes U.S. and PRC income taxes. There were no U.S. current taxes for the six months ended June 30, 2012 according to net loss incurred in the U.S. entity, which will not be anticipated to have any tax benefit in the future since no revenue is expected to be generated in the U.S as a result of discontinuing the U.S. operating company in Maryland in October 2007. There was $162 of PRC current income taxes accrued for the six months ended June 30, 2012 in SD Chaoying. </p> 0.33 0.3 0.03 0.25 0.33 0.5 0.5 0.15 0.15 162 <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> <b>NOTE F &#8211; CONTINGENCIES AND LITIGATION LIABILITIES</b> </p> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;"> On June 7, 2011, Weifang Shili Hesin Engineering Equipment Co., Ltd. (the &#8220;Plaintiff&#8221;) filed a complaint against SD Chaoying at the Basic People's Court of Changle County in Shandong Province, China, for alleged damages caused by SD Chaoying for not performing appropriately and completely the obligations in accordance with the agreement signed by both parties on April 28, 2011. Pursuant to the agreement, SD Chaoying agreed to transfer: (1) the rights of development, construction, and land of the #1 and #2 residential buildings for RMB7.6 million, or $1,207,518, and (2) the 12 unsold residential units in the #3 and #4 residential buildings at a price as agreed upon. As of June 30, 2012, the Plaintiff paid $94,444 (equivalent to RMB600,000) deposit as agreed upon, and prepaid $184,183 (equivalent to RMB1,170,114), both of which were recorded as Other Payables under current liabilities. Plaintiff was seeking for the discharge of the original agreement signed, the return of prepayment of $184,183 (equivalent to RMB1,170,114), repayment of the deposit plus 100% penalty, totaling $188,888 (equivalent to RMB1,200,000), and for attorneys&#8217; fees and costs. The Company disputed Plaintiff&#8217;s claim for a land use right certificate of underlying construction base of the #1 and #2 residential buildings, which certificate was inseparable from other part of the land and was not specifically stated in the agreement. The Company also disputed Plaintiff&#8217;s entitlement to the amounts claimed and instructed the Company&#8217;s legal counsel to contest the action, while concurrently pursuing opportunities for reasonable settlement. The case went to trial on July 7, 2011. On November 15, 2011, the Basic People's Court of Changle County pronounced its judgment against Plaintiff and that SD Chaoying had no liability. However, the plaintiff still has a right to appeal the judgment to the Intermediate Court in Weifang City, Shandong Province, China within 15 days after receiving verdict from the court. The verdict was released by the court on March 23, 2012. An appeal was filed on April 6, 2012 by the Plaintiff after the verdict was released. The court session for the appeal was held on May 16, 2012 at Intermediate Court in Weifang City, Shandong Province, China. As of the date of this report on Form 10Q, the verdict of the appeal has not yet been released by the intermediate court in Weifang City. As of June 30, 2012, the Company has recorded an estimate of loss contingencies of $37,700 under accrued expenses, which was estimated by the Company&#8217;s legal counsel to be reasonable. The Company recorded the estimated liability and loss contingencies according to FASB ASC 450-20-25-2 under Topic 450, &#8220;Contingencies Loss Contingencies Recognition&#8221;. </p> 7600000 1207518 12 94444 600000 184183 1170114 184183 1170114 1 188888 1200000 15 37700 EX-101.SCH 7 cydi-20120630.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 102 - Statement - CONSOLIDATED BALANCE SHEETS link:calculationLink link:presentationLink link:definitionLink 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:calculationLink link:presentationLink link:definitionLink 105 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:calculationLink link:presentationLink link:definitionLink 106 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:calculationLink link:presentationLink link:definitionLink 107 - Disclosure - ASSETS link:calculationLink link:presentationLink link:definitionLink 108 - Disclosure - LIABILITIES link:calculationLink link:presentationLink link:definitionLink 109 - Disclosure - STOCKHOLDERS EQUITY link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - INCOME TAXES link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - CONTINGENCIES AND LITIGATION LIABILITIES link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - ASSETS (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - LIABILITIES (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - STOCKHOLDERS EQUITY (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 117 - Disclosure - INCOME TAXES (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 118 - Disclosure - CONTINGENCIES AND LITIGATION LIABILITIES (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 8 cydi-20120630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 cydi-20120630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 cydi-20120630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document, Entity Information Statement Entities [Table] Legal Entity [Axis] Entity [Domain] Document and Entity Information Document Type Amendment Flag Amendment Description Document Period End Date Trading Symbol Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Entity Current Reporting Status Entity Voluntary Filers Entity Well Known Seasoned Issuer Entity Public Float Document Fiscal Year Focus Document Fiscal Period Focus Statement of Financial Position Statement [Table] Statement [Line Items] ASSETS CURRENT ASSETS Cash and equivalents Accounts receivable, net Inventories Deferred tax assets Due from related companies Loan to unaffiliated company,net Other receivables, net and prepaid expenses Advance to suppliers TOTAL CURRENT ASSETS TOTAL CURRENT ASSETS (AssetsCurrent) PROPERTY, PLANT AND EQUIPMENT, NET CONSTRUCTION IN PROGRESS INTANGIBLE ASSETS, NET TOTAL ASSETS TOTAL ASSETS (Assets) LIABILITIES AND EQUITY CURRENT LIABILITIES Short-term loan Accounts payable Accrued expenses Deferred revenue Customers deposits Due to related parties Deferred tax liabilities Other payables TOTAL CURRENT LIABILITIES TOTAL CURRENT LIABILITIES (LiabilitiesCurrent) CONSTRUCTION PAYABLE TOTAL LIABILITIES TOTAL LIABILITIES (Liabilities) EQUITY Preferred Stock, $1.00 per value, 500,000 shares authorized, no shares issued and outstanding Common Stock, no par value, 150,000,000 shares authorized, and 120,225,323 and 120,225,323 shares issued and outstanding, respectively Additional paid-in capital Reserve funds Accumulated deficit Accumulated other comprehensive income TOTAL STOCKHOLDERS' EQUITY TOTAL STOCKHOLDERS' EQUITY (StockholdersEquity) NONCONTROLLING INTEREST TOTAL EQUITY TOTAL EQUITY (StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest) TOTAL LIABILITIES AND EQUITY TOTAL LIABILITIES AND EQUITY (LiabilitiesAndStockholdersEquity) Preferred Stock, Par Value Per Share Preferred Stock, Shares Authorized Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Income Statement Revenue Housing Commercial rental Commercial rental Tissue array products Tissue array products Total revenue Total revenue (Revenues) Cost of Sales Housing Housing (HomeBuildingCosts) Commercial rental Commercial rental (CommercialRentalCosts) Commercial rental Tissue array products Tissue array products (TissueArrayProductsCosts) Tissue array products Total cost of sales Total cost of sales (CostOfRevenue) Gross Profit Gross Profit (GrossProfit) Operating Expenses: Salaries and wages Depreciation and amortization Professional fees Operating tax expenses Selling and distribution expenses Other general and administrative expenses Bad debt expense Total Operating Expenses Total Operating Expenses (OperatingExpenses) Loss from Operations Loss from Operations (OperatingIncomeLoss) Other Income Net interest expense Other (expense) income, net Total Other Expense, Net Total Other Income, Net (NonoperatingIncomeExpense) Loss before Income Taxes Loss before Income Taxes (IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments) Income Tax Expense Income Tax Benefit (Expense) (IncomeTaxExpenseBenefit) Net loss Net loss (ProfitLoss) Net loss attributable to the noncontrolling interest Net loss attributable to CYBRDI, INC. AND SUBSIDIARIES Net loss attributable to CYBRDI, INC. AND SUBSIDIARIES (NetIncomeLoss) Comprehensive income Comprehensive income (ComprehensiveIncomeNetOfTax) Net Loss Per Common Share Basic and Diluted Weighted Average Number of Shares Outstanding Basic and Diluted Basic and Diluted (WeightedAverageNumberOfDilutedSharesOutstanding) Statement of Cash Flows CASH FLOWS FROM OPERATING ACTIVITIES Net Loss Adjustments to Reconcile Net Loss to Net Cash Provided by Operating Activities: Depreciation and amortization Depreciation and amortization (DepreciationAndamortization) Depreciation and amortization Bad debt expense Minority interest Changes in Operating Assets and Liabilities: Accounts receivable Accounts receivable (IncreaseDecreaseInAccountsReceivable) Inventories Inventories (IncreaseDecreaseInInventories) Other receivable and prepaid expenses Other receivable and prepaid expenses (IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets) Accounts payable and other current liabilities Deferred revenue Deferred revenue (IncreaseDecreaseInDeferredRevenue) Customer deposits Customer deposits (IncreaseDecreaseInCustomerDeposits) Net Cash Used in Operating Activities Net Cash Used in Operating Activities (NetCashProvidedByUsedInOperatingActivities) CASH FLOWS FROM INVESTING ACTIVITIES Advance for loan to affiliated companies Advance for loan to affiliated companies (PaymentsForAdvanceToAffiliate) Purchase of property, plant, and equipment Purchase of property, plant, and equipment (PaymentsToAcquirePropertyPlantAndEquipment) Payments for construction in progress Payments for construction in progress (PaymentsForConstructionInProcess) Net Cash Used in Investing Activities Net Cash Used in Investing Activities (NetCashProvidedByUsedInInvestingActivities) CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from loans from related companies Proceeds from shareholders/officers Repayments of loan from shareholders/officers Repayments of loan from shareholders/officers (RepaymentsOfRelatedPartyDebt) Net Cash (Used in) Provided by Financing Activities Net Cash (Used in) Provided by Financing Activities (NetCashProvidedByUsedInFinancingActivities) NET DECREASE IN CASH & CASH EQUIVALENTS NET DECREASE IN CASH &amp; CASH EQUIVALENTS (CashAndCashEquivalentsPeriodIncreaseDecrease) EFFECT OF EXCHANGE RATE CHANGE ON CASH & CASH EQUIVALENTS CASH & CASH EQUIVALENTS, BEGINNING BALANCE CASH & CASH EQUIVALENTS, ENDING BALANCE SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION Interest paid Income taxes paid NONCASH INVESTING TRANSACTIONS Notes to the Financial Statements BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Text Block] ASSETS [Text Block] Assets LIABILITIES [Text Block] LIABILITIES STOCKHOLDERS EQUITY [Text Block] INCOME TAXES [Text Block] CONTINGENCIES AND LITIGATION LIABILITIES [Text Block] Interim Financial Statements [Policy Text Block] Description of Business [Policy Text Block] Going Concern [Policy Text Block] Use of Estimates [Policy Text Block] Revenue Recognition [Policy Text Block] Reverse Merger [Policy Text Block] Reverse Merger Income Taxes [Policy Text Block] Contingencies [Policy Text Block] Recent Accounting Pronouncements [Policy Text Block] Basis Of Presentation And Summary Of Significant Accounting Policies 1 Basis Of Presentation And Summary Of Significant Accounting Policies 1 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightqsnmgxdOneWTTS) Basis Of Presentation And Summary Of Significant Accounting Policies 1 Basis Of Presentation And Summary Of Significant Accounting Policies 2 Basis Of Presentation And Summary Of Significant Accounting Policies 2 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightHNMpFTwoyXCwFourl) Basis Of Presentation And Summary Of Significant Accounting Policies 2 Basis Of Presentation And Summary Of Significant Accounting Policies 3 Basis Of Presentation And Summary Of Significant Accounting Policies 3 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightgrNVBDlMEightLPTwo) Basis Of Presentation And Summary Of Significant Accounting Policies 3 Basis Of Presentation And Summary Of Significant Accounting Policies 4 Basis Of Presentation And Summary Of Significant Accounting Policies 4 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightxbcpgEightrFiveLFivenM) Basis Of Presentation And Summary Of Significant Accounting Policies 4 Basis Of Presentation And Summary Of Significant Accounting Policies 5 Basis Of Presentation And Summary Of Significant Accounting Policies 5 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightZerowVTFiveNinenSDHMT) Basis Of Presentation And Summary Of Significant Accounting Policies 5 Basis Of Presentation And Summary Of Significant Accounting Policies 6 Basis Of Presentation And Summary Of Significant Accounting Policies 6 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightsXmSLCSrMZSevenp) Basis Of Presentation And Summary Of Significant Accounting Policies 6 Basis Of Presentation And Summary Of Significant Accounting Policies 7 Basis Of Presentation And Summary Of Significant Accounting Policies 7 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightkTqdVbrLTwoBTF) Basis Of Presentation And Summary Of Significant Accounting Policies 7 Basis Of Presentation And Summary Of Significant Accounting Policies 8 Basis Of Presentation And Summary Of Significant Accounting Policies 8 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightFourlwfdTqZeroPFyk) Basis Of Presentation And Summary Of Significant Accounting Policies 8 Basis Of Presentation And Summary Of Significant Accounting Policies 9 Basis Of Presentation And Summary Of Significant Accounting Policies 9 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightNineSixThreeJZmKDhOnezn) Basis Of Presentation And Summary Of Significant Accounting Policies 9 Basis Of Presentation And Summary Of Significant Accounting Policies 10 Basis Of Presentation And Summary Of Significant Accounting Policies 10 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightzEightSmSevenzTWXqgFive) Basis Of Presentation And Summary Of Significant Accounting Policies 10 Basis Of Presentation And Summary Of Significant Accounting Policies 11 Basis Of Presentation And Summary Of Significant Accounting Policies 11 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightHThreeFourcwFiveDhSevenSdN) Basis Of Presentation And Summary Of Significant Accounting Policies 11 Basis Of Presentation And Summary Of Significant Accounting Policies 12 Basis Of Presentation And Summary Of Significant Accounting Policies 12 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightGxPZerovVSevenXfmBSix) Basis Of Presentation And Summary Of Significant Accounting Policies 12 Basis Of Presentation And Summary Of Significant Accounting Policies 13 Basis Of Presentation And Summary Of Significant Accounting Policies 13 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightFivetppxJdEightsTSL) Basis Of Presentation And Summary Of Significant Accounting Policies 13 Basis Of Presentation And Summary Of Significant Accounting Policies 14 Basis Of Presentation And Summary Of Significant Accounting Policies 14 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightwLmSixsJgFourZerodZeroThree) Basis Of Presentation And Summary Of Significant Accounting Policies 14 Basis Of Presentation And Summary Of Significant Accounting Policies 15 Basis Of Presentation And Summary Of Significant Accounting Policies 15 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightvBcxZCLDmkdD) Basis Of Presentation And Summary Of Significant Accounting Policies 15 Basis Of Presentation And Summary Of Significant Accounting Policies 16 Basis Of Presentation And Summary Of Significant Accounting Policies 16 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightCThreegTwoNineZeroFNinegZtJ) Basis Of Presentation And Summary Of Significant Accounting Policies 16 Basis Of Presentation And Summary Of Significant Accounting Policies 17 Basis Of Presentation And Summary Of Significant Accounting Policies 17 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEighthdNinexBxqSevenFourZerotd) Basis Of Presentation And Summary Of Significant Accounting Policies 17 Basis Of Presentation And Summary Of Significant Accounting Policies 18 Basis Of Presentation And Summary Of Significant Accounting Policies 18 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightsJSFourHMNgPNHv) Basis Of Presentation And Summary Of Significant Accounting Policies 18 Basis Of Presentation And Summary Of Significant Accounting Policies 19 Basis Of Presentation And Summary Of Significant Accounting Policies 19 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightMthmkVTwokkZeroqk) Basis Of Presentation And Summary Of Significant Accounting Policies 19 Basis Of Presentation And Summary Of Significant Accounting Policies 20 Basis Of Presentation And Summary Of Significant Accounting Policies 20 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightTgTSLLNineSevenpNThreeThree) Basis Of Presentation And Summary Of Significant Accounting Policies 20 Basis Of Presentation And Summary Of Significant Accounting Policies 21 Basis Of Presentation And Summary Of Significant Accounting Policies 21 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightdxGSevenhFourSixREightpbOne) Basis Of Presentation And Summary Of Significant Accounting Policies 21 Basis Of Presentation And Summary Of Significant Accounting Policies 22 Basis Of Presentation And Summary Of Significant Accounting Policies 22 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightRzFnlNineThreeXTxzSix) Basis Of Presentation And Summary Of Significant Accounting Policies 22 Basis Of Presentation And Summary Of Significant Accounting Policies 23 Basis Of Presentation And Summary Of Significant Accounting Policies 23 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightSixPdzDZeroTMMNineSevenF) Basis Of Presentation And Summary Of Significant Accounting Policies 23 Basis Of Presentation And Summary Of Significant Accounting Policies 24 Basis Of Presentation And Summary Of Significant Accounting Policies 24 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightTNinedcMfqzFXTy) Basis Of Presentation And Summary Of Significant Accounting Policies 24 Basis Of Presentation And Summary Of Significant Accounting Policies 25 Basis Of Presentation And Summary Of Significant Accounting Policies 25 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightqGgvCgGFQJgH) Basis Of Presentation And Summary Of Significant Accounting Policies 25 Basis Of Presentation And Summary Of Significant Accounting Policies 26 Basis Of Presentation And Summary Of Significant Accounting Policies 26 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightSixOneBqfThreecJFourTDk) Basis Of Presentation And Summary Of Significant Accounting Policies 26 Basis Of Presentation And Summary Of Significant Accounting Policies 27 Basis Of Presentation And Summary Of Significant Accounting Policies 27 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightwWHFourgwvTworyVG) Basis Of Presentation And Summary Of Significant Accounting Policies 27 Basis Of Presentation And Summary Of Significant Accounting Policies 28 Basis Of Presentation And Summary Of Significant Accounting Policies 28 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightEighthnmTmHdTnSixd) Basis Of Presentation And Summary Of Significant Accounting Policies 28 Basis Of Presentation And Summary Of Significant Accounting Policies 29 Basis Of Presentation And Summary Of Significant Accounting Policies 29 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightbsRDnSixMVmlEightT) Basis Of Presentation And Summary Of Significant Accounting Policies 29 Basis Of Presentation And Summary Of Significant Accounting Policies 30 Basis Of Presentation And Summary Of Significant Accounting Policies 30 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightZerozEightqQThreeLtzqpD) Basis Of Presentation And Summary Of Significant Accounting Policies 30 Basis Of Presentation And Summary Of Significant Accounting Policies 31 Basis Of Presentation And Summary Of Significant Accounting Policies 31 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightMyThreeOneTgPqgSixFourx) Basis Of Presentation And Summary Of Significant Accounting Policies 31 Basis Of Presentation And Summary Of Significant Accounting Policies 32 Basis Of Presentation And Summary Of Significant Accounting Policies 32 (BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesZeroFiveEightOneSevenThreeEightQCNinevHXSevenspmRp) Basis Of Presentation And Summary Of Significant Accounting Policies 32 Assets 1 Assets 1 (AssetsZeroFiveEightOneZerosZrHmVgTbTwovNine) Assets 1 Assets 2 Assets 2 (AssetsZeroFiveEightOneZerobSixEightfPvCrPNDX) Assets 2 Assets 3 Assets 3 (AssetsZeroFiveEightOneZerokchWrZZerovTSLF) Assets 3 Assets 4 Assets 4 (AssetsZeroFiveEightOneZeroThreeGFourRFivebnxFpGV) Assets 4 Assets 5 Assets 5 (AssetsZeroFiveEightOneZeroXZvmTmThreeWgbpSix) Assets 5 Assets 6 Assets 6 (AssetsZeroFiveEightOneZeroVbFwsNineFyEightNFiveL) Assets 6 Assets 7 Assets 7 (AssetsZeroFiveEightOneZeroCzThreeKbNKThreecTwoEightB) Assets 7 Assets 8 Assets 8 (AssetsZeroFiveEightOneZerofSevenRttZXFmnlK) Assets 8 Assets 9 Assets 9 (AssetsZeroFiveEightOneZeroTSevenSevenOneGGFiveXtnFourH) Assets 9 Assets 10 Assets 10 (AssetsZeroFiveEightOneZeroSixTdEightKSSJEightkZL) Assets 10 Assets 11 Assets 11 (AssetsZeroFiveEightOneZerowBBbdqzcNzFZ) Assets 11 Assets 12 Assets 12 (AssetsZeroFiveEightOneZeroxrFiveFiveXTwoJgTwoDpP) Assets 12 Assets 13 Assets 13 (AssetsZeroFiveEightOneZeronThreehtvZThreeLStWk) Assets 13 Assets 14 Assets 14 (AssetsZeroFiveEightOneZeroWXLxNSevenTgxBsg) Assets 14 Assets 15 Assets 15 (AssetsZeroFiveEightOneZeropThreemNxLTwsqThreed) Assets 15 Assets 16 Assets 16 (AssetsZeroFiveEightOneZeroLMNinelFivelTScrTwos) Assets 16 Assets 17 Assets 17 (AssetsZeroFiveEightOneZeroJZerogKNgMNNNls) Assets 17 Assets 18 Assets 18 (AssetsZeroFiveEightOneZeroQOnePDZlVfhfVr) Assets 18 Assets 19 Assets 19 (AssetsZeroFiveEightOneZeroDsxTssSixSCZeroRM) Assets 19 Assets 20 Assets 20 (AssetsZeroFiveEightOneZeroFSixTsMEightlfFourqXT) Assets 20 Assets 21 Assets 21 (AssetsZeroFiveEightOneZeroZeroFourFiveCWEighthmdTpFour) Assets 21 Assets 22 Assets 22 (AssetsZeroFiveEightOneZeroThreeSqgHSixNCwHtl) Assets 22 Assets 23 Assets 23 (AssetsZeroFiveEightOneZeroXXgTgLfCTwoOnetd) Assets 23 Assets 24 Assets 24 (AssetsZeroFiveEightOneZeroTPTssSevenPSixFivexKt) Assets 24 Liabilities 1 Liabilities 1 (LiabilitiesZeroFiveEightOneZerokTwoyLvRtkRkTwoX) Liabilities 1 Liabilities 2 Liabilities 2 (LiabilitiesZeroFiveEightOneZeroTwolxXhwTntNinenz) Liabilities 2 Liabilities 3 Liabilities 3 (LiabilitiesZeroFiveEightOneZeroZeropVPkfBzFourFBx) Liabilities 3 Liabilities 4 Liabilities 4 (LiabilitiesZeroFiveEightOneZeroTNineKFourcCRHOnecRq) Liabilities 4 Liabilities 5 Liabilities 5 (LiabilitiesZeroFiveEightOneZeroBZxMFivemTFoursmvR) Liabilities 5 Liabilities 6 Liabilities 6 (LiabilitiesZeroFiveEightOneZeroVfTwoTZerobpwSevenNineDw) Liabilities 6 Liabilities 7 Liabilities 7 (LiabilitiesZeroFiveEightOneZeroGHTyfSmkXFiveXN) Liabilities 7 Liabilities 8 Liabilities 8 (LiabilitiesZeroFiveEightOneZeroRSJpLSSTwofkTH) Liabilities 8 Liabilities 9 Liabilities 9 (LiabilitiesZeroFiveEightOneZeroJWQhgCThreeFourLEightThreeC) Liabilities 9 Liabilities 10 Liabilities 10 (LiabilitiesZeroFiveEightOneZeroNThreeyNqLwwyOnevN) Liabilities 10 Liabilities 11 Liabilities 11 (LiabilitiesZeroFiveEightOneZerolTwoWSThreePcPxThreedw) Liabilities 11 Liabilities 12 Liabilities 12 (LiabilitiesZeroFiveEightOneSevenThreeEightTxEightTcZeroThreeTddEightw) Liabilities 12 Liabilities 13 Liabilities 13 (LiabilitiesZeroFiveEightOneZerodmtGcrgQOneDqk) Liabilities 13 Liabilities 14 Liabilities 14 (LiabilitiesZeroFiveEightOneZerogsKFourJsFourSixrvwd) Liabilities 14 Liabilities 15 Liabilities 15 (LiabilitiesZeroFiveEightOneZeroNinevxlXZeroyJpTwoVV) Liabilities 15 Liabilities 16 Liabilities 16 (LiabilitiesZeroFiveEightOneZerovDrclThreenrJxrF) Liabilities 16 Liabilities 17 Liabilities 17 (LiabilitiesZeroFiveEightOneZeroWJvwZZeropFLDSixq) Liabilities 17 Liabilities 18 Liabilities 18 (LiabilitiesZeroFiveEightOneZeroXFiveTwoxrMFivevZTMm) Liabilities 18 Liabilities 19 Liabilities 19 (LiabilitiesZeroFiveEightOneZeroZBvxRGbNlSevenJL) Liabilities 19 Liabilities 20 Liabilities 20 (LiabilitiesZeroFiveEightOneZeroTMTNineSixrmkMnNinem) Liabilities 20 Stockholders Equity 1 Stockholders Equity 1 (StockholdersEquityZeroFiveEightOneZeromQTTVEightFourZOnerfSix) Stockholders Equity 1 Stockholders Equity 2 Stockholders Equity 2 (StockholdersEquityZeroFiveEightOneZeroOneQThreeKrsFourCTOneBF) Stockholders Equity 2 Stockholders Equity 3 Stockholders Equity 3 (StockholdersEquityZeroFiveEightOneZerohdkvTwoPRfRyZerop) Stockholders Equity 3 Stockholders Equity 4 Stockholders Equity 4 (StockholdersEquityZeroFiveEightOneZeroyJvqvFournTRtLb) Stockholders Equity 4 Stockholders Equity 5 Stockholders Equity 5 (StockholdersEquityZeroFiveEightOneZeroxcnCnFkThreeCNineSevenV) Stockholders Equity 5 Stockholders Equity 6 Stockholders Equity 6 (StockholdersEquityZeroFiveEightOneZerokEightZlThreeWHFcsrx) Stockholders Equity 6 Stockholders Equity 7 Stockholders Equity 7 (StockholdersEquityZeroFiveEightOneZeroNqmbshEightPqCxM) Stockholders Equity 7 Stockholders Equity 8 Stockholders Equity 8 (StockholdersEquityZeroFiveEightOneZeroBsTwowFiveMRdFiveSixCz) Stockholders Equity 8 Stockholders Equity 9 Stockholders Equity 9 (StockholdersEquityZeroFiveEightOneZeroZKdNBrwKSQvOne) Stockholders Equity 9 Stockholders Equity 10 Stockholders Equity 10 (StockholdersEquityZeroFiveEightOneZeroFPNMxSixGWMpMJ) Stockholders Equity 10 Stockholders Equity 11 Stockholders Equity 11 (StockholdersEquityZeroFiveEightOneZeroRGRrMThreeghrvwl) Stockholders Equity 11 Stockholders Equity 12 Stockholders Equity 12 (StockholdersEquityZeroFiveEightOneZerofsFourTwotZTwoDpQmFive) Stockholders Equity 12 Stockholders Equity 13 Stockholders Equity 13 (StockholdersEquityZeroFiveEightOneZeroZThreeMJZVZRQkQV) Stockholders Equity 13 Stockholders Equity 14 Stockholders Equity 14 (StockholdersEquityZeroFiveEightOneZerofTwomPTwovbckyDSix) Stockholders Equity 14 Stockholders Equity 15 Stockholders Equity 15 (StockholdersEquityZeroFiveEightOneZeroFKZeroTqFourWWcOneTF) Stockholders Equity 15 Stockholders Equity 16 Stockholders Equity 16 (StockholdersEquityZeroFiveEightOneZeroMOneWqVWfxTwokPD) Stockholders Equity 16 Stockholders Equity 17 Stockholders Equity 17 (StockholdersEquityZeroFiveEightOneZerocSmGPzhCVLFH) Stockholders Equity 17 Stockholders Equity 18 Stockholders Equity 18 (StockholdersEquityZeroFiveEightOneZeroxtPlKTGvBGROne) Stockholders Equity 18 Income Taxes 1 Income Taxes 1 (IncomeTaxesZeroFiveEightOneZerovxvWTRqFiveZSixqn) Income Taxes 1 Income Taxes 2 Income Taxes 2 (IncomeTaxesZeroFiveEightOneZeroqTQJXprZpsCK) Income Taxes 2 Income Taxes 3 Income Taxes 3 (IncomeTaxesZeroFiveEightOneZeroCZeroCVlbWhkmSevenq) Income Taxes 3 Income Taxes 4 Income Taxes 4 (IncomeTaxesZeroFiveEightOneZeroNineKVfZZLtLWBp) Income Taxes 4 Income Taxes 5 Income Taxes 5 (IncomeTaxesZeroFiveEightOneZeroFourTNMZVkvySPH) Income Taxes 5 Income Taxes 6 Income Taxes 6 (IncomeTaxesZeroFiveEightOneZeroTkznSevenKqsSixXDZ) Income Taxes 6 Income Taxes 7 Income Taxes 7 (IncomeTaxesZeroFiveEightOneZeroDdMvThreeSThreepCkKy) Income Taxes 7 Income Taxes 8 Income Taxes 8 (IncomeTaxesZeroFiveEightOneZerowqdBTNghSXfB) Income Taxes 8 Income Taxes 9 Income Taxes 9 (IncomeTaxesZeroFiveEightOneZerodfrOnedtpWKVSixy) Income Taxes 9 Income Taxes 10 Income Taxes 10 (IncomeTaxesZeroFiveEightOneZeroThreeWvCsmtRrSevenNx) Income Taxes 10 Contingencies And Litigation Liabilities 1 Contingencies And Litigation Liabilities 1 (ContingenciesAndLitigationLiabilitiesZeroFiveEightOneZeroTwogkdlrmQTrcl) Contingencies And Litigation Liabilities 1 Contingencies And Litigation Liabilities 2 Contingencies And Litigation Liabilities 2 (ContingenciesAndLitigationLiabilitiesZeroFiveEightOneZeroMGOneSdryFiveTwoLFourk) Contingencies And Litigation Liabilities 2 Contingencies And Litigation Liabilities 3 Contingencies And Litigation Liabilities 3 (ContingenciesAndLitigationLiabilitiesZeroFiveEightOneZerozVTwoFourHQwccrVC) Contingencies And Litigation Liabilities 3 Contingencies And Litigation Liabilities 4 Contingencies And Litigation Liabilities 4 (ContingenciesAndLitigationLiabilitiesZeroFiveEightOneZeroZeroRZeroFiveSixKqhtFTJ) Contingencies And Litigation Liabilities 4 Contingencies And Litigation Liabilities 5 Contingencies And Litigation Liabilities 5 (ContingenciesAndLitigationLiabilitiesZeroFiveEightOneZeroxDSevenhVXhzwmdEight) Contingencies And Litigation Liabilities 5 Contingencies And Litigation Liabilities 6 Contingencies And Litigation Liabilities 6 (ContingenciesAndLitigationLiabilitiesZeroFiveEightOneZeroFFiveSevenrsTyTJNcT) Contingencies And Litigation Liabilities 6 Contingencies And Litigation Liabilities 7 Contingencies And Litigation Liabilities 7 (ContingenciesAndLitigationLiabilitiesZeroFiveEightOneZeroznnvgSixNZwbBr) Contingencies And Litigation Liabilities 7 Contingencies And Litigation Liabilities 8 Contingencies And Litigation Liabilities 8 (ContingenciesAndLitigationLiabilitiesZeroFiveEightOneZerovbqOneNSixKdZeroGTm) Contingencies And Litigation Liabilities 8 Contingencies And Litigation Liabilities 9 Contingencies And Litigation Liabilities 9 (ContingenciesAndLitigationLiabilitiesZeroFiveEightOneZeronqywkFbxMSixky) Contingencies And Litigation Liabilities 9 Contingencies And Litigation Liabilities 10 Contingencies And Litigation Liabilities 10 (ContingenciesAndLitigationLiabilitiesZeroFiveEightOneZeroSixzwpsfbwyXzb) Contingencies And Litigation Liabilities 10 Contingencies And Litigation Liabilities 11 Contingencies And Litigation Liabilities 11 (ContingenciesAndLitigationLiabilitiesZeroFiveEightOneZeroFPSevenEightpmFourmcmJX) Contingencies And Litigation Liabilities 11 Contingencies And Litigation Liabilities 12 Contingencies And Litigation Liabilities 12 (ContingenciesAndLitigationLiabilitiesZeroFiveEightOneZeroXdNinepFiveTwoCbSPyT) Contingencies And Litigation Liabilities 12 Contingencies And Litigation Liabilities 13 Contingencies And Litigation Liabilities 13 (ContingenciesAndLitigationLiabilitiesZeroFiveEightOneZerowNineThreeDkKOnePqbdr) Contingencies And Litigation Liabilities 13 Contingencies And Litigation Liabilities 14 Contingencies And Litigation Liabilities 14 (ContingenciesAndLitigationLiabilitiesZeroFiveEightOneZeroHFcpnTxZOneThreeNL) Contingencies And Litigation Liabilities 14 EX-101.PRE 11 cydi-20120630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 13 0001062993-12-002934-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001062993-12-002934-xbrl.zip M4$L#!!0````(`+EQ#D$V#7E($TH``*/V`0`1`!P`8WED:2TR,#$R,#8S,"YX M;6Q55`D``UZ5*E!>E2I0=7@+``$$)0X```0Y`0``[%UM<]LXDOY^5?+ZZ MV9DJRR;X3B>9+46VL]Y);(_MS.Y\2E$B)'%"D5J0M*WY]=<`20FD*)D@(2=; MM?XP&9%`]].-1G?CE6__^KP(E4=,DB".WAVA$_5(P=$D]H-H]NXH2Z<#YTA) M4B_RO3".\+NC%4Z._OKS?__7V_\9#)11O%B&@1=-L/+/)<%)\N01K%Q%M`(\ M.X\GV0)'J3)/T^79Z>G3T]/)9%WE>5V#/CQ5E,&@I/M;CN=,`3PG*GV1LR/8 M2^&YXGLI/D/VF:&?(5?Y\.EAH!JJRA$8Q>\FZ^/-6^2>=E4:NZYZRMV71((D-#=G[L.0EUK23H(DR%$6G__ST M\7XRQPMO4!?`QYM:C'R")R>S^/$47D!=I`U4--!163S",V@,OUHE2TZS9##S MO.5I\9YR=0:JSM6D)?T:KP*?=9J_K!1-&XN:>=&T+%KP79>=>LF8E2T!;8LP M6?E514U68^('S"II:=72H5>`12C*6]H@9PG3W!V>*JR!SM+5$GI&$H"5436R M9QZ9D#C$[4R!U9@3/'UW1,$,2JXGSXE_=)IS!O6?C3)"H#]=!LG$"W_''KF( M_'-0KS*)HQ0_IW>,PO,7%7WYNQ=E'EE]H:2^/-Q\T=4O?\\BS'X?_3P8@!)T M]/9T']4-WP?B48=POUJ,XU"8&14IYU2ALR%_$:5!NKK#LR!)B1>EU]Y"7*01 M:[1C\#Z3DYQ;$]D-T](YW6(2Q'Y71>;69`UT->?92+4NZ0@*$"^\BGS\_`M> M"3-5Z1]R557C!:U1K3/]+0ZS*`6BET$([E68Z77,,ZM1JS-C3T<@^BPFXO+= M+[P0ZH-#7L8D!8-A'MR+5CR""HLZ_W_@,/PEBI^B>^PE$+?\JR3)@&(_H7=0 MW;:I!W`(PKR0.OBU:D24S(;X$![Y]/%EZ,V$J4^],,$Y^0JA+=N,%XLXND_C MR=?[.83)Y"9+6?RGS5!CBHPOPVR6)6G.0\FB('^7L)I'BH\G`;0EQ,^KZTN0 M4%,US=0UO6*V>QAN@<5!`T4MUNU8V#O(0GXFSI?ZL- M7*.XBV7N3+HQ_;61)46[4D&UO7/).K>WCKZ MC#&ATJ'O23I4YF%]K'FX)$'X[V'+QJO8,J\35-/)MV_^BDY0.YT@&3KAO-[W MKY4V7J^_5FJ^0?WF:N!\@]K;-WQ7#5SQ>L(^G::63*PBM2RK+"`3SPC^.7_\ M]K3\G9.@M6KU,QA1URL7\R9GG^_/VU'XPMBMZ?C!(ZAC(RHM>@W9%O'2F*P? MMV&8JZ&Y/B-[CJ-X$42["#>I84-SNS+DAAOLC=(N,T[0DBQ]V$)3*TALMYN* M3@>7-OB]FVG73KHUU:^M]JA;OIFCZ[R MJ;&SD9?,AY%/_[GX5Q8\>B%TZ628CCQ"5C`P^LT+LZUQ;27?V`P!:3_CQG_@ M60W7-%SP'$+<9`"LYW_[0-H.4@VG%\CA9!)G4.@.F$*%<8BO<5J,,3LK3T>: MN4&UCT4/,"**4KN@N8H>X5E,5E"@LRI<#5FJM6'/$Q5@)R(L4DU=U9TV/,\S M?$GBQ1T.Z;3W+:0O`4[ZMKZKZC01:,.C!QJA?N(:AM8%T2W!2R_P+YZ7.$HP M=*V;=([),$EPVEM-MF:8G&&T8-4?FY#23-5Q>^`;^H]TI2:YB=;V=YN1R=Q+ M\-;$4&NE63K?E?=PZ(%%1$F.KG7"(\6"D.GHEL$K9$]K2+,+Y#K0G=Q67&]) M#%ERNKH-(7$&FZ%1:4DG]OJX5*3INNXBWC1W<^F!1T@I.GA=S>V":13#N()D M$[I6?!5!O1E=]/U`XJ1'-X',0+,-+C/8S:0[&A$%68[FZKR"6B.ZBF#4-0L@ M4.>&!@J\>)Z$&9UR_Q#'_E,0;JWRM7?"R+0,FP^5+S.3`$\LR=,T9/:!F)?K MWM]4'>FNJ=5[?"LF8HF+BY"IO<#H?AZ3]`&3Q?N8D/@)I.XAFF5JML4Q;"`N MSEU(9@MZAB."H$Q@;[T5S5Y[Y^HZC%5Y'3!4QC3@_(8QSG4<3?JZ64-%IMH\2MC#3PY(H8&_:]B]@7+:[JPQT])-76TVH?;< M1$0W'63J=K/1;$U1Y3Z&;9CJ-R&O\F/K+;+B?#M.'[_(F]LAUG,%`D9=%JJ, MX:N4!?D*^04QWD/?#ZCA>^&M%_A7TG?PKQC$PA+LE'GB&"4[6[XJ:X!SN,[(,L^2]%[(]_]W'<9;C<&Z@%XI# M"B04GP\GU!U.O2#"_H5'(CK(!HK9(F/I(F1&P23H'L0&FFVHNLMYC9>9]08G MHM:!9ABV9>C=`7+O6!"<]!F6(3FAPQE2G+,A7R!R0HUI\IK^?][9. MP$+R.=Y;NN\[CH9I2H)QEM),\R&F&2:@(W$80I'>FC(LVZG,B\O!\RHR"J6R MJ@MICG-8.;GTF,8D>3UY>V+^)58]@?6;S!<#5TVT;SUR0VB$QS[+/V\Q8>@'9 M/K#PND#VGAC;/]S2-/6@>.2KAFT9IC:%R23PPCL<-@4FG4H++)5TA@_)%L'L@RZ5+:; M51\H@M[!9B=OI$+I[C`TQ]D5PB6`$=,,A"TZ4=8*3$,XD6PREHFT/<%+!B!! MPU$U9%L'0=1C,&(8NG%H3()Z"+J[&%6U-%4V!L'L1$.J;;7"P$XW@*E,M]=ONQN"KCHV-[O"\>C$ M7$QX`_&[QSOR[MS\IN[PNRS[LQ?L`18RC1;L[[W0(_FJQS^\F% MDX1M:+O$4J='7%6K'&ZN,NH.0S2MM1U=(HSNB8IMZ^9A@(AIQ+01;\G[@7Q. MB_7ZFR6]-@2&UL7Q[P?O6:JUJ"Z_RV\_6UD0!?5FO!*^[G.SX$&_`4C1Z?//(5S.U%\/F_BT!A(' MQ_9G%H4_X`B,D^XF'OJ+(&*W,Z?!(Y9N?9IA&AQ6`0P'`2\X"#9U?A_:-P+? M?2!I.+R#__;P!8,3LG1;`GS(!AX#F@QL$14\T`Z59EAE,2 MG,YV,]`,2],."DA00[IFZ;S+?A$0O9HK2>E-3'F)7><(>AB182'^6K!='/OC M$K4FU3$/"*N[5;D:T@ZIL.[F9;J.*"Z6?5W'45RU1(D3N89KU9*];7:],8G: M5CU]E@>IA[?2*E/>A\,ENF+H"H+:?B]]^#DPP)-R=K63I01DPG[+=0\*K+N% M(618_`SS8<&)QD9+7&V;L$FO2!W%](QU!E6*N!I'R7L\C4EQ8)5-U-5/,L)8 MLTHE/][U":?SV-_X4*EIFVF85N66W5>3XKM4GW"::;ON?]37W0WHENHB]3\* M[)/&6Z[YW2@0"!;>\3V.L-3M.LC2ZF)N<>L-J?,V6LF`NF_D.*"69&PW;@4I MWPLD>X;"-&RMMH*;,^G"O&>@Z,2\CYM%JJW)8]_32>UB?XW3C>?I.\EP012N?,@ MS-+MT_L"%M)XJX9:N57C!>;2D+Z@OF^/M+V]?5=87UFO_\#!;`Y/AX\P*)GA MZXS>BW`S+)E"6]MM?[."(*"#2;.O'79(8YFV:9F6_=T(T[(+_-LT3LMN MF:MN3O0/MV4::J=(+P5_B*0.9X$X`W=0-LRTR;LA)L)?@Q5M M?\I,ZAX!9%3'X"]REXVWS^B\-]CR$TX-MR7W6S'0-,VV]F'E.$L#*6B@9F4I MJ!?$XKMAY6WSC=\/D[PDPW^VK!N@PPLEN$=&M\Q#RU3[ZDI9>;VA8L_UX7W: MR]69+Y2"Z]5$%#T+IO)W[1Y4Q-JW4>0>KM-M9Y\8-=Y2H4J,!8(PZU]8D>NL M5-5Q]MI&G;U!+[P!R>1GO+NB!\_"%KLN8U)\I?(A'DZGX%2\5.Y.>H?W MYGO92D,H&$N=RG;3#A"AP.1?64#PSH\\2G6[;@/:ER$&L43-U M9%>^.+*;KRR$G0<-[<'M<`*7002IQ.$\J>MHEOFB*VI`<1CTHM-++K+=_NAI M)<@:Z#\T_M%8!Q*`-'[TRS^H[;=!6@N,X0^ M1<@*ND^;S\&I+PSJS,IG,EMQE`&R]0%HS=#X:TTZ`"RWI]`/NTF^.DA'_*S) MADU7`((#!4OE[6P?@/5>6ME*:-HYF7/I`:'_YLTF"'3%'Z+^+>B(7@Y:+,O= M![,HF`83.D[=?'HN#H,)1*4'@/@^C"=?157V\P]A^F:I>"%0?W?T1P;#ANGJ M2$G258C?'4V!V&#J+8)P=::DP0*"<(2?%,CIO.B8_3Y.P$%/WRBL9!+\B<\4 MI"[3-T<_S-(W5"KZ1WF,Z8/KFX<+9:@,E/?#^ZM[Y>92N;V[N+^X?A@^7-U< M*\/K<^7^\Z=/P[O?Z;O[JP_75Y=7H^'U@S(3YEG^O(6-%3G2B,",/%DJ10D"VS;Z.PS*Z.O)=Z`^)^V&.P5:] MS`^*/2T)F))/TTQENH:@@@B>+_(E<0ICF9$D@UZAI+&2@E0$LYF='#8E`7CHBC;0 MAAJ74!?4,/CU1!DR`6!LV'C&*=XS2.4R@'"`M> MOC)>[9"A05C0"Z7Z.6*J9V;!]#M<@*03CV'V(NBT86-3G"A_BY_P(R;'6^`* MX"6+!#>HCVM3@J430BWZ)6'Z MBJORD_(T#R9S!1K^N!0P7@811055P2:]&>-Z#%9*9X/`(S%!:<&I%Q!J-FMW M1ZO0%SO,DLWMEXVQ50[H9&%NL?'ZK,:)]`PTJ;+*#EY^/#MOM[\D%=,Y^1:. MM'5;Y"U87GRR]JG'&Z=*U\N>YC$XC`'8*:YY65KBCQB:1*&['S*0&]P8F!P8 M$D!DSA'^9Y(W=&EQ>;64>%'BL8;A=8W#8`&``7BCYKY1`-5.H#LD$Q(L2W?P M/DN@GR7?1>RL--J/T].OIQZS;`)01S$!4V>F^)/R(VWNLK]IZIM:#]30&P7< M!E^`4>;>_\2<`%A/018,`I@,LQE(I("?0*YE'4,@!S?!;"OTGI+24['(PHP, MU``=*`J\$X@Z:0#.GH`%^@K-`\'5J,;Q3@3'-!HN?%$GALG#^>S*,XC&?@I$,E'[8FI;];L!O6EJ$'%9F_ M3Q,.%2>P$L:@S8!%Q`6X)Q;V-NDV.)Q\53GO2"`W!*!<#T#UB<1,R],:@:#8 MH+2"'@H5B[A1*`\$BB>Y'X/^604#PA=^F[E.2K6FL=1;XG7#@+Q/F$4N$`/$ M)U"&;6QC*1J]-R">\J(K(:V6UXG'-+JG^-6=Y@T$&CPF=%P"3VFX4\V*%N@/ ML-$99!0[W"$4\29%]E4F:K0(2>;!,O>#]-P)V`+?7:$2-:5'Z!E@CW,<^DKI M+2N=K#"A=1?Z!`Q#JM$?CXHTN'QR]%-3`S=`6?=+&LN@F=@^U^+SHUQZ7=(] M9C;;$$RX?!927VJ*A0%Q'IYYC11B,DNN/AWG`;K&%S(.8./S MD8KE>KFN"3.K!F>WOQJ&I!7<14Q8/^5SGT(G248>@\=\WW#1'$EN_]N:>75K MY4-475M4T="XT.,"2.R8X8`Q(^K%"ME!8Q5S'`GIFNGOZY=>'CJ_$ MZQ*F&O;.6=0'A:?K*[A[J=VL:R[<:B"B_`]8)0W38MC&G[<(X"(P],U"G]D.>A]+9-L:"`)O16^Q9F'L7V-ELV]L M2"N(0+9KRPU7.BQ`HZ?;?LCC+^/Q%$C]!IK%.+$]?XSO8:LQ]?!C,9KLA__5 M_IAX.)\NDT.VAH'-ZVR$JT?G8JFF_X7'4T,!L8A3%"Y37IMTT'38=:+<"MJ^ MY$,*&%=+//;9"S#/T%:93N#&\32::,6=)9]\!&3$*+K*&M1"V(7ZL+!P8TAL.>@VH(3&.XVR6/CNO/07K!_6@[ M@5!S\;R`AP.0N?`+3>$%]G#J6BS)Y#2-IO!+I1']B;@!9:"#JBDB)8G3!^,9 M!OX<1PH:@[G(,P\;*_!Y_I52?7E&+=DV:&_W$W(_RPC#_V>EQ2X!SQK3R4BW M99]A?"P&Z@8-KF&N;F*;3`I<6F@`>;KNTB246IY2IDY8[)G"BTA2/EZZFLJ- M/8/BF'`>%(Q#RUE_@.V-''L`*\X M.*6(?%;S4\W!@;EF!AQ*_H(IN#H_3`I^>+]+^_^=K2*2N*;^:K\IF2GT;GV^`2Z!FO3XD;7\8#UZV#*%H_TTZ3>,H=)USPP`[\'RA.+";4)LO4),H6ODFS= MB:7I(Q-8S,82QUU@<-BTP^B1T[_K]\$B$/TO36-HC;LN?>J1;Q(_X:]Q.Z1BK''DQ&&0XED"PT_[DNXPG4,<=] M]ONW8#RN\7&`88>0#N^KWO=BTUR9+'0]1*`"'0KG)&5Y3\MX)1DU]]&8J%%=%(&!%)%6NT:;U\!`.JMX3_)%0L2)!S:\'BUF07E>VZL!XT M"W`E%/G<^HUJ^(URDX-@CVFX-Z5:U6Q4ROH#4KH-E6#&K).:0]<''+M$K-(. M$@ZI+[`2G&C*WK^58V0+!!"YLBZM:,0.$EV;??G6;K4NT\Z0-7[,A`O$%_I= M2*$*;AX_%-M>R7@130+S7KU>GIS8M/Y)[$B8Z]\*@D\*8N@E:@8I.^\/BI!>,+!@Y]UT[8 M=4J*KQYO5+A[927@(N\'2`%.8>"`9B'WHD368XG*LT&6@-+TM*LL=(/#6UW' MGDEW>]='TQ2W&#Z*M.-"_(%',8?%#PQBV.!^AF["S_D MLC6`473PDCL1=N$3PG"_,D)%"2L%X\2G[>B#E@B\EQ`;U`GM"-\:R6V!B?%$ MG#@CC<:"$^X8?ZTK`3*61)C,9G?AT!>O0%9(I4OI8*#=*,>$G2*QCQD6I<6% MXE*!A_!%.+"4&>-JY")$%S#$[%[I)DE=7O"S>SS+'0&8BVHHW/DU^*Q0.V MV)N*688GUI('3L&9)@RSU$A^$VW&EB2%G)`"@C9"WSLHE]#6C7*CCRU>8/'X MTVB]>RU>6H]LGQ?B_M:7)HL+X0;35GQ\MI,.PG`$&N0#\&@,>MB[!Y46L->, M]X#%-:9B[T@=CV=*L4O^Z0?22Q+^4P]WT!KQ`\HUT*SFK/./?G;BHZ;4IAG' M$Y./;@NRU%U<385BEJF>H<":F1H,".B)&B?4G+.+'O371\BFP#7X9# M6!+-+,=EE0VLI..8U1,;PHSMA%B6PXH%R=BS32%O2)VG>,T:@9X@C`]R=:(X MU*3I@=2WS2>2SQ!?H8(B/SVM< M#:D3-V?:T:?D?JLW*V:Q6'PA4N]=][UQA?E\+#'BI6(,;#OI+.%TP"?$RY\R MRS'@A\HG.*'F'N#)2/.E5D2^Z,2!X!4)GN?9=)%EAKX-$)Q#F;^HO#/25V%% M^D,K%(@6.;]#;.(N'U?@[5&J%_];.*H2>C,97I#VE/2;H*1Q,<,7UTWP-$>% M_;#6-2CX^5*62>^]\5$8+#BP3+6F1"VK/HFJ`-M0!0Y`7*-GU1X8GU20X!NK M/U,^%>R86LUL-JHZ`<)+U5+Y0QG9J7B3T-RZTHX=9B&G$N,N)\MTG=TBDA_P MJ#!5MCBETR?LMJT#WGK(A>(?7LPEDZZ"5,%PB-@D$RZ1-*:3##G2:);2^V55 M9V?%)!(J&VUXUIL).WW[6'X\>;!3ZO5BEK$LI^MA"@80[.UXVO2YU68Q:7X] MXU[0C4.,QHM:!+48T"R9>OU0;/DEJ%_[GOQ>PG#&T`+=$(W(;A1+C'Q`G"(G M-3\J$TQJH<,6XD(9;.3PZ2D@4>KY=%(-B$GD`GE4QTLQR>=1]'P%0LW'U,N7 MJYMC:PP>CTE_]",+8Q:#^$M3C&WEY^P6IM^CXQ<,9)`6U@P,&+R4FG+Q:`,_ MKR<*Q6T7;GDCJC,@S.,4# M"XX+3=*7E,-=+1A_L8?@D]"RX9\OP4/#22DVUQ_P:65-RKXL/$";ENS0W$I\ MQ%X-=55,6N#>5C:)4%GH_9D(`YW6(]F_PCA$(8DNHK$J*-`<.FGG1]\)>ZX? MBK`1GWZ'VCE^Y3?\EKY(@:74U2Q&Q?DVJ^0(VR(4GE31N[,_#:1#2TN*(\F+ M95D1&VM<9].C"I.^`\,.5)T#1C)Y1^`64!Q[246STF-:$]:#ZRO3@Y"P\KPKCH8_6'"(@'V<1BQ0.]'5T7N(!X(S\Z!IVZ M@HB;):IBR(UOVQPK$2GE2:<_[0&L\8*='N`J'5,O'R)>"`=1"\:'-683G8?E MK;A'E1C!>@Q9NI&\SR0*V#ZD/#`VCHAQFFO5%"&;I:SH2Q\FN],E)KM0;AV6 M._+/)1_D2U_4SJGSSL'#_CFE2+V$39,*4F8D>E%*YQ\MD+`X\T<@C_YXG\S^ M7^@5L:W>B'^\;J!KIUCG(1WP M:=[XQ.'9CS\T-4U\%N)?*%;&R5H);9FH=Q!YL7%1XV2*F3[T398*3=3Q)VHS MY<%/*ZL0.EV6%W)Q"8F, M<;)8(#_C[&+^@_!CJ>E$'UX<+OBHS1$;&::N!Y6?"TUR5>HD@X#B],B9TJ%! M%1\!A^J=@&(/0R^V#_YE>5W'\M&Y2C5-H.2P4$78K93&:CG!V%*I5H>^%="F M/I*O*$CO+!.$A3.>2@Z0.`KK?_V";-D&^F=)?!+8STNP9`4]$=*3.'4IGRA\ ME0BSZ6Z8[5"PZ#FFS&N?3 M/]5*J](N7@J4&KS6ZY&LH&6310X^]CRPHM)I6?<\=0@5!T$*D_"SX*/'A4\/ M4R94>>@TZJ6WG;2$[9`KM4N/8*\D'LBP>,7!O^A\3*;L&O^,.-3Q*1B-4#N* MW,3I64PR.?;%W>+PC:R)B\!$P@D[F`+=T1JAX3.`)\OA.MKR>4D[[:!@M*1+ M"R&Q7L)6:ZDE/[=9<7@SWYWQ[D$<@2G72\%\#F,!RAYV%XX(F+E/P6+TP!>, M&]JK(0:I;!&`']ALH6AY,72\"$.1,Z-C!05,Q!@E?<)MC"O,QPY`L76_U*AB MRY)SJ]%'0GY^VUCZ4Y'K2.^7$@(7%HT@&CD!)Y;@V9=*S*PAO!&$PE0/`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`ZYV!F]PBO^O>$5LZ$5?P&L8A:DXHN"4\R&4OQ-8!2?2SC\AT,G;@*; M^`J9^`J9^"S[\_>'27P6KKU4:,3<81%_2TC$9UD2SPF#^`J!^`0$XB/PA\\" M?9@O[.&^DXQ?X0Z-5[C#;+C#V!GSF),EZ8[Y*[2_#10XXYN5X1&E\1&A]!:(QWY9,[CS=J M;]EW_A28BHS^\UMMT"J)2QX-Q<)"9%Z84]US",$K"*OR&FX$^` M9#Y7M/H5'#.Y@+==B)H/>PVNYG0,AN#RV^!1@,T[._"/@0>?T"7TS;/;Z#OO MC.`\3%<>0F\\7/3ABYM.I[WMXC>P2H%NGH`2^@-T8`]VOQO^OS]@8Q0+!^+\ MLC?Z]\.SSQ?GD^/.W%_>MN;'(/3,>%X]E>^^CS>>?GV3@-^VDV-@\JQ<8>A%_F2/;# MQ/!VW#YKM8/S._IBDI\(K)+FJ%3*OYY_Z4'LAW7WG8?^=3;SR'>R@?VLZ"+IS> MC;\>C>">'UZNVF-?RF/-6/;#R!_T;WM,EW]T;FX?AGCW[[@6UPQE3T8T?<3M MT)OC;4R'G2>+2[QC=DW7;P?C0]@AN>J61K58:>Z!DYDC MV9.*@:^BR61QVF?SH-,^RY6%U6JC7JWL0Y,K()J['QZ_GXR'#VP\_986]QUSH[&M_WC_+=S)5:N?[K&:C3OQ^.M>CC M$`Q3M!+H9OPPO(M.\V1@I5PJU?;A;'AD//MAZ*B/[UL<+A[H"[D3HGZ^&[I2 M*C7VP,ZUH]G3J?FTC:_\?'XQO+SX/,MU1>[+TDF-83^,.X]&X_MKV`7W]WCG MPPYGOPPCL;DOWJT,8S_R[.)UVZ[2Q^['1XR0RJ%/=@ M=V>.8S\LA!==]G\BZN&\J>9"6^L-\['SS\.+[M M;-VXZ#'^-9JE_O6+M?K>^#=FI'LR>EP\QG?-YS/P+`*EMZ-/.:L/SBBJ%?S\+5L>R'A]WPZ@A?=WX]=EG^ M_CP/N<`CM8DQ&G!0KN_!@%D=ROY"\AR->/A.5\^B'P^3'5Q>F7R4Z0U[$(AK M!K2GP_*2/L,7G>'EPQ#F$T7+#@9U)C=K^SHS9X]F/ZS\WD);:O;YEJZ'D_'5 M#ID.&>KYU[,O8P0:ZSY2\<1ODOQZ\:WSR3A,E$-_;+<_==HOH3`>M2$&9\2[*UA+V86%[H M/(&/GQ,>/A4UI'A!E3R*M:K9+M=`,V:4AK5H4J75.KA-KIJ(?QH*Q"Q[8CDQ M&(VIXZ-*&#/7$.1P)M]SQ;`-QJ5"CTJL.8J M41G>FWP,TY$!*+E*!E42J&H#UY]SEYP>]9<*1#=3+-OAZK3$:W&1$)3GF+I> M^ZDZLX$3<-<__H#U(Z*2607N.):7>Q>03\2'4'@5UAQ@9]BN!:L&AO9UO/T@41) MPLN/2_V66&+WR`F3>\^<>O`V[#)FB27L.^'UC`N MJYQ8Q9T2<&T.;.Y9[Q(,+Z$\QAAON&]!);LFD>'&8D"K MN9?%ELCDN#658JEHV<(8-SP1)%E6N_50'1"+?8&X"CR[.C\L-PN5<\=UE9Q> MA3!^4S7KM3(JA??8O!`DCE#.6,1>!V(U0%BMRA@>WB@HL(4U\,B@<$JUIEEJ M%KD7M.K,)\`10.)Q&9-L1%*N4NW\02$+C70=(C=-GFJ8)6D4F!K<-#06N7'K M`V*ZJI@*L`B4*7L#[T.(=RR&^:5;-:K>JZ\TWIH&B6:ZK)"T$'(^3W M8.IN3E,&J+AV&X$IC@P!%5"W%+;;%7Y*,@[<*1%8"07>Y2A9+9>*A M*D"`MV+JO_4B'YE+S5%@]I\3*;036,?6SH-K-'!#!@ M4FDBX9=C[1YVC&(:0W\0S6$L'^9V-W0B`=L]MGK8=0NVX#04EI-L@!VWH.0: MXD1[G5UE*%8Q@S&"9:*DLKS'68Q"$*7:%$F($<"P.P)JU0_8K%NACLP$'$E< MD0ECPUWB.@-5FBBGHD--I_[MDSY)?,?551D/F5'YM\+(4!8NU7,4C$,Q65Q^ MFYJO#1]:ULUFM742+\K:R1J_$_#T#K&7EJ0V"7(N8S'^IFXV#DIF.48*3JY% MMDX(RX=17_1..A(6(-$G#*1>U:Q9Q:JW'\\I8 M6""'#+U?BN($]900%AACUV?R)M(70<'X).L\E3W$K;/*IMX48&TYZ7`*9W14 MJ4C%"1Q!&*D,".>SF<8C=I>8&1SF2GWJZX*XK2PK"2R"^2W`[U(BE\XPHM$Q M,]B1/-)^AP(9@6?T$OF!_9@,Q0>F6:\M$\=;&<'/O;A2+S03KU8M1:BT'_MA M:7HA31'R6YM?_`9X=($J%RV;.DYBM9'1@"K+=;7BU$K[Q?#O\"[X/+X>=KJ= MN3]#OUB^:?L'%;#-$^1M1,1&I'?;SH+^'ES.6L'EQ=%MGK0?-"K%2JG\).VK M5&Q$_'UO=!/<45IWIWV6:U)"M5FK-I\F/$7!1E23$_4$OXAXY M7G+I#U6+YCD%C0UG()N2C0;1^D'C_MJ]^,KQ<=CX]/UAKN('SN^EYM,#64_- M1H,94!SA*HKN;H_'GOLUSR$\37SZ[9OM8R[%P7_@RLD)?G\;4?+O#JDJJ^0W MJ_"_I[?R(]1L-!PL?>/"CJ_M]BE]N+_+M5"E=%`LUPZ>'$DV(1N-87YXV.T_ M_.A=_#B^VRWCX'_1[EC-]GN:>IV$C6A>4*DZ31=LF5/,R3^:7.:=IEA[DO!L M.C8:`L<%1]'LCH/2[>AFAW2C3`"&I_=P%A$;47]S>[:XX/#F<'$8#O.EO/PT MY6D"-J)Z0J,<7RS..O/P@?[8(=COM7@!K;>N. M(8^F.#<.2N7&TT(SBXZ-!G"*_PR_7@S/+RXNW%QIKU;*&UD.*1(V(OL[_/?R MZ,Z]'HP&UT&N=2*EVD94)RG8B.BC<-$)0]`*[1;^>;4#-LG/T[U"Q$:D'Z,N M"QG2Q1V@+GZXS143I%QM;D1^)B$;#8&NP?UXO77#R7#C?F>"UW+=LO6-!O(8 M.9N?OMH/P\_`D8O6_'.T`\S23X]BE8C-SERWP\[P;-`",057=JF5^TD=FR9@ M,XY?XLY!]7:)65;P[>)KE"_IZ#!ZFNE9=&@C.(MA7G^GS*66\<$X^_+Q\,O9 ME\Z73R\B:6EM(\E'TY5TF%UTU-?,>J5F5A!'7?4'C\,=64V@*11@-IHULU1+ M-'M.!!LFUI*!?S''J5J$>XN%1+11;^FG/YY@NU<"`)Q6A>E0E9IJ@;W:J;!9 M6.U5^$3L0&^ER!V4M7#?2D!&ND,IQX&2/0)GZ'C4#Q1HE8GB\*6BQ(I-A:-C7VVCT*S7.-J,_47'U#]2/D1%YR5Z(_#4 MGA-B.0PJS4GE50^M<2+^]9/LY<89CX1F.J*=1]SX%JC#E8C4A)%%F-LZHV3* M@?3+*U>TA%=5`^=5+S$G<9_1FDMRD2:6/BGVQ7"V-)X]F3\^)'LA-49M13-S4(5UTE&NWG1XR/]6Y68@6#(`5.E+:5$D#L9 M`EC9\NEX82+6QS/9]?W[N(M69JQN==&5L?YO9=E1X"HK(IGQ@$:ANKIN,WB4 M#BO_)P85=138&-?>"44UXH#&P"<6Q[P^'4 M-\Z<:2J-CK"X"\;'1-+J$TH-!&RC6C,/BB7Y1H)^5NEF&8FL,3CNK:-M12#E M7Y8WL.,XKN>[_C#."2S$+87EC5PJNK_"C[F&`FM@S%64&W)+0C8?`MSM+FY'\XY'>&[>CUQ=,V!:@F6Y MV1A6*-E\$.1;N[Z\'QS^H+/N8:ZQ-;!YP>3=;!"KE&PQ%3CLKX1=UKKZ#!=[ M5P^YAA/`*`2;<,/9R"!F\Z$/)S-YTNX-MMA8:4'PUND6=UPBZR2LODP7)C.FS8]X+)W MR?"F_1VV_%,^])\B9[/AI`$I.&>HTU,NU4Z?`\<[#"\CFZ98K&PVOLWIVWSZ M^N/HI!<,,6YRM`L^U5.!IJW(V)S\84A*]S04($#!;+Z#VSICO"O<7/R],)+.3K'=*V=MQ'6<1L/I394=!S:4EZP>DBR!B$!+DLV'U.Q@T3[Y7>A;1LX(<9'PXE@(=7?FSEV MXWZZ.?JS-]U^JN&V\J-Q9W/ZH5C.6Q=_QLW!5%E6J5PTR^4:T*=HTXJV,KX5 ME&>WAT_YWW^WT*I-\D'$1^N-`[,.,Q-17U0KVQYG=Z/<[S\?R;%U<` MU3@L:JYILJQ:TU'+RRDC6W`/1]G5F_KA(M]F#"]@>Z%J_7UO+['`TQIRV\M4 M&^H!M9L-9@YVNG4B$A6JCW#2*TT[B!K(^D$TDCMXE5Y=O,8D&PPNDCWH-=3# M]N%"0$*R$+&ZK.;E9>P\GMU]/"W+$FYVGP(?6AMM$^.1]L#XM,!NJ4C0-_:Q MT^9%T!M@S`H737WM5UAQ;XJ%8GE% MN)NBA@KQ.#`\$2<.9$5$DEQ8MP^&`98&XZ)YYEVJB<649J!R5ZD]+6,.HB8" M)7MD=R/L)8RZ&YG_44(P<.CPYZ-0!>.=921B[L*?+'3OE*A:$_2.YY`I&VQF#$6)YMC\- MW25'9JE\F3=]7'FI`F2[Q`X+&F-D07.&Y.%NLU,R1.#U0FC`?5U;V@]ZP2*Q M3-''@>S57R?KI]-O)(4\#2B<+'J#=W':5IZ3QM^H-\UF(S&9H.R+O2.$XL3!,;+HO%,PT#]:67\&8&0D`'(9-XLM"D)_$@RG:%>J(EY7TN=*#7$ M6U:CUUN?:K5S_>IOLD[4X^^=SC5=H/8,<#48Y(H'G@E,NA-M6X\1_L.XD%\# M7@VNZ/L<6T02L'$1CH5P*MQJ;"LT M;3VJY>GL889L\3I7T5DW;X32GQI5BJ:MQ[3H>2WO^)[#;@IO/5>/>17.LG75 MLFDGLK8>WCW]<)($;3V>JY.KX)Q[;8V"V3S76J-*L;[M:-+D;#V>`>EN6+O1'=4'?Q\? M.SMV*?U?FJO5BN7MY$0V8=MO*&+.^>G=]=W5]_OON2HK.%G9>D"]]OCD\L>H=7UV MO$-26S9,?!4.QW`VWFI`.CW;F[/1I?NUO;^2>C\_'V9=0W_D6E*^AH^81N94*(-ICC M!K`\@;#YZ4LG@5(<5^F9Z)[QR;\(8K1!X0Q/E!V(AW*!P-#V$(;0729J8[!Z MB]X8P1M%M%&[YZ M;V`CM'4<'XZ?.5#Q#ZKJ($14PQI@?$('QR;"J39.8*9./1>+>!0\)3.6D'I5 MW:-E8!R6H6_[=@C3;'&\;2@1_]@]-O:!!>S!M^*[&'>6@BLWL-; M"L8A/,.C^B4]TL%XQ,*S!XL%)M1PK3E%WX`%KD5(NN22=D(*\\"W'#T]`C;! MI9ZV3,+$XCCZ%"86!SK1CH%P&!4AK%.QZ[H?'W])_EHXEH%$BEJC;Q-I32V% MW'XV,HT]MIA0($$64 M$RBBB:6'=%TO7"3^(P!Q)'VG>&5$+0V6.M0MEJ`AP+R'3,!W*:Q1VW7&#LU[ M!I3V#7(MP-`.@:#B-Y'QEB;5N>"H76WB;\RZL$)-S5 M\1+&M\EEK!)&M*<*+&?"T7X^*=E9XW;7Q)9H>"#3%4+CKT*[P.%;F!I=\-`Z M"VRNQ/)\OE'6L['P4D6HL.BHWA4G#X.EJ302?<$@RC=H1R)J&@2Q,*/GT]PO M$TBW.)%=Q/&&;>U,9#T856I19!@&U05Q/7`B^231SX*GQ/,I4>C!!'D9M?B#WU0YSXF7:C(&5'JJQBS#-(XA*C..47P6>)ZHZ91O*32 MO[J*$V2JPG-`%P+I@**>@,F/Y&[$?O['[-3-!--W;8FBW0QN^E#E M.\S`]'+V657D:6!;.C8?PD/G^^GM)+B;A*T=P.^RJ=^,>)V"S>DF.)S6M=N] M&=V/R96Z0R+NXRU6MZ=D\V%0>=CUX.[N+#J[.V,[#``&R/'!>3>$(\EGAPHK6Y2=$GU>Q"RS:+ MDNTIX*#DP$P.!HE3Z<"A+'2&S\<;#&L(_PD3>/FR]1?V'.S%T#$M4`D18\

A+G01LRA/Z".]P MC?*!3)RYG`:8+Q/)"V<8:,Z>"1;7YAQ7POA M2?JO$EWZK[(A,U[Q\"E[T_"QB'HUI0%93&S,]J9DEHL-LU8ZX">_*[_7/0(E M=3B88M?!?N(=*&I">5;YKPJ345U#!GJH1#Y2,G-H3;\/.I_+Y4J$*_TDC1%UB,< M+CWA>M`RM+8;7.*GG.'&_-/]@:5B$6&^@):($O,BBRH"X$T'YL'!P6-O*HMY M,5631]`N=V MI%R4!F_C*9#?<;E!#`BG;M-Z]54D@-M'3PZ,\I3)7E`JLBY\ M0M+I&K.7R(K6O%2L"'IE:(>AWM!'>]G(=D7[P*51DJ^"*=N%FU(ED2@4P^!+2XJNK6WU MI`Q3]%+<1&L#)/84&SFKQ"=\M\;G0,T@Z`B1O@!V?P+C9%GP:3&M[W MW6#\O1/T=L@BRFA44M<3`W(B,(\AGY\@HD8_6(JZ]#/T+N4*@%$"RQ<,WUV' MGDUH'BSX<0V/HPX>W^>P/:]S1-.AX>\Z\A7Z\A@TY:G)+]K.XNO#*#KN[)`+ M^'A'E;SIS(,%BR-RNHRN;T<_YF.&C,ESS^>SY;.HS&/TQ\10?'00=I:=TXM> MKI#Y<#*"@]&N@\\@,I<=[WFS(8+"W\V[ASO@ZV!GK'4R[FHLRPR\QC^'!]+$96C^Z]P[?*AV]]! MLN.!?@7E:=>Q9]*8Q^`_'_!%8WT^(M<&\I5&HW=YWV51!CX__QST0WP M&/-_4$L#!!0````(`+EQ#D'`:OEO8@X``!*X```5`!P`8WED:2TR,#$R,#8S M,%]C86PN>&UL550)``->E2I07I4J4'5X"P`!!"4.```$.0$``.U=67/CN!%^ M3U7^`Z-]2:HBRQY/=G=I@ZW=O(Q'1'>C&_WA:EP__;R81=XKIBPD\67O[.2TY^'8)T$83RY["1_W M?^QYC*,X0!&)\65OB5GOYW_^^4\__:7?]Z[);!Z%*/:Q]^N<8L;>$,7>72P9 MQ+<;XBWL[\=GU^'=Z>CY8W9X->'^Z=4^7Z8>6?-5G7Y_?BK+XSLIY+>2D$%!)1]%?A*E+KD7OTOR\8+C.,!!GH.4 MU$+G-+<\OXCXI3PBB0="RT9D6:0>&R/VDA9IPOH3A.8#:=P`1YSE7U)S^Z=G M&0"^RS[_=HW8=!@'\L_'_R3A*XI$=6)#?HTH78HJ^@N*DG7I1>@%1Y>]1CP\ MY+)`W'@&717#D#',V75"J5"K8JXR+3.KG%96OX":(2U;@JB?"Q+_K4&F7`LS MB@%+9K-46C_D>);SCRF9Z70D[7Q54/S"*TGV./$<)29,2")S*01%/8_0`-/+ MWGG/>\.R,10]08?>]GV2"*4?L8^%`2\1_HRYQOD.I#D63*0`H='`-#,BS(+4 M0'@/`@AW\:O0D=#E9UQUO"HI*XU2$D#'&E0W.[+,J';$:+ ME17:"NQ`F96-B1*@E]T-,SO=*$>-@>]A8"#!MZ*('K$P#0X)BES[=F3XK-SL]0%PT-=(,#@=I M:H3\"`(A(XKG*`P^+N8X9EC8\85/,34-^AMP9`7HP@$0)\T--2/%29X:*Q]` M8&48O,II.?L2KX=#HX3Z4\0PJTX.'$CSR8&)%"`L&IAFF1P8!:F!<'8*`PFI M+YBCN))*(:=ZWGJQX4?)7(EZ1,AP5L81;4@CCO+ M.KCCP`()$2ULU$##39(&(S`">D]30ODSIK,K0BEY$XI7FP0#158Z*HK.#+H/ MT4L8A?K0AIX@,T=!T!U\#=H2%]^4D%L7)E&L%*(!+8S9:1X_'Z&EG%2;%R+4 M1)4EB`H15'\[V>3@!S#-]GR8XL%9P*]W&]QHZP.YWLLP-`3I1:A"\ M@S'%S(/OCUC,C1--U3<3558O*D10?>]DDX/C=7(T7H;U.&"[6>7@>:T@C>MAS%UO$OQ,')>L+(2;!2L=(50,.-OFT@`8 M9&F0`&,Z6UAWM8X!G&CKR]A'-!9H8F&#;D$C3@,,&'/8=,'$"@D+5594.BJH M,'"SR@$`6D$:U\/8UE)06#_-U\_O8;BUZ,_6KI0^;.`^&#M2BK'5\EQT&`>? M2>RKQWG-N!0!:Q,7.$BT,]>$$V>)&O#`V,52,$JH_<2)_VU*(J$ADTLS?*EO M$(SD]59"30X")V9+B*D9U`%$*;+2NFB1`2,^.*+9:"8U1+4CWT"QV9U2H^@N M2F\#MQ7.H`!LAJS=-R7HJL&J%*+98@\CLG5-9C,2:Q&K2U[W;I5DJ-ZUV.'@ MVKH$C5]AQ*Z&01"N-!NA,+B+K]$\Y*BZ\&JA6F^*4E-!=;:;50X^UPK2N!Y& M[.J)(Y[(#5S9>DL83T84B6&7C]DZ+3-%=KL)G4<)RXZYU5KX'X''HA]4IF3M#5L`. M#%!QUMA6!S"YR-0@!D8,KJ!P&DF2![PIGN*8A:_X+O;)#-\3)G?(?!D_HT5] MR;8-]V8AMQ$W5&!M5PHNO6C3##20@Q'[J]LH3%AMOAH1FOJ3-4E9Z582_X]8JJBZ'`&FBI07=6M M?E[/)K//W36S-0L00/*47+$25!XM=.6QHH,MM4%+"< M8[=!ZQ\E*^0+==)S9$+5<2VDIDC)K"^F=.)RC3UHUZ,:T[Z*EU)'8?E%!8DE+M4Y&YF^>P;K/T>3S"[4 M"VE\Z0F`[L_4?)KZP`J?_9J/?I<;KN>8(I[&6O(U@PK8#13Y1FL%17?>-.E+ M3&.QDD\54J1O2]R@+PEY0A&BJ]#?+'-7D[@&:W:JDA6!7& M//LKS]:'JL8\HT7-QV[$65%9B('ZOY&)=C38Q&FP`6,Q_`FG2WRBF7I`]!LN M:%\=J5@)\S&+GA`H'IQ-<^C\#:(T.(!Q]"?=O91I_PG'PC2YQ7(8S,(X9%P: M^HK5P&C!63P9ZL@)%#KMC;=CJ9%LT+<+B?[R-93=Y2VA-R1YX>,DRB_,J0\Q MK*2;X8:>%"A>&ICG-`PQ"&M^\Q"@\(!M.ND2)%#(L%_$TV40:*.^O`7]FL@= M\(G0/S.$Q.P*CPG-]I6FHXOJUBG10)2EK';[/&`^)8&\_99QN:NB6NLZR'E] MU^'A,-%2=;A*P8Q M*3M%/>2STJU?+=#1=5<5[;H39P^6:H]6,*Q[B^0<]"59HRU*E@0M)FC14^"@'V M2X2ZG,9^QER[BT&9EH\62VD=#@N4.A)#NUCN_8OL^6I1S@;ZDI^2YBU.>K;F M5P$`^/E-+4BV+00SEEI(UT#N`XS&0G%@6G.BW8%RLUM32]GEGC^[_E7\F+!A MD%=#2I.+FO9S-24V/HFTD[/\0VB8O$&WQCCK1PZHORS!=H1`> MN%I^95@,5]&NS)VVFLTM:Y)D^`NWKF%V--1N,H6*>2\ MZTQ%J=YUAF#L.FOGKMP"`,1/(1[S^4.O)[0#4=J&Y&8+:K$##"'[]?ZYS MT%YK!Q.AMCW;-K,D,,$SBA'#-WCU]R[.Z]CF&>QZ),V991-6L[,<&PA;E,,6 MN'/+S7J4KN,]*!43\C>3ZV-U)UHMNHJTQP\KO>4[Q5,I&^MI/EA`RIYES]]% M43[/;D58$R%:Z#D).7Y,MBBKG8+5+7_8!S/U37KVS$-NSKI4]`^H[$26M;=V MD77\V&Y?IT3+=FW5+Z#!X ME5=]/I/A>"S&`XC7GD]RHJ.R+AH5B8;1H)/AR%*'TX3W9W,R+]]]6*IL[ M8Z7F.3`>*^`:E\D.T.>2I_WT-`0HBGI4?`I2QD"(C^L[K!W)ZPV^FOQ8P>9H M_VX:.$U.]I/3-6`=\=C-WJGN8^RFS+7Y`>7#;C'P,0[2+?>%I]V7-_BEUILX MD&ZV&.A)H0W<;L-8#`A:#-P,C.:!FXH17--FLHXT0H-+LZ;(+=MX8<@%]"': MHNKR2$RZ.(\#]2..;L2*VJ4@/F8D66W?$994^6C0!".R^(CG60\O[_HTMM,N MI.O7#PRDQX:C!G9O@2)S+O93SK^G09:]`]S'($N9J_NIXOWL^[\)F1\1EE!\ MA5@HL#&BF,F+I;--IT_A)`['H2_G>YM7/TD4^D+]9[S@5Z+Q^'8C'W.,VI\= MV*T6^S]_L#]]MW3B:M%^#W[1"#YD43NHL&7I%5:#]U"$)NF'+$=7/;8LS/J; M9I\)QYOT/91PXRP/6>Q;*;>E+]8GE?=:_"ZY'++$F^JS;>N!)RAZ0)P+!\OA M0GJ=P`3'>^HI&V5WT/:EJ6+9R$;^\R*&4.++_P!02P,$%`````@`N7$.07;` M%2:;*P``&?@"`!4`'`!C>61I+3(P,3(P-C,P7V1E9BYX;6Q55`D``UZ5*E!> ME2I0=7@+``$$)0X```0Y`0``[7U;<]NZLN;[5,U_\.2\S%1-5I*U]C[GK-1> M<\J68CNVI"@2M^WQRRY*A"2.*5(BJ9M__0#4Q1*(2X,B2##F0QR;!/J"_AIH MXM+XQW^MI][%$H61&_A_??CRV^X&/ M_OJP0=&'__H___V__>-_?/QXT0BF,\^U_2&Z>)J%*(I6=H@NOOND`G[6#(:+ M*?+CBTDH'E^>TS>;%E%R([ MQL\O'#M&7[_\Q]>__?'URQ\7-VWKX^>_??Y\1*`1S#:A.Y[$%_]S^+_88O[O MBU:K^]O%I>==]$C)Z**'(A0ND?/;CI#G^B]?R8^!':&+=>1^C883-+5;P3`1 MXZ\/1WJM!Z'W6Q"./_W^^?,?GPZUN"7(7Q_WQ3Z21Q^__/[QCR^_K2/GPP4V MBA\EO`%,]L6QA">E5W_LRW[Y]-1N]1/A/[H[ZQQJI;CLZGWY\\\_/R5O#T4Q M>R<^E#V6YN^?MB\_X(:[N-@VG1T.P\!#/32Z2,A\C3_#Q8[P/WO?T[*X?OS)<:>?=F4^D0J?-`N%^2&?`/:C M@T;VPHO51$Q7+U#@8&J[?F9YM[6UBYNP^3A%TP$*%64]J:I;T`DF$0X7`_3Q MT$9JXK(('`N]EY@FF/2LFT'HN$E?&MOKP`^FFT\)T7TW?.D[W_S8C3??_5$0 M3I,^[(-4^>'&<;&&7W[__.]_?$ZT)$3_)21Z+#+&M.N[Y'$+_WG"#JUCY#O( MV3,DA'-0*6&^9^\%PQ.>'NF\@Y!IX,0L$1K^-@Z6GQSD?B)JDU\2_3]^_K+K MG_\-/_I7PM=%D64/WIK,LP?(^^L#\QU^1-0[??>I&&'W[7743-@:Z'N,IA$E M.Z3H3A5AT5/-WE!P&9[JB*&_)[OS`EBGOJLS"H,I4.A`;)@W$3]B^E\O1#0O MXN""HK6(,(U@1HK96+H@=%"(`ZK/O__V.V:4=!1?AUX0(>>O#W&X0&\/`S_& MGO#-0X0;=D(T)K\4!8T6&MO>UHDNURZ-!L[;79/1;W7:G-FW'F.`;=M`IL.1 MV0\LOIX:EU@[181M[S^*,MM6E.9N^$[W/M2KX\YG_TJGM1@AT;&M>"8)A-(? MF6I']2MMEX-C'BBP[?0WP^STK]\%EL(O"[+5B9A*IDHI<&RLI(345H0$VUI_ M+WJ4F,;[S^*,MXEEL0A MTEQ[]IBR'O/=3N_3=X;;3Z1(!@-2Y-@6_,_"+=A$T3!T9\=?*+0A&45H>QX7 MJ8I9^6J=8]T3JFPC_UET']M%H1O@SS>G:<>\SI99ANIU3\L8;F>(8F?TPQ19 MWC=)4::V0IM,)/\J<[>`4.8EFJ2*&VQ6@5@;SLJERK$S'_9JMW,!RA[;WW7?0^AYMF&;F ME#FQ,UVF$H86*Y;9TBFR'%,7-G'06(0AB??<:&A[_Q?9(7L$EA7;M0NWF.$V M!ZJ7P>Q\RAS+%SP5<>UZ*&Q@@<9!R'9Q9HD3!S\M8;BIY4IE=FZ**,?`A M['J<8#H-_'X<#%_Z$SM$T8]%G*S@XZB"W:4#*ISV[Z(*E4"#@LK9>WXA#PY6 M_KU@K&P[JQZ:!6%,HL[8CA?T&@"DZ"D^V$6K@0R(FMDQP:'.04-A4V=;Z1X" M;^''=KCMU]@PX)0YL3]=IA*&%RN6V>(ILAQ3%S;'MA7K$7G>O1^L_#ZRH\!' MSO0XD"IN1VXK770P\=WCM!7;,A`'C M_8GIC]]7PMQ\A3*;^(0DVZR_%S;[MA?Y[5/D&C_A[??@E*(F6^E2AAL:IMP9 M$ZXIPARC%S9?=RK8=CY8;G9&.:;AC\M5RO1\!<\V_@EICOGW$WG_^$0U%J;[ M8XSL:)!@:!%]'-OV;.L=R(NC M_1/:37:/_T6"[V3/%6L+'_OE#C/4RS-=.P<-4AY`:Y%V$4J3MP*%;MP3"!A( MC$#OUTN3(KY*DZBWZ96\38]CTXS[]$ZIU1OUU$?:/#9_\4T%W/JE;9M>]K[U M,HI0'%T.R#+=D/XB8K_<[S\Y?5E2G"3N684*,$(B=N=*4^%TKF4;<3?K)K0E MI\R)2>DR)5F68[L`I@K#N*<$WPR;(L2);LNS;\..)I>^0_[[-E^X2]O#\D:7 M<<,.PXWKCQ]L;Y%:V52ILU_F!-4I%0\\JP?9-.;"A.*3+'G"Z&L:B,_H'8;# M8($E[:$APE+C`**#XIU^="[U5@>O0@)+[&3!!25.M M#==.Q?A"JFPLG+V>?086%N@:MU8/>3AT=;IV2,YS<<``*+I'@ZBHL7"`ZZ>$ M!R%93:=!L@.B$\0HPG%**[!]R)@/+K]K.GEY4_&AJJD*2`"T-9TZR8Z4;HAF MMNM\6\^0'R$L_(]X@L(3%2FL*-38M2&DAJEX4==6!3$@ZIH.L9SQ,>$LR9)& M],,_Q$C=13B#O+K\\^[G#,8!#,4QINN9V\3CLP7[HQ,A:8_$B%%#]V_H*AQ$XL*BH'F M%\7T=)V&.6.>,?"Q\(LA$>F[CZ4?DS1B-V$0T7T[H.1^3E%0TC@`P-4"V5]( M3M<)F7/FA6+;'[LX;#U\]WY;#[T%VHT3Y MP!!\&,I5$F.`\8W()*GK(,WYZ\E=>T.F.,4KR>Q"U!HR5M3AH`XG)O&."4,QT&(/6R((%'6-=)F_,7HGMHB?P%IRL0%Z*6 MGZE"1F,`I)@R`'A4=1VY.6.Z:!'%P12%330+(IR`I^+;S@%?0:"R`%53O$`24.8@H<1+Q:/>,-$8`E4WO M3ZI:K*"B9N;A@D.<`Y`29PZ396XI-"2E=JW%*V4T'&"J*0.!2Y8#`3.F*=G6 ME[9.U6R>O[D5+%WB1.+Q"MCIM^VE[W0"?\@.&=5J,58:1;7*!PIXOC%;0YPY M^0AFRH%;B3.11VKR>Q1^5U(E:/`5RF_NF6OB$F)V*QS ME"0I==ASS"YEM-%AJBG;GDN6`X$29QR37))D4_1NR'=3GXR MF"W"F;>(=IEX4B%"#K2.4LQDIV4TZ/)L)F5HGLF<`^`2)TA[*,;F0,XW._3) M$C_6:S%=)+.[3=PX0Y<.9.$5=FT,J&`TWI055@85A`,'.67NN7R3,IGL(Q<^ MAVA"$MLLT7=_&$Q1*XC(%M(?(\M>IQ?DL]1^6Z97JFTTP,YK"O71594=!WHE MSMBF%91^;4N_LLW&B%2A#"-9FB+'TB7.V+9=/PB3JX9C%**('HQXKW>-DGIM MM(TERBA;.$V/8]\R-VNF-,`]T/:\09=D:\>FB>/0'2QB,O%K!63"-_!CW.!8 ME#$'%?D2Y?88F8@:C4`M#9=#SY1-"@[:2YPMELUL\E<)A,6!!R"J-'^LJ'I^ MBPP<;APL[>>2M:<8[MIDD6N"\(?FT?S*.?F&3RD6FGSXE'7I>7SK3,1U)N(Z M$W&=B5B+X;[5F8@KF8GX=(D1CU@_P@1L3K(:U45A6F3Z:L)N8@`E$SO$:@&%N"J@8$@)&E<^N.4M,E]9%($G);B67]7JAJ69ZJ4 MW>I[S73\[")MYIH:FHWU^ MAF98^IQ&/2M3S\K4LS+UK$P]*U//RASM5DNR$/!NB.*]/NQ$HUX;&2=)E`#' M1FDZQLV3W.*0XVKA>B1K!(EV95KN0"B",.P-$%B5B:A'"<[ MT@$I>9)\Q>#^W;6]'@9::I,[[_71U\K):P,M)%$!:)XTE1R'.HYM+)=\^UZ& MH;WIAH&S&*9280I*[-1CE3#02')%@'9B$C)VO..,-N-CH>=XG,M$]RWS/BE.W[ MDFPKMEX@UX1A6B9-.EK9T`\2;:I.7V&=&XY8PT M,%0ML+D%!,V[;Z=O>W:XW0+_:(]3'YV\U_M%*_IU21:6VS"0ZL*P+Y=LLIZ5 M(F?>=3I--`L1CN82$_C.Y90$:JB)!2-F\>W/( M2(2B*!'H&J5FVRS26ZJ!HZ3\.-=&:6/8Z96M8X5UK M20J;C`,E/551(2-NWMTZ?92!` M0-B\VW.2E!`[D6^0C_4B>6PNG2G6F>@4NTO$!DB&FL=YDX$U3890]A90Q902 M)_/N[,&#Y](E8^=U$#:#Q2`>+;S]G3/I$$1:]"T3EC02"JII@6``(FW=1SW=_B:*8Z+(5F9/( M1U8LWM_AS"E6$A+@M@[`.C+P(&6SO=&91]Z\RWJ2J#:M%>L[@U_J^)N"4:H* MD(!IF!417.KF7<[#U0(X&QE$ ME=?TX'"L4!'-NV'IH-:NZ[A"/DKO`9&4.H%[NI3!T)2II`@C!CGS;CG:[F9A M?,:G7QRM&^Y>&&E+KN`*R4G>*)AW:5$'Q6\=3(;\JIGK[\,PY?I&PN3<9H!_ MXJLS,N_NHQ,E1(`2@:4"0,C%R(;>9D3GB>?D]@>4?-MASRUII*GAJJGD,.&3 M-._2H_TE%?OT:YQI75FQ_9%Z7C$CK0]4"FQZ/CWS;CJB9;VR(W>(/U6:KK>( M4PFL@*4Y**!+EP0&J;D9D!`KRD`&CPD+'RGBYMTG](C<\03+=KG$W[MCU%D0 M+7^,4MF9.-U&UNJ[]E6N;F0WLWCQ9->?;&P7MV=[>6)6> M):W.\U;G>:OSO-5YWK08KL[S5LT\;QT4DR$JV;V*![BKS3]QG_#=/VR!NQS& M[G)[7P]G5UEF`F_3CJH$C/R6.+LA5"8PE3D9EY&NTK/49]A:?19;G1EXEKO$ M6:Y+Y_\M=LOK9&D%*YC@VPIZ",<@0]=#)QI8P7G=5%'LXOTE\YK951+X!1LA M-U_2+[?^U(74>6D;?"J=59)]*MTVX%1Z81!+'VX7-!0#B;H%99R1MP%GY,L] M(O].SJH5"=+SCKP5@=(L)^=*W`];[^DQ$.4:=@@5`?W<]AN5NQ$U1':$FFC[ M_Y'2#7OFQK;'"ZNVMP?&O.=Y!#A910AUO&H,XAP$0REE^I]VU-Z3'WJMP:(Z6:P]V^;K`(Z\"+>F0#*%5<4AG M;S:-@SA(&/.2\Z85VOLH.UTVN#P7J'3YBH-1K+X&P*48FI?T-RUT8Q'%^-L_ M;*)9$+F`\9U7@0NK5(6*XTK2`!J`E>9H7L)A^#=^YKT;F?=L5',&)G/#Y+E\ M#Y;`O&S''.FW1^K/V%4$("!&J(A`E785P1OBW%U%0D[F96+&$6LC#BCI=&P<*331(Q7N`HF][$OE%S>KA(,@(E)2']VD"WKM] M@P*>YN7K/I:7I"M,-GLA9S<-*4`3OS`#3XS"E4>4M`&T8(K%U;P$WSTTV\68 MY)I280\%*7JXX%Y0M))X4E`^-S2)>9J7%ARN9>;X*G-<54W496Z8W#"H(H%Y M>^0_XCU$6A2Q+TGB[649C,4G6?+$^EJI%Q_AG*P]/I*?$P M+['YM]$(#>,?HV_KX<3VQZB'E?SAL[6BL)6EZC[E@4I5([%UAO+P?'U*/,S+ MSLV6]!)WQ6&XP;WN@^VE=A$IU1'V5'0=(V&41=TS^Z84P>ULEUFY\Y_`UE_1?G$$B6V7JEB]@92.'C+,:`'Y[I"(720)J M+2DT.T&,(BNP)F@GE>T=E(E([N/HQZB+>S_B-KOD$7UW[+LC=T@V2&QW]V-5 MNH'G#EU,"JWC*XS[EP\GUE5(R:E/(NTI/O6)7GK"S3IE:)TRM$X96J<,U6*X M.F5H-5.&YA$?[.R<2ZBQ;=H<8@3#PM4<&P<.H$0#[]Z- M1&/SSI?X@ZIA`15`&7!4Q:9E6FC5C[%8D\##8D1D4UJ\(<6;;D0Z]$6(-,=; MM0L`X%TV=T MY-$?:*BG3N]4)L934`X& MP7BKD3@0`)>/]UG\9>6-M+ZJFF!```BS,9(I2S7GH`<1(HQ0&X5C%,KM+2MZ M9&IN46.M#%1.R/]'2Z*U8V$V)F-H'`OGBH?-MS^U+ER]?8-=$Y"L":*;=?+OG:5KQ3: M5Z_R%;?TU9]Z_:I>OZK7K^KUJWK]ZI=8O^+,1G"&JL5T:H>;'R/AF/6,PN#: M7:)O[G@2__!1GTRO6)C=]LD\\J?CM8-?/%I6G[VF51S?TV6Q`O@:&>66U>SG M)J#5(6".ZWO%.]=MISV[ME;!YJFQN@X6(7U_MW]L8O-^;NTF;WP1_8PF98WQ?O,.M M!\/9./DM)*5:Y(??+L[IQ/SU.QZ'_WMS/I`93'!`GJ"5_GPCKUWH M]YNW;:LX'Q2RU^^";/;OS0,A1C#!`3ERZM_,H5&GZ&G:;S7Z8?LY>3$KSO5X MG/5[78KS>W,X2=.;X&MI$7/<5U.\F[U8<^=A$+9PU'QE71?G9&R^^EV,XOO> M'$S8[":X%RU@CKN7BG>N9/9G-7*L.2G8O=X`+X#3RUN_DS%XOS='DS:_"<[& M$C+'W5W%.QR)?OON.GEP]SR];TYPF5=ZB;4\`?2['D^`]^9_,$.8X(1<2<4; MWPSWQ-?D9W^:/'ZU'I_F8U*Z.$^4"*#?$WD"O#=/A!G"!$_D2LK;'U8-5[Q- M?B5C_7!%BC4G28&^TREPT5PJ0P&KYWP9WIM/@LUA@EN*A.5X9D5VL=RLNZ3$ M\B%Y_C2:7N%`H#BG%++7[X]L]N_-%2%&,,$+.7)R'+`B6UO(JW@V6]\YV[E= MJ]\J<(:&S[R`*1H&\_?F>G(#F.!X3"DY;E>1#2ZKUA1W'M'=F`SJI*Q#?B3O MBW,_@!#ZW5`DQ'MS1[A!3'!+H;0<]ZS(UI?EU7#]W&@UIR].LSA_9''5[X`G M7-^;QPF:W`07.Q6/XU,5V<[22'X=6ZN`S/6%E)P7N$&-RUJ_FZ59OS='DS6^":[&D)'C;!79$V.-K7ZK ME>SW2;:.=Y)7!4][`H30[X`B(=Z;*\(-8H)3"J7E''.OR#X99WV3/)F0`;[O MKGO)T]D`ERS./0%"Z'=/D1#OS3WA!C'!/872J_7OD@ZK\UDF;/=/H0`!1X:E$F@ MWPVY$KPW3P2:P@1GY(O*\<>*[**QB"K.L#V:OUX_6:E+D`IG7,!G(\7XO3F= MN.%-\+64A!P7J\A.F/G->-D8WUS_O!O?%N=?+*X%Y.\\YOK>/$O0Y":XU:EX M')^JR$X8/!SCAU?S4?)H>$>^5*UF@0L/$@$*"2*9`KPWIX,9P@3_XTK*<<6* M['I9/=X23<:KI;4*PLW#38&[KWFL"]ASG6+]WAQ/UO@FN!Q#1HZS560WRW:O MCC^UIK>.Y>,>I<"]97S>^MV-P?N]^9NT^4UP.):0'(^KR.:60=1K$D7:#U-O M^W5:G,?Q>>OW.`;O]^9QTN8WP>-80G(\KB([7,CK;1:-^<_D:2M^G<\*/$0D M$:"8Q+DL`=Z;`\(,88(7'=THL]%_?RA=G@+_,DK]'W64C['::3V"<\*M*@<*H6C&D2)7/`2HL'OJO M'^7+\S*EU6_1F\65ZTE10M>K&$3$:N>`CQ0#_5=E\H5)OC]OR"1/ MC[P:^.OKV^F\DY,OS,+A>121VNMXDCSND`)WN-VMU*68XU2N& M&U`CY(`='A_]5^WQ96J\)EB^'W3NM[M`<2R>O+\"8TA.0HHC`8F*80G<&#G@ M2<1+_PUS?+E&R6Q[+XZ?GZZGOGGP)N].$+M=V1,HF7S]NMF/WXD3X9FJVR%#S,RA6##J`!<@`. MFTL!-]+P17I\:JT[VQU-X_55-`9#AE=1"I=4Q8I!1:)X#C!)>%"QT MO8KA1*QV#A!),2C@9@2^-#_Q_]WFL_0C`XV-6DV*"J50P:0J5S0`9- MOX!\_GQAFM':BJ*^N^XWR)^]-A@;W)I2>*1K5@PA,M5S``F#10&IZ/GR7)/) MP*B=//)&9")Y_D0?;L]86XH7=NV*80;2!#G@AL.F@#SI?)F29U@2\KSQF+R9 M3!UK1IZ!(00A(D62D$C%`*70(#G@2LRM@#S?DFUB_?GX%D._TUC=QAX85/RJ ML*U\IU4K!B"I\GEMX:-X%)"36K!'[&ELC5NC!OYBPT]2M^VI5Y3OW:,K5@PF M$L7SV+>7XE!`FF0!9KLD\B+3B%UR'AR_7=_'\"Y%5%O>JS!K5PPQD";(HV]A MLY'D_]5\A+CEV@/7PX21CG/$(NH%'B86B5'Z>=SZ1'%]HK@^45R?*-9BN/I$ ML2$GBH^&(%9L\()CR4UKV8M?>N17^K1HQMI[#U2L;63X=EX3@,,W93;Z3QE+ M1,)B>.NGR=/4JHD?6"'G!A\%'_\ECB4S)MH*'[LOH MZC69,+NB3PAFK@]#$*-^%2$D;8:\,,1BI/^$L@S8!,[W1)YAHW>+'PY[<\5^ M2$`!V!6Q*%012H"FR*U#8K(J/1RZ>EZWR;.I142+ILN>&ICX]6%08M2O(I"D MS9`7C%B,])]DE@CU,,+#K45^&\Q6R;P;`7MSI08E&148H+A4J@@K8)/D!2X^ M._V'G26BW=Q:FU%_^O*4'!+HJ"&+4QD&*+IR%7$D;H"\X)/BHO\XLT2B7O]N MUNKW,:I'+Q9]1C5371AFJ+I5A(Q0_;P00S/1?[I9(M#=X\_)N)&L39/QM96\ M2_YLJ*$'0`@&)1&A*N(*WC!Y@4S(4?^)9XETG42236?>6JTV^-E2<6SCUX?A MBU&_BK"2-D->:&(Q*N#8LT0J#W>AC_U$M.ZPN]X>5U&,O\4T8&CBT*@BHD#- MD1>J>,P*.$$MD(R^4'F;S-$:)O,9Y+'E;+,`*"!-G:8<>0HTJX;$S,V5!S)5 MF!=P5%OB0\XTOAF&8W*(HCFG3VIGJ@OK\ZBZ54.85/V\^CB:20&GM"42C:-D M0O8N(C_[[CIB:K`LYZ2^1:-L.AEPRT?GBW#NF$U1EK MPW"4JEU%#$F:("_\I-D4<.!;(M/CW7*5I-:>7;>:N(]47"3F5H>A)UV]BO"1 M-4)>^&'P*>!,N$2H9!8?=X7K,%EP7#Y;[:D:AD048#!B4J@BD@!-D1>8V*P* M.$HNVTUSM5SW;@8=+_FJO*,S.V:L#=SY1->N(H8D39#;KJ<4FP*.E\LVS[23 M[3,DU)^^M)-5:<6^2$0!N.F)1:&*.`(T16Z;GIBL)$?.-9_#ZL?!\&42>)AI M]&V^<.--)XC1VWL-A[.4619X8DM9MM(/0=7'N.IC7/4QKOH8EQ;#U<>X##G& ME1Z76`'&]*=E/20/R%3P,WX:CM(W+^5"Z]`%GT/+R'@QS^8!1XYG,M5_&`PF M(/[OY_8^ES!9C6A8^,D5/5.;"RTE`/)H51B`L.;)&8!LD\%UI*0./1JC#@ M8,V3,_"X3/6?6(,)^)+\\;Q=NWV\O1Y&8;9O!Q$A)>@Q"548=X"&R1ET;([Z M#[#!I.O,IX-HDCSISAMK.JGR>424D)8B4F&421HD9X2EN>D_Z`:3["K"(>2* M/&WW'/(?_E9NT&E*\B"EA#0.J0KC#=0X.:..QU/_F3F8?,_W3N>D_%0>3Z[K;::\QSF\>V[/V729,L4DH88HB M46%,"1LC9TS1O`HX)`<3K'?3"]M)=#B>A,L5G1/\/")*P$H1J3"T)`V2,[C2 MW`HX*0<3;93,$^.Q.GY.KK'\.24E,H%,3$H):AQ2%08>(3[;OGA^?>SY>?V:;2>$34`C&:2(6A)FF0O(.Q%+<"3LH!\8]1/^WB'\O! M\&73S+K2SB>CUJ>ER5089-)&R;LO8_`KX`@=,'B\)S^M.>EN'Q^'^*F5;4U= M1$CM(X!%J,)P`S1,WA\$3(X%G+*#B=?&_S_.'QY':^P3+]UF)KCQB"A!+46D MPC"3-$C.$$MS*^`@'DRT87]ZTWV=-!Y:UW0BLNP$E&!U0J#"D!(T1,YP.N54 MP)$\X+)JW/7NK9OEU4TOZTPKFX3:(ODIB0H#2M@8>2^)4[PDY_(TGX7Y[N.W MR++76H^_0+@4>.(%(D[I1T3J0R[U(9?ZD$M]R$6+X>I#+H8<9DF6W3I9$'9"S(&R(O"#$YZ3\P(I$JN>/F8?3\W(I;CU?T4:1LE6$(HBM7$3WB!L@+.2DN MI8-E_N- M&HQ$%&!`8E*H(I0`39$7F-BL]!_#D(BUFCM75F<\Z3^-KM1@Q*H)@\])S2K" M1J!Z7G`Y9:'_Q(1$'&<4XM^<>/9X_X"[0L4>AU<;!I=4[2I"1M($><$FS4;_ MP0C9*)J<:EPVHFG<"[=7]-%[\,Z@`(Q\6!2J""-`4^06_3!92N/T;^T$61AF5@)78%K@JN!?.B:F0$J:?) MP%%E;NSUKT5G%K5]@W_I.^&&O,!RM\A<,WU_FR;JYT*80_W7@C*H"?5#FB>& M_O7SS"*_/F`YB9BW/U?#8?A`7R*=/^%S`9TF_&MA6=9P^F',D$#_NGUF:7C>3R;C)P]/D=37= MWF:;%[A%M,]%-I/VKP5K0//IQS1;"/V;'S(+?)TX'Y$YC*R-==<96GGA64#Z M7#BS2/]::)8WGGXP,V70OPZCD^\LQ'D@ZSZO!59A;[,RD>G;@?$KUUP*O ML,D*")DI]OKW>606=3F8X]\Z)/IQR-\W%GU1G0[2YX*71?K70K"\\?3#F"F# M_LTHF>7UYYO5R_5@W<82O]";5'*F>BZ"*:J_%GB%3:8?MS1[_9M@,HN*)7Q= MS:+18+5Y>J5OJLB9ZKF0I:C^6I`5-IE^R-+L"T@^FCTJ[R8A>?)H-B4S@]/A M].XIMZ\V,?FSO]PXY'\M.,,:L8`O.)XSV<^=::7+.9"-YIY85I/N5S`&UL550)``->E2I07I4J4'5X"P`! M!"4.```$.0$``-V];7,;.9(N^OU&G/]0I^^->[P1=MO=O3.[TW=G-_1JRY8H MMJ6*180":0`!)`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`71%3B7O[8AEHJ-(8=2N+DV(VE=`@BD:UD8 MDO\:"I*KI&0C%RFZ"NE1P7%B4*44%9)NL*@SA"F&N$-:4XL:XBIA,:-.BH2P MM4FULK$STU:!L3F$IL5\;E`K94& M^;*P!/'RQW8`NM$4(("!QA(`6Y:``;J4A0'Y;Z$`N5-8,BRM.1SWKP7(@,_J MMVP^<\8D6)4[*$6U:E0V2J]@N?XQ*7^-BTNX03+MAVPBLU&D"4U!&L;FOP?' MYGXZ'^2CR@X,HD`1$:F;1?@`"U3,B-NF=B)\-X1D%&\\;`F8H::#,8TWL@CM MC9((PANZ8*#_+716L)XVV.\OL/0`+"/D"WB]7672?)Y?96$`? M^*Q^\>8S9WB#5;G#6E2KAG.C]`K&]8_)\M>XX(4;)--^R"98&T6:(!6D$7"& MG=QX/D^O1^5LRW31Z4_`.0ZD2&,\3BC"-"X'5\PU/B=IIXS3-86$\;J7ATGY MM`W#=DC;`<-WRE9N#.,U2T+#>:(N!.K!YD>65NT5!)'WQT?38?KT)7T&L8Z4 M:8!=+,.$=J1J+KC+ZBEX%Z0$P-=/D^IQ4CQO`^2Q)@0PKV[M!NB%HA#J)6T( M[(/-L.S=YWG9U1W-!_WQ/])^#B?>NF+UYT"+.>-?9X"["RAJ4'L!)KARA/IY MLBR0E"5:DHMK6S4S:8*F2V"EFUZ!ZT0<(]@\S])?#T?C--\K#+K.#2?WZZG0 MYPV_V7S.Y"M`E5S^T51-\8D-"<$/ED^2ZE$;D`^U%(!VO$$;"-\H!J&ZH079 MZA%L3GDUU?TRK'98_((M3T9*"=M0ZUX":5N$<.!)`]]@HKG*0AE;$19SGOJ_Z\\OJ0ZW. M1JC\)!TOUJOLGD? M-R-ZH1%`,I<6;/HG1?+%5[T9AD%R/WN46>`\S&RQQ(O M(,+ZF&<_I=XR9G@?D_90XF(`S,MG2?6P+5B76P_'.];2(N:/Y:V1*ETP]IWG MX^VQOS.?IXLYDFW!#^LO(3QDP3M<(0_6)=UZG#=%UCM\NMV#7C?REAZX920\ M*UNPQG*SC(QC44?KTI&E@?6\H1+*2)D&HL4RC,!&JN?$MUP%%>:"Y'IAX9_G MYP>=7M(>U&.-B(!?W>8-'Q"*8JX@:6Q=1K/7G]_L3(?E_QW^N/"WOG. M8J^?Y\^CZ?5%?WPOK;XUD5DMQ27)L'B0D7D\'D6M4N]A)$UKCRM*5:=/I"]% M(R_A-8*&Y(6GJ>#M+"ZZ"YUTD4=;D1" M(Q1=\9JJ*`^]$8QA8CEU302R4RA89WAUF21?%WJ;3-/($XZD%I=)D(Z3%1ND[Z=7:>%0PU[_:9F!HJQ`*+F:8524 M9$$XP10>P*LKTN-?(;^>=:R+)(O^4]*O"D6>;"2TL^0E='"L)AUQ`=F'E-H] M'0;FX%+WZ6'Q)<_3<76*>#\O#U%%?(I0=.54JJ(\7D4PALFMU#41_$JA8.U8 M1?9>(KK(M*I227EG1W\:G79(;2X[&!TI*P]32``NIM3OZ7PS>Q_K9(MT7G3# MCK/^E-*E(9>OOZ&^/(O+D$Y(RF:*H]4BLFNR6A)D_GN]G[YEF>SOJCX<'3+)W.T\+XT\5-FC?& M-P6G,)"HORA%@L5##4SC\5%:A7HO)>A9^6GU9&-`8EZ-2%3CA+.EEB1=JHE, MG28XD9S6'&2UVQ($9<;IQ#J'0<+A0WFIUOQTNNZVGA4N9HU-7&117OQV;#9EC#C&BRI8;'V"WFEO MYSAI[6PQ<9:8,#NLF16FGZ<7&!.$L&FS\].S@O/>/ MM\G9\4X)F,Y^D>GG>2HDQ1N]_'\H!N9HRF-+:\G(2.D=BV%`+!V1*7= MUTF*+A/:BP(;H\MQNIYU.7@:C._+@X<^9MGP<3063WPV$5E/@!-$F";&Z<9Q M39B3:J1,I.L5K2?8.[V=SL>CW>.#.D-J`=,9X0*8@S=&U7IN7B\)S=E3ZO-U MPJ-K_Q+L6((]2LYN@[<^I&GGL=E7:$]O4==-5/4/L8XA_1C&4$U+[0H:]`&A M!EUU^EK1VSL>]2]'X^JNU")=K@[JN\G&14/,R]1Y\8SL&S`5J[\F68P%`:9& M\F#$H%8]BJC*UM.61SN[1\='O:.#[KK'V/M'Y/M33;$B!1E+M-5AB"HM!RIZ MO;Y.LF1Q;/46('U!V7F];`;2&\+NH#;;@G!Q<6_0AC.VQ@/)NX3(L)"]3+M? M2*7;UWF6#ON@;[)\T4OSR6Z6Y]ECD4=+&Z'Q$JN=T$`)GJW0>-5,>Z'!"@B; MH66Y]6[H\M&[1?$L&6?]V"=C*-I.W@>M;>C:&X""P$YH2)NODRW==]^<]9_+ M%1;J?3=P(6''C5"(=:\-;`#O+ANI#OK^FJ:HM+-FMGSVF4;;_J M$X)E\?TSHDY?!U4ZN4=^GPYE3I,]1%WNQ4F0`DMO.$Q9 MH"5KN_1-"_D,"0TO;@,7!ST'T^SK;$SW+3SGZ4,ZO4>X15U(V+@C%&+=LP,; MP+M=1ZJ#OE.G*2IMTLF7C]NQ0P=I2W1SCK+M:R>!R^);OI\O MLDF:[Z>S\O@SA%DTI5;3PD@IGBEAM0E,T\%H)82I8%CVY9ZPY>-Y,JP+Q+X= M3-VD\N0O"0.KB5^X,##IBVEMWZF9^_=I+R/N6],4?-FUAA7DVK.F,81MQQI> M#VF_&B*^N5NM@,YJK]IL62CZ3C5=*T/[U&C(6/$-6A[8HOL/KKFE!R'UOZU MRR"%96=!M2)N$O&T#ZV':#^.+[]P MRZ^L%8E]$1=C;,08G/YQWF6*TJ\'$(DE>`Z=`BKFNV0(:`"TJ%"HMQZK_7JT1(T M;Y/_YY>?/WQ(9FF>/)3EWB9_^?#A[8?BI_E-O_@*2?]^<9/EHQ_I\&TRS5:_ MCLK+=(?5V4/9_6*^*/X83:]C;]/&D0`=,Z2!3>U;0$'P&"%9&W*V>,0E*'O9 M9))-45?"'J\[?,)CIIX=7"E7%T[23NFK-876G;+J]Y7C%,XPZZ^]YI>_5%Z# M>4[I*+_\^N'MK[_^Y>UOO_XF_;?2K=XFQ;-96O1A'M+Q<^QN(((1H+^G1-.Z M8]N/AD?3O?YLM.B+NZXUI=;'<,&EF$[@4IK` M=?@65@GEW"U0]N7(K=7CI#RW[=UHF@R6)6(?O*5N6N#,+0H6:B=!"D,G;2%: M$9>)?.7>?7D46+W\N8AS9V46.AJD\_6SVOYR1]I]/AO?SW?[X_(H,:GGQ*!K MXR(_>UUL=_XYOPY7%\W-%-I-@M8UK,+">3I/\X]U/[JME3?OIU6@P$@=P MZ`)U0Q`$6`(*W3">J$&J3Q\:]&HV]DBLGB3#Y:.X4<``"I*K&\.H]F>]G.RT ME+H0SXQY@,J+E=6JCJ*+,,O3FW0Z+WI(1]-!-DF/LWEY'LSI5:__)*;A=M(O M>Y:,I+EV,MF8S+:_R;!RTJXG$YV0GV?5$J?!IF`RJB2C[Y"R@A>T;\H!IZNN M@YD2<(^5F15(N(BXG$H>\M;.O&AG7'S-M'B89`4K(,LD;6:H5D[5H=T*YO*=T\[>::=W?GI\ M?-3YF!QU>@?G!]W(AQRBC2;%!TWSUM%!+"7'!ED/$AEB'OTB.6!![LNS%,^R MO#1T9['(1Y?WBW(-52\KUTYETT7QL0M3KA'_X%6*DK&54D\QV.4%O9*^I6'6 MB8)-?4VF:&F"EW560@DR_541=&D*MNF MQ9E:O&C6:Q+Q5@=,FJQN52=>)W)07UM635=6SG?6JQ&5GHP5!CU8*NS!IIXHJ4`]=%DQ>2K;)/U$4:/Q2@Q[0'T49G1_*=2#;%EJQSEKC?(22 M\NIK/VY',(5]3;:5PRGDX97:+7,U2INK5E/3G$PAH%QC376OB`NS)&N/JF7S M.M=JEL+M\(K MH5RG",JN;U"L'B?KY['O3E0W*'!=(@4!M<<@A:%+$1&MK1NEJ,^DGB,.@CU> MKYT7'C.ME(6G!&>=H(P&KVI7-6<-<+`6M6!?UM`[8 MGPH'W+T?C4M^JLT50*FZD:C,) M[?H&K@$/%)0Q#VIC'/4:/`]'%9@__/6W#Q64RU^JO"O-!Z/^^+Q@$FD[,_9X MHV_0>.P$7Z5!;L#%5..0!24V4_SE[TE>/8B?TH.ME)$^K9RW;Y9Z@2JBA#AV M%!@+PVQP7R9'_=(N9TPTM+%AP\%O>]4Q$CMYWG\^R[/A_4"Z;%I1HOX,4`GW M1E/4R^##L':-&P-"Z[G]ZE'2+Y\EL_IA7&]6-5Q&_=1-GP8*"FX-JB*.<(4' M"=&YZ6`!_)L/-.&[6T@W"^E>\7:K3-J1N!)M0S5QQ=E*8MUB99%V7!DE-0;: MC5)WG_!N$WF\+%Q#T_O-1OUEL'F3-ZO'K5AZM9?-%Z=7M4G(.(BRS#K7ALHP M#<`KJN<:>8>KH`RY`Y(OR=9\D6172; M--M-.70"-3$P<%(54P^;U)I@P$O;[B*@Q&Q@304/C92`B^2-5,*1&HFC29![ M*\L@XTH,;JZWC\7/E=5H'1V7WI*1)\3O]1]?/08E.+]*'>S]COO->,!C.#RI M]W\+N"1OP/**(?QH)BI*X8/Z'%%3IT%?,%341,M M?F(*MFO(3Q5)B7#`!_^@>(HKA4.JX[XQ-E29#Q@3`ZL5CI(WF!AOB.7X9PW*`>FYFW;&R&."9#&(O1 MC,&@RU:DZP$"0\)PN,Y\F$X!A#(!W2C9BB':CWDVGQ>1Z4HZ[A5X4G^OS2C>3>U$Y]X06K5H]5.R_"VN3T--(WDTWGZU/V\4D+VY(8WXLK0&+6CK MZSU9W_!H>:C-DS<;!5KAO*>S-.^7)U$?/,W2Z1Q=:ZHMM[IS&BW'<^NTS@R> M9E=50[AY&I->WSV]*I"L2OP>^0)J;>O*5U`3`5%'"K0X<`TUKAF)(C$O:>B/ M^_GR\(JO_6MI[0#V>'50F_B8YUPGI%*F$YID[82SE@2AE2>L?J\N]'DLGT0^ MS`QK+_E8,G7+UK`72P%'A4EZ$)!'W$ZZG\[R=#"J^J2%G3N3\@BK'XV.;PU$ M0LGZ`ZE*LG@!P10>AU!7I/<-A?S*33:+5*[2WR@4UV,H+2XY#QTFM1\I!&27 M4FI'O"OBQM,R&TSG\\J@PU2B$.SQ^KP1X3'3"2-PI5QGBDC:*:>(-(5>S@UY M^3VY2F,S"-IO/ MI"G,X@TT@WA\0UN7WE/4*N1.R*+_E*1UKAW7>8@M+[F2$6)JQU++R&ZFJP-Q MNHA+Q;II=9IH08$G_?PVW3!9[*5H"Z[Z*WA!GIZ+UA"F/HRJ'D)O!A5?]VN6 M):I<;3B:+X]Z+9.5=O@9H<'E#@\5)*NN#UH>Z`0I="-^%?$@^.J6E]KDC^FT MB`;E=6T[P\EH6C9UO[R%%G8T"\G5N)J!),](F[FI3&-O1A431N/H^M;46%V< M=+TLO.QO-8JWQ(MMT"2/XUE#@]0W])0;Y"*CY>>(2H!]A(5^A'7DE8I19R8TDU(Z2:B/$U`>9AMANH@SCE+ MHLVU!/+$4\OFG0SFFXCS3(3Y)?2D"*:5)DZ8L9BLM)NDU"$E>2.)M&L&^^6J M12Q4R"7$8+%1@K?IY:I]!(Q&+:8AXT5X!87R[Z3TU!4]J5WE7PKG*9^^3:9IY(7-ZAD*_JB+UWCPP*2>]FT,/.^ ML/2E'[V;7F5YNBQ7K3H1KTW?F0Z;6I:7*)ZDBYML^)+7B`-D$6ING-X?IF;& M&P&"?BK&^![6>B)C!#2J,4AU66FM(T12Z8W=!0KOALB="S%BP;JC%LP`[&Z( M0&^/<+FT8O!512K*P$?L(!7-'EU\2MX$-*9%25'Q'G6FMIM.4WFCN:94(]F0 M2S&Z&VI"PS6J;W*_?O<-QW@_3:_+^W,)#@)5!8&YUJB3%JX,*IZO>F=M($6\ M:1$"TV&A039288P8`*U($&PQNL5K*(NSN>D.C6Y'H/U[8V5EQLZ.3-R[-6N&EAV$LRL[-8;K3H7X[3 M7M8I$%/D1\4G&E?C/>"$HK7\:O#76)YGH,[6;*8!/(OJ"0-[IEHE=/8WA$H_ M7MRDR;0ANI[UC#S<;`T[>1C:$<&KX6E3-<"PM;DE2#B-N.ZX\1*J8*$*!!Z< MW,=LCZ"?.L.S*:9UP;U_[)[O'[U-CCI[/R<[G?VD^^=N]VC_:.?\Z*#;(B32.@5[YQ;3:V!HUAF'?/*2[825YTU#6BNQC+YO,\O2FZ+N,'NHAE\+( MTZNB2R.T$:'DR^GM:$FN"\-UIK">C*FJC7Q.)JIDX\3IER+U\HS8QV;JFQRZ M*9R(DSKT*`3`>\)Q[4A88EK+S(0Z?9`R!QQ97H6UZFAX3+`5P>J@GT^+Y&M^ MEN;5)?'($F==L?JCH\58T*(S@@*`M65#-DTJ0K&C4K: MYI5"$A$0=3S"2LO!"->+1**(RY-%6W?[\]%@9SK<'XWO-X;K$1="2B.>));V MXE"(27[\2J[,W+T$'2];?XN?JRWZ]8-V>1?6\EHG4T,&\35!2.]R4BV(YT5< MX?PU'5W?%+;M/*1Y_SKMW$\NT_STJC)_?GJ_F"^*QB_/#H'9S%:\_M#&XBS. M:FLTC_=:U*YW9U.E*_]>R26U8+*4K&XMK&23#>&XOF\--2D8.(*VC@ZF6N1P M86X'$C\BKO9&WJ&.>-*KT,*'3EH=/5!IG\%#9S(E=I#O:32W@7R+HZ'JEN8) MMKBBA@HB0-61`E-"#A2X%4B<8%K&[M$%K.G3$/M..E'0)V\,-;5BX**[Z"_2 M?WYS.,X>L6L**$579QFJBO*<9D@PAND\0W5-A!,-%0K69QJNRI3) M5UDJJ8I%/LF0TN#R689TF-0A4B4!G&>HU(\[VCBZ->&V9M;;$&3>VZX?9E_M=0#SA) M;&P+,9*$7GZ0YI1.`FGYP5J5?DKY6+D0,5PTW1G^__?U$OIRV4O1ID<%&R)C$3;I M.')/N7`A39]\?Q)4$KX_J<]V?Q+58I8!0T)EM&O+%3JV[Q(EL-DSTP92WJ#4 M!V]0TJN&G44:WX\'.9QM+;%&$R:!+'FCT,![PSG3UR1>3>% MQG1>P&VSZS2?IXOE?:O'H_YE?:=5Y&Z4!9:@?=]V>*P3)+H\N#N<7#><046\ MSD@V?D4811=`;$&I MI*4TLLK1S_K/Y2NO;%X/>FR,+)%'#@QT:8<4*+H\=]T,7L=WGXYFBDMGCU"# MU`N<+64J=\DJ'QK<%WXP723C%ZFV,8X-6`V&.,Q]0#OV05!I,BA"LA!AHX@K MG.476H7=\[3(V>_U`YQ(>304B>4]A1O$+-;=7)1:R?NWM,I>YGJ7/Q?46OW> MME"``8+@[FHLH2XMB%'<5JH)<4WI:(46X-.&\FC`--2"(1)*Z@31EN9O>_?S M139)\_UTELU'A"X_)H"&/TG`$[XPPSP'0*!:AP@H:EM/X-:_)\/Z0=MB(`H+ M0A#40`J-@J(<)0S*=2%Q4%KUV0:EFUL>%"UAF0=7.GR M+MO5T&#KN&K8+][U0=<9ZK;JC%!>'9M*5-SF`+V\F,9A,S)!@3I@JQ3X!#+! M<*^`5M=O#6R%6FPS\E'GXJ"[#9N1*5BC1G,Z;M517:&''-V5MB!17CK3)>`= M+OWG:N/889;O#!_Z12OVLIVKJ]%XU%^(KD@JN[KI15F6YR80BCF<<].Z"BE3 MT$H=+_L_JR?)598GXZQ?[3[JKPH-DT$VF?6GT=,S&ASD:V8,4%2[JU($N(Q& M70/BA$QW"IJCTO[*&@L\&F@P16/R1JFN%9G3RL+"KL'=_2A/B_!=)'F+Y[/B M2Y77_I47_X@NM9\8EN^O.T/()I M5A=^F\S*XF^KF=1T)=&.\&F`*#26&J-2"*QZ>3S*4NI&0B[3#8".D'>.O]9@ MMU5G#O67V*S7WJI`75#)7C8M\N?[08F>)Q>7L%"[.G0HHC?*4 MHV)U&J:IH)HU`NMR57(PV"A9CK44D+PN/E1[TE0U-%29*@54 M)'YR7:EH@U..K-4$H69*C/#92%Q!=:T(B?0!!^O1/NM1OM"C>^&F9>#*W:9E M`)WH@/6Z;-NG951PU5%N6YGUQK#U(U0UT2ZP1U5L.X^U&62TF>JP>_ZSWPIT)JI&`H&Y/XM M'3FKOJU"`NC7*O4C3A=Q!\2FO7OE&57EJ57IL#Z>1N%V>&'`\8#"[*Z'&\3O M?&!=9NXGJX`=<%[>O7&3C0NDS-]G5U>C0?%'>SQ/`0.E[VGA`WB?+*/V/Z@. MQ`,CWB%YGL[JD9C3*PWM48K6GT]9E,7W*,9PCO)JZJ.,\*I4K+SOI4PYPU#- M_;;5#TEPD+S0`$2U#ZHD9`]4ZT?\CVF!O3$FK=G``HUT!5983-ZH5&[98('U M(('UX$#H08%PH[EPY6ZCN8!.:9SK33W0]2^-T_K7DFT?VU6!RV$TP'44P*7W MCX9?OTON'='/.13&/`3F@'ETI!>HIA7!N[1U9SHL_Z]<-O'0'Y=,TD2@+B&V,90SBAM43P[B)UC6H#WK)_L'>^<%.]R`YZB35^.[_ MVY_,_K_EGP=__'ETL7-\T.E%'M:U@I<4PAU`6@=Q$PUR&#>K'PGD3#>E^O(! M?2AG@+^]0CWR0?0G;TPJ:44P/[BZ2@>+TZN#IT%U&OAYT5DXG<*O(2#%1K1N M:B-1%B#;&,L#9,.:]4`V4;@"\L'AX<%>+SD]3`Z^[7W:Z7P\2,YW>@=)_?=I MBX.Z%Z4R2A>?YK=W>.=SI[!VV(TD8MILRU MQ4_R*RG-EJ7"`?'%1#H4#Z9#)B!6M>-07%5DJI0$Q8/./@F'\5)K'$W$K%H' M1V5"+0E3ZZ)TKQ7'MO9B)/%D:O5)^`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`)R)HUG"\(K$]=ZW8/>FUR M*ZR),LJ';2)?*"2PL:0"&:Z,"X-A-KB?K#S-%0X-96I85#^[3<@B'KIQ/Q'F MIJHB];N#1=Q;2E4S@]Y]^71ZO']PWJV67?3^T:)0 M90X=>1K6$GVKB5BJ.#`52Z\9#H+2+I0([O#DQQ1CF>3!;5U4I M6,^0=?9.3PZ2WLZW5F40I";'I\W(SJ>24$RH&;A8Q%/WC]/K_OBDOU@4X:%< MFY55_?)TJAJA,Y)9)>,D&1;O,S*/QPVI5>K]D:1IO6#QM!KZ.NA4XU[E,%F9 MIWU?$1>&&M[7OZK&7LG"C5' MV75"G./I1`-91\[U=9+'R#6J&FNL1A-P1BWY[Z50TAK/-L0.-JQMAKWF`+9& M%AVJUM;9OOFV^_EHFL[G>]GDLD!':=A\:;7HT=J"*R_&"_)XKM80)F]5U4/P M4%3\Y6+A^2`?55@HS_]8";30(?5-+SLA%2XKQT/+`\ZFT$T<6`^8%X^*OO*P MZ"WKNYZ4HNLA:451GN278`Q3SJNNB9#J*A2LG.UC5I[/L%>"/)^VS\5(32\G ML73`K,>U<0D@957J)PYUAW.U/^?IZ=7!?#&:%,F-N*\9?EA_'>$ABP/!%?*X MC*1;[R1-D95;_+F\:67]>_L\`VDWR1>4[5NCOUE&QKNHHW7CF.?I0SJ]3\_3 M078]'95VJ;MAY/+K8P5UY9G.<2.:Q768F[XZRHEN&BTOQ[I5!9.-DNUS*SHR M@!,&S4!5.Y]6##IK4%L3XS@HLH:@-"*?IR=I?IWF>G?3%=WP-+2H^V0QQ1*& M-0:::C1K#532F\Y4E$F6A=KI1]HFSXS;1G8=3$)8E:!63AQ$A6U]UO=-+'C0F:/)L6 M?PZ6LV"4.4U;\?59U8;B3&?VVAG-=7*O<>V4\WO-E+YD`CVXSN)Y-^_GQZI=QO]#W-L\/1 M0WHPNKY9G$[3;CEBT2NJ6_YR-Y].KI^&Q8.OO5X77B,1KE[U9D8/];IW*X-_ M(TK<*SJ$E]D\/5:/C80T'0J:FU8&MFB]"[.L,#F]2C:K3(HZD[K2\ME&M8W8 M7%><_-**U2@!O32+ZP&D'9W\U0OC6`%?F[@FY[5$+\V0;NRP%<,4WGB5O`EF MN.*P\=<"5^*`<&S8`J/+6PI?+QMQ/7Z+3YV3V6'O,7O^MO=X6"!7K6(-!K^]VN1-;/'BUY9HC.:IM/N_J>37KA4 M7UF]_TP?KK[5E*?\8EN1YV-O$#W-!PUC#0]_>;59OMJ1@R7YE'CB/\<'K0B7 MXB,?@7@NRBL+=_$2?),X%]$BW@#G-;T'[=^:[-X9RO&3>Q-(A\WMHW)W.U/[ M^;=)]WBOFY]\KQ[,PF7U6,W^$WJIYE:3&_:=MB*-!XR/GL&+-K$&@+^^VN0= M]==@>;LF8OA/V44#PF7K\JO[.Y*MI;$L7HY.#&)QC.&-7EXS<]'TK4G*76`; M/Q\GPC=L*AZ+A-N9A=_V[H87E_EQ[S';[1V&R\'A>OUGX$*]K>8L^!MM1?8M MF1X]]VY:Q.KT__9J,V_$2X/EW'M%CF\,8RKWFY;/S6Y.9N\(V?GY-A'#9'CT?-[@*/F,8:*O[V M:K-XG4L'2^5IL<5_/H_8$2ZI1S\$\=Z.5Q?\XJ7W9E$OJDV\XR MV/Y-5:`[[(3K`^AM"'!/$VY#JZE0_^VVHC.@?(WH_0'<.M[H\7JO4"6X>+A; MG:CAQG_'`#J]X57MRL`X!):#X[PN`5H3K!B`?`>D!M/S.5^>` M%R_Y-XET$2UB#G%>4W[P!;8FVW?&ZQP%W[N*5!]BZ"U3>:IY3?*VM2.MA^Z,G]8!9O#'A]5X,J_+?V8:`6WBA#X"D\BV_'=8QQ$7F^1I?AYL*2?'G3\)_\*6\)U`I0?!.D,M/QJ6:;0&*]3 M8!X3H]O%'`R]=A(4K[$UG04FC,?O-)AC/6SGH0T)0#L[$0^[@Z?O>\?[D]OA M?KA>`U2K_VY"H]96DQ_T?;:B(R`8'CWSW[2'U]-?[U6RH',&R^T5H<%_,K]9 M>;CLO?G*2+K>\GMB;2-6O/R<$*K"&\(T1/ MR!7F\<:0UWM;+,7/@Z7K]*#C/WM7V!(NF5=^$"2W;_G5LDRA,5ZJ;QX3H]O% M'`R]=@04K[$U_0(FC,?O)IAC/6ROH0T)0#L[$3?#\D,\[3[=50]64Q6+8;@N MA-8$_QT(W(16-A.0GRJ M;V<78?ZY6WZ+3R>=Z[/.IX=P'0.D8O_=`;'B5O,>\I6V(O67;8^>\`LF\?K^ MZ[U7%_/58,F].ECX3^F%^L,E\M*+(^E[RR_3=0AC\9)V6OR*8@MSX/*:H`NF M;TU:[H#9^,DX#;MA4_!8Y-O.Q/MD<3.YO>@]9K>W9#U7HN+>VVP-%P7./PGXI(%X5)QX.619+SE]]\Z M!;5XZ3@UFD6RACF,>4W))>.W)BEWPF[\M)R*X;")>3Q*;F=JWKON=8^/JRM_ MRP>S3O6HL8G:?Y).,,)_NJXRHM4<1_AZ6Y'"J]\C>C*O,(\UAOSZ>N^[I?AY ML`2?'G3\I_H*6\(E_$Z/;Q1P,O78.%*^Q-=T$ M)HS'[S"88SULUZ$-"4`[.Q'#IX_5+S?EG$=W]'1>_3J[+$J&ZT00C/#?B5`9 MT6JF)'R]K>A$J-\C>B="81YO#'F]-^12_#Q8)X(>=/QW(A2VA.M$*#\(THEH M^2VY3*$Q7B?"/"9&MXLY&'KM1"A>8VLZ$4P8C]^),,=ZV$Y$&Q*`=G8BSG\< M3L=E[ZKZZ5OOZ4?0RW*5U?OO.,#5MYH7E5]L*SH+V!M$[R:`AO'&A]=[6:[: MDX-U#2@!Q7^G`+0B7'<`^0A(1Z#EE^4Z![QX70"32!?1(N80YS7M!U]@:Q)^ M9RS'3_5-,!TVR8]+W^U,[XLO<#;\L5^6ZIVJ_2U3IVL)R?&&+\I_V8(>$R?_Q3(,E_RZ_7Y8B" M\?)_P_`7URCFN.>U%X"]P]9T!#AP';\O8(COL-V!Z/S>SAY!K_P2P\')U=V/ MPV^]YX#;#>"*`VPQ$"IN->$A7VDKLGW9]NA)OF`2K^^_WIMS,5\-MTU`&2P" M;`UHUA]P.X#XXDC>WO*;]/1, M>],>7D]_O;?6@LX9+,=6A`;_"?9FY>&RZ^8K(ZEURV^MM8U8\?)J0J@*;PAS MC/*:46_:O37IM"U.X^?2!+R&3:2C<&L[L^CNZ*GXF^GU?ETR)4LA.`29"$+9$?0 M=2SPAT!R]I;?1LL0_J*N8C&(>U%M8@YXOM>P0*^P-?D]`Z;CI_IFV`Z^@"4J MJ;>S`_#X]5/Y(:X?'WJ/6?Y\\3%@^9'S\]EJWBCP>N]^U7ANL$R=&WX\)^BRR:$R]&AUT>2]);? M`^L6V^)EZ>2@%LL34WVD5?8FHR?`=/QTWXS;(?-_6.3>CL[`"?/U=_%@][UV=UUT3%X[`,@K;$T'@`'3\3L`9M@. MVP&(3>KM[`#\L5<>I?GPZ5OU^WPV.9^%2_X5E?M/_*'*6\UZBJ^U%0D_;'_T M9!\PBS&B6C8"1'TZ,&YI"#X":W>MWC0S(S(7):6A+E?+HO8F,(0I*K=F4C0:,`&\6-QG&I M",,)E8?4.-.2D"!.9B"I6F30MZWXM>8>&G!M5(F(5;&.(!J*F1RPT6UQ`:(^O1QW-(0 MA`;6[DIFLE(!2)'OLK6"#97$M,C3$IBL@4Q>4.4P<7%<[^H+U-:D14:SI381 MQBJRDJ5#$97;QW/\W(R[/"Y^KE3%C@F$Y1:7$M2 MB+A/GU9;'(*L4`M<"0M6+``L\L6/UE"B$A<)D5KR@K60"0PS`B8QCOL.?0+> MFLB,D.Z@482XBM!@#:%(S;TQG(G-J%&,R,TU_G@AN+T?%=M^N>Q\J?X8]!ZS MZODNF>3T*K1$IU#AT_?UEH<@/*45KJ2'*Q>`%_E2-"=X4*:R"2H M,@8F0HX[PWP[@S49&GN!HU81_BI2Q+6$(D:>QG$F1^-&,B)(CECEA22OJO7] MYXO%]V^'D^GX"YD:,4$M(4J"/CT?LS($^0%UNU*>J%(`3^3+A2S`0J4W#=JT MI";*DZE,KA@F,([[=/S`V)JVB/BUTB4"5T51HFPH8G+YZ,YT1/SX1B1D'SW\ M+/^HS*G^*7[Y^+%\_FTQ+>?P/M$7@1"4Z)>"J)1XG1\G6!]D68C:#N?%(0KU M`@@CW[GA"#3R0A$Z:O7+112ZZ(M&E`;!E,=Q+85_U[!?0&+N$\YZ16=0+B91 MZ`FVI(2ID=P7EI@WEMGR$I8(YH5&NZ.GWK#ZX4NW^[GZX_8[?1Y/+:ZE3D3< M9V106QR"+E$+7(D25BSN5HQ\FKTUEJCL2(*DEA=A+61&Q(Q`]D)SG.+N$_+6 M-&B$=0>-$LA5W`>K",5Z[JWAS'=&K6+$=,XAR`O)/>[N7@[O?@PZ/PZ_DZD- M$M(26D/(IT]#UH4@+Z%>5\K:5">BI+4'=(#(H-*3`E9:4MJ4)5-1LT*$@/R> MQF$+5FO:(:#46(\$3Q7%;`J&(A;;K^Q,)X2O;40BED'!"W4\Y>4O58>M]YA] MOB[^V9^=D4E$+:ZE$T3F,P-T6^N38*VB,DA!*")S;05G&C-H#2,2 MK@`V9J6B`BVTB5!5T5'HG`H*G+YZLXT M1/SZ1A3D$$"\T,^L8L))Y^FX]SB_J_YC2*8@E;"6AD!AGQZLLC8$'2'UNU(2 MI%9$56L/[E`BB$I-!!AJZ0G20:8HV`"$IOR>X.$*N8$!AH M"WOH6E,,";,6FB2PJ@BF*1J*7^R_MC.]D+ZZ$;M8APHOY+(_?^K-Y]W14W>O M_,_S$S*_H)):BI$E?;HJ:F<(HH$J=^4:2:>(H=:>3H%#ALHX.M!I24=20.8= MH&J$>OP>.>&$9VOVH0+93IF$8!4'2=*A:,CIRSLS$;4%C,C()99XX:/#RKU M(@I;>^P$"6E4$C2`K98+5;K(E*@V"&%&O\=6<#F'-4%:>(6S7LD=5'2I4A2* M-;E:R9D\+5K+B$.9@IB_RYB[=]>?"I[O[#U^6HS)!(J+TBYA;HIZOX\6M#3( M*;M0[2P7+S>4BDAJ[7$8"MP8W;BL@IZ6^F0-9C\TH5?8&Z2LA!CAWER"](K9:>WB%&D;D M3A,!C/I^$Z2$WG6"34`(R^^!%LY8M^]`&8#<7J&$;F4W"M(0K"?EVA+NG2F# M%C'K3SG&'0=..Q[U+T?CT6*4@I;=%@S[?/QPOK@]+__\)C2-HX":O&2H1>,W8!&0Y8[OAKJ$U'IS; M*P0!GKPQU,)+;1Y;@TAM/*T"4)O?\../W@ICQD_?;AY[TT6YW7GZPXS?4'$: MPM3@8Q4$6L'"3I+FL\&;&<#I8TFI.TF/$<8`32@6LYZMV8 MC@IW!XT@SK5<)ZD)2G9.+<+#=M26,:<[UTCDC^_*_\TNSFZO=G]42TUVG\P( M#Y>G,1X@[]WY<9N#<1YH`@OIR9HAK$6>3[,'E1'M:<%)XSU9C1GQ06;`S,85_&[41T:]BTH0[EKRD_4$93^W5N&A/W+KF/.?/@_,ZPSZ?00.SV01K\Y\`*N\-U_F`C>/I_@&X(=Y'G[US@9=8+U`.5V!$$ M%!GV!4%38%+DF,[S[`J./4*Z#[@I!<&O[Q<"FL)V#1U;AZEW2&\EBPZB>ZCR M1Y&[WY].RM\FO=+`^>3AW(P@<7D:/0+RWB,";G,P:@1-8"%&63.$M"D4:*LQHP0(3-@.N0X!]\K^-W(D(QZ%Y4@W+5$*.L)2H-NK<)#@N36 M,:=`YZ#DCP`OKGJ/6:_\ZW+V6*W**>EZ_]&,!G5::&2(:O$>%73V!R-&A2$L M](CIA_`8^7A]5\@94241P#3"Q)29T29N$DR>'"?P!W`3-PHU]`]WQ:!C:.D4 MTQ:45#E:BX=:#5O-G&"9PIH_FOWXJ?=\U9W/B-UB+FM.86<_RQV7GW\^RXVRTX]^JV]\F,S&!9&I<) MLMY='+8U&)-)U;,065,KA*G(5PG8`I4EW(T]KAZ M5OWGGAF3$131:$VER'L((+Q%,,)3V\+"?HHJ((1&ON:``8%&O$B'-(TD%?K, M&%-I&$R?'#@.1GSQ3U_S-RI M['GNW!T_/CX7OST8CI/B\C0>!N2]AQ#&P^LF`6,UUZHG60*?7 MZ&+^;D&(V,@L9V*FUP:"O+VG[5@@ETSW M9CUS6);6(Q=DO7=E.%6<]: MK!XAV@`G!ME#W*TG3<*VK3H8U-J>0W:+-?X(['I> M'5[^VQT]Y0^/XAU2#AIH9`9J\.[O*KN#$1MB!`N]0;I!X+7[8"`EOHRH MCH!4&N%!BLQH#S8%(;\`)P.Y.H,;!1IX@9M2&/Y:.H14!25%U^;AH4:#9C(G M2(YHY7$YTFB:/CR-OY5_/W^>]1ZSBPO#!4D*#<0E29`&_ZLR%':'6Y8$&\&S M,`G0#0*OW0<%*?%EMCA)CU3B\B1`D>$")=`4A"8#G!CDZ@R.BY3H7N"F%(:_ M?J$2H"KL4B7'YF%:K$1O)HOE2@S1RA]-/NSG@W$U5CO-/S_EAV84B4G3Z%&2 M]AX-,'N#T2)@``LEBGI!@+7[2"`42T94J$$DC09%)684*)N`T%^`,W]<`.]& M?42DVRN$(:ZE/%%-4+IS:0X>JB,VBSG-N48@?Q3W]?/#X_?RC]GA\7[13S4\ M11T5IY&<+.[=Z5&+@]$<9`$+STF*09BU^R@?'%!&3*?#)8WJ)"UF7`<8@9!= M@#-]G'#OQG94P#MHA)&NY3M)3U#"*Z6%/2"`&OW84`H MELSNE50CDD:#HA+#.R4E$Q#Z"W#"CPO@W:B/B'1[A3#$M90GJ@E[EZ1#2=`4F`I_#7!4CZLSN-&A@1>X M*87AKZ5%2%78FR0=FX?I)DEZ,UG<),D0K1QHLKO(!K.FR[WN,'R+GQTZFH.C5B=:EF!=E-) MLM221#[OAP>8&3]`FNSKI%+@84?SD,[I-CF6AII]>!27>J4K)6^<=//R=[#6 M)#*YCU8%.#U&H/1.\L7__5&M5/J25WM7]GK%+[OBTE<6748DC^D*%8LT[Q*: MY'%S.$D>J46%WYMB MDCRB.P;),[0F*\F;M:HUR?,&2N\D?S.\?>@]9F?G5^?5\YD5O:-:C(A=UA(J M\J#VAR9SR!!.&I?TJW`9^8P@5^C94+<.R$:D+2FSHFO`))BH.8X2"N`N+!1- M]1-WQ4H'H=*RI#4&(3NU&BL54UO/FH2YPIQW^GW^_'#W4*8)T][YXOC2BGP1 M'4;4*^H(%4D0VT/3KFP&)^D*VE58C'QBD1O@;`A7#5XCNA5469&M9`Y,M1P' M%WEW$!:BI7F&JUJE2U!)5M`9@V(=6HN58&FM9DVO/`'-.[D^#:9[T\/;Y05P MU:1ZN>I,/-Z(19<1V6*Z0L44S;N$)E_<'$X21FI183?RN4@\P+0A91K8C<@9 M46E%TJAY,%ES')\4S+%82-O,H[C4*UV)2N*([AADSM":K*1NUJK6Y,X;*+V3 M_&WU']^79VI\_70XF.=VZ]!4BHSH'504*@2IWB(TL2.V<+(Z5(4*J9'/=F)` MH@V?$Z!M1.:0/BLFAPV#:9SC&*@P/L3"X0;.PZ);Z354]H84QZ!NUQ9DY6V# MEK0F;<8XZ)VQ.W>3R_E-]]2L^@LJ^H-`;S MNK08*^L26\Z:<9EBFW>VW9WW'K/'\M>3\V'Y?]W1T]X/*\Y5JS)B7D15J+BB M?I/0+(Q:P\G%<"4JU$8^&(L%DS:\3(*Y$3O#&JTX&C,.9FJ.L[-">10+7QNY M$I-VI0]1N1M6'8/!W5N2E<>-6M2:S5FCHW=.__YEV-G-'[]T_W@H?K'BO) M[.2S%9?"*HRX5%`1*F+`EH?F4LD*3BYM*E?NM8]\_I<3V&S(5(E;(S)M:K(B M4]$8Y,01CC/`?/L&"YN2G,)1J]H;J'3:U!F#3NV;BI5.24UF3:<\@&.]7+Q%!:6);J(LUZU;U"95M0:@VM=FHR5;8E-9\VW M7.'-.^->5>>,]!ZSQ??BG_W9'Y.RA!7OJE49L2^B*E1D4;]):"9&K>'D8[@2 M)6RWXH@N#2AMN)F$,*3&;Z165!)O10JP/ M/MLKV\$ZWRNH5T)R*T[E0F%G->FKQK#9M*^@RV[B5S((X>9P1W*Y>`K/["_- M19SUJGV#/`4L:(TR">S09+S3P+2FLY\(9@IO_GO215HP.2O^>;@TIY%ZQI#=*C]BIZ7A[P]0FM.\)LP4]_^NSOI3_ M]N[*KOO7KX/BUY[=%10J169KM2!%P5:E*-XB^+HMV!;6U5M`%4JH;L6974HH M6JWDTF/;;#T7H,]N51=H&,+3X0[J=/=AT:WV&_)J+T!SE#5?CDW( MN_*+WI3VZ[\80Z%WUCXI_O_KW<77JZS'S=[%\>'GZS8%E)@Q+0-!:%B M!V1U:(85;.!DUTW52NAMQ?%9(,1L6%6!52-&W=1CQ:9-0Q`F#7=>EJTWL+`H MP0V<=*KQ3V7/38TQF-.VB5A9D]!4UHS)$;+\7PVQ.!M_Z7U\V/UX?FIY@@:L MPNPBB*:*8,?4@Y8'O_9!M(+UMH>&]]@X5"24SAJ57L#^:*&ALXH]S-8-Q7OM0R4)K._C8$ED#GPZ=%T MD$W27O\IG4/V/3P]?.V=WY4_?^^.GNZF0JO:BM>M82SN'B=L+>;C3PL+:-QI MJG@%MZ5<4@DFD7?R6@,J8VGE)D^::A$XTMP(A!];#GL--3+AW4$C#/3DC:D> M7AKTV21$"F1J&H#^?,G1VR,QB] M"96S,-NF3A!(D3?"VN#&B,\4R*-1V:8",Q9K5@T3&,<>5D^8=N,N`ICME,$H MUC+6IHJ@9&7[^7EXBM`,YA3E$E3\L=->]<_%^/+KS>VDNKKOSHRD%`IH7`4I M\.[>"JN#,1=L`PN!`:I!R$7>'.H`+2,ZTV.4QFJ`'C-R`PV!.8YC+ZA?)W"C M.CKZG73"L-<2'Z`I*/\Y-@T/#=*;R)P-&2*4/U(LK[']S,M861$?&HLTDA/T&%&>)(!,-EQ M;+GT!W0WHJ,AW%H?#&TMP0E:@I*;0U/P$!NM2HU?[N;=T=.W_>]FG(;+TV@-D/?N\+C-P<@--(&%WV3-(-@B[PBT1Y41RVG1 M22,Z68T9UT%FP'3'L?G/*_K=&(\,>Q>5,-ZUO"P MY(\#]X=WJW]G>[9=G,Q94::#Q(*C!>RQ0V1V,"Q$C6-@0T@T"+_(^ M/A=\&3$B`:DT3H04F;$B;`K,BQQ;^3S[@ALS&CB!FU(8_5IVA%0%Y4?7YN%A M2(-F,N=(CF#ECR4?[X:[O<[U3??;U:X9.T*2-%9L2'J/`)"=P5A0J)R%_39U M@D"*O`?/!C=&;*=`'HWE-A68L5NS:IC5.+;7><*T&YL1P&RG#$:QEKTV501E M+=O/S\-6A&8P9RF7H.*/G897>?'7<#'[^N6BZ%\:]M\P:1I+2=+>O1JS-QA; M`0:P,):H%P28XMKR%K`6BB4CYM(@DL9>HA(S!I--@%GL;^W&NQN3$8%NKQ!& MN);11#5!6(\KX92.^(U&0X:B+-U MD`;_,Q8*N\/-V,%&\,S9`;KA?9>*&\9;0'U*@)E-W.FA2IRZ`Q093MZ!IB`; MPC^TWQL<9_#H;N"F%,&_?AH/T!5V(L^Q?9BF\NCM9#&9QQ&O')AR+YLN1M/K M=#H8I?.=Z?!XM!A=5^8?C_J7HW'QGXCAC]GU[7"<3_[HY8.QT,3,6NLFX]+J M'E>8WX^/>?D,H[$Q4WTKQ#?4)86^Y$5ALJ$Q]@DNW/C.?**K2?),R@7B9S/9 MW^DP$7Q6DQ_X=5;^BLR]-'G#5#5OVA$!"L14Q"\D@/2DA0$\1C9S\K'XHSO, MG\L'Q:L=EZN,;[FR&K5VU^P&T1XQ8JK?MP79#FJ@YZP'KM?8>2(?]>/+#YBR M()*WN69#<"5<61'V"OZ.'HKHZ[ZR)",G]U>AN7<[9$VP"2W)GMRAXCN+,H(, M9S;EGQAB9%4_+HI7*=_DTQ^/@T%^L<>54*&*77,I67'$T(J^90LR*,@VS\F3 M5*6Q>T0^6LH#W)E2)IT_N69+DGZN1`DPW-_157$9*@S3J79,A3'W$ M2*IYXQ8D1KB%GM,CI&)C%XI\!)DW9V!*E6@^YYHP(;5PI4WH2_@["BVFR_M* MH)P, MJT=<.99*MVN"!>J.&&I5[]J"U`HQSW->!=5J[#"1C\'S@WZFC(K@8:[I%%0% M5RX%F^_O"+YHWNTKBS)P:U_5F?NS0_X$&="2Y,D5(KXS)P.H<*9-OBD@1LYT M6*6`Y6OE\]YS[W-GT.-*F12J73,F2'7$D*IXTQ;D2[!UGM,EH%)C5XE\HJ(7 MX#,E2WK?'^G-\9R:U^)$MV?/=5F[L@.:1)0?TNR)$=X^$Z2 MZ##AS)$\Q_THRY>FTX?K[NBI\_WQF09)CO M]4J-^HR=(?(QFMSXYEJII/(>YV5*#>5L:Y0$D_T=RQG!9[VM3J(X*W]%YE[J MLBZI475+DAM[*'A?D42!!.MR)&\!/$8V\W!Y5_S5*6?]AN5_?^Q-N%(:A6K7 MO`92'3%0*MZT!1D.;)WG-`>HU-A5(A^>Z@7X3`F/WK=WP&N ML=S:5Q)$]V=/M9D[LD,Z!-3?DIS($1Z^$R,Z3#BS(\]Q/T:*-+U[?KP]O'PZ M*5[J5CSWEEFK:V(D:(T8/.'W:T$Z)!GF.1-JUF?L#)'/XN7&-U/^H_0>U]2G MJ9PKZQ%-]G?6;P2?]97KD)R5OR)S+W7(<)I5MR2YL8>"[[R&!`G.E,9?`(^1 MS10O\>-Q-K^Z?'S^]N.2*YN!M;IF,X+6B)$1?K\69#.289ZSF69]Y@=\13Y? MF1O@3.F,TGUQPQ7;.Y#VWI4M5$S7`O;PF;L)9!<*>IYU@Q.[VV% MLY&W>ZS1PLU=ECK#1K0DGV+`B_M07I%6*>Y]P*JM7<8[;U%&PE_)FR*H*+N:94 M4!5<^11L/I),13W^VM6_?652!H[MJSH+CW;(H2`+6I)`N6+$=_9D@!7.U,D[ M"\3(FQ[+=ZHN==N__5+\=G9W.63;.J94[IHYP;2O M/(GLRGXJL_!AAPQ)KK\EZ9$;-GSG1F2,<"9&?N+]Y@_'Q5_%CZN?BG\N^_.T M^.7_`%!+`P04````"`"Y<0Y!/H*Z\I\M``"J-P,`%0`<`&-Y9&DM,C`Q,C`V M,S!?<')E+GAM;%54"0`#7I4J4%Z5*E!U>`L``00E#@``!#D!``#M?=MSVSBS MY_M6G?_!F_.R6[6)D\EW+C/US9ZRI=B)+2F*Q+&]?IFB1$CBFB)EDKKYKS\` M=;$(XM+@%;3Y$,F?'Y;AY.-_?C@+0M.U3,=ST9\?MBCX\%__]U_^QS__Y\>/9RUOOG!LTQVC MLX>%CX)@;?KH[(=+*N!G;6^\G",W/)N%X>*/\_/U>OUI?*RR.=8@#\_/SCY^ M/-"]V[7GCS//:_QO^;W%[#AJ@R1GY_Z_!CUC%\7;D6W:DS=#< M>*XWWYZ3CP;.:CR9\? MQEO+QCWTY;?/__[U,^F??R5$_Q82/3]I,E$Y+A>]Z.`',89H$R+70M:!)2&= M@U`1^T,#'&\!R,0I"WQR'!T*..4+.GQ]4JN#71%Y0 ME7-UH?;]&.$V0.-/4V]U;B'[G,A)?HD$_OCYRQ[X_XH?_1TUP$:!88Y>D;`7 MC?EN+T/\7;RQIQ"X\.,--_WQ@1+^-:'_N,WM2YPO\`CBAA_',]LY0F?B>W/% MWO?$(ITV^X\S".6ST#NC*"X#3,E;D%*F\^',\RWD__GAM[+4V4%3T]FU]V)C M!Y1".6_W\M-O*U,J6TF>K/UQ_<6($$4E*K-5];54R]NVO;EINRS#HUZ=VMWA M564:XBG"$[8]KB"*QM&6CG79^OF'9OKY^S>!AOXNS?`/P]7)*(6_ONA'B.;T M*``I2GVIF$7U&Q\4)),,%F)*;&3^>]FZ-C!9CFY/7U&ZC%Y5_L$6JL@3"L+^ M3K,(GFIR1XBMN?\H2W,7N"46:>2)1U+1'46*K[S]+ M5U\;!6/?7IS.J&@M,HK0RCPM4A^=\@5+J=H80;:&?R][:.TCW_:PXV^US9`W MQC++4(-MO(SV2H:(EF[XI2BRU?SE`4B;GJ5!'ME0H03$VW;((<%9Y6*E,6N*'D>[_U;RX.W-YYX[#+WQTW"&.R[XN0RC[4WL2;!'BL3'`*1-3/EVF)EH7BY9&W0F*'#V7 MMHJV:]8]RW#Q$NWGIJ@R=%X:2MR\8;MEGOE.F>48VK]M%S-],X7,8OF M8U0YNC\LU?WS/-%3F/)3UCC#2],AH8W#&4*OXY=J7&&,2`EQA#%^V2QC8@:C M"#[+X./4-!<[\T!.&!R>T':R?_PW\;@1T>7/R97MXO;86*%>8`O"#%6J[.$% MJI)Q=,BA#UB1A^R7M%P5QQXJJ<23"!4?"R"DR9A`DVRB#W-4:Z;PPSB5)OZP MB3_,<!WTL)ET2ZBA\[6`AG8F%4-F:BP";&UF7A!/K\V+($!AP/G M`HCB+ZO7(-,+%HK`T6#,X:4)<-8IJM;@?CE5J$A.F9@^Z3*5J96C.`\F3%RS M<5JO6DW0*,AS2:_6FO3`>W-[@(6Z;O;VUW>FM4J= MPX8UJ$[%8."IW$LG,PLC%(MH\QI&NB`_*L.X,!Y[2]S2`1HCW&K\4>JA<"\? M/3P`BAY&"5%1??&A("$0%F**VGEM/]P5;ICG;WN(UC[KU;XO8J_TU:Y``J`V MXQ2T\]+::()PFRW#W.Q$X)HRH.1A:5-04E]5P^4#:EY(L*`C-AF`L$17N*,& MR,&^JM4W?7)>B(,$0-$#%$1%-<8"7$(H&(04"SJVDQX-/2]$`?9-.I[I0K[S MX/+[7I.7UQ<J'I M1"5S/-*4Y>OA+9`?;ON.N4M\\[RT%V29-#F3A!0]?B\$135<=%003;;V*"95 MU(&G#&N0GHL;OQR3)OUP<>NG))_6M>\%],<`4/*PWB@HJ:'VX8+)E"^D5-0A MJ"S+1J'I3FWLX1XGQ]\V8V=)PO:O/<]:VPY]<%6ERG&9"5!%0UBD$%6&#QC) MHHY-9?41F,X!TRO049W,YL)VD@KXY%>XW-BQS9'M1+EH\/LLF]+]\TM63@5;TBS"U%;T50AS94.$DU%[SR"11VHRJ1Z M?XD]HH0X2>V+R[T"@%-.?PR`!%2$`8]F4<>PLN]G#]`*N4O.("`N1.UB4X4T M!P!(-!7M\P@6=1XKPVK2,@B].?+;:$&.$G"&`$FI8YH5=BG-M0\33D7]7(J2 M,UG51#`8'C!^05+P-7J!5U!S((!%5!H*!$0Y<*AP@?$D_$;J%X#*)J.;ZN.V9[EVJU&'N6HEHZX`N\%IFN*](O M3(+Y<0:C"EN."+E,NB=`&C4(5KFN`=,O#FD(Z[8&E@E'(W M3`55ZKMBOU6X!MH_X#QJ-NOXGJ#$:ZQMHD2%>Z,0',B%HK=#12IG4N,%C;+B'==C]2R@SA:?#)JD^6W-MQBB4GXHXSKSR]:I.5N\G* MW63E;K)R-UFYFZS<35;NQ$#)$^--9.6.;W!CQ^2G'[7;BK9#^\B/[E`4!@[( M*C%C";B5JD="4M^)L`*@R)"#UU#"VF4#CS=\=]7FQ3*<>;[]\NH@,Q'#*\Q$ M2J)P+1`B$5$=&4F"^J40IV]>Y<(!4#(9FU(7(,"%@Z!`2$V[5.")UD:7+DK5 M'R_%4_V^5%W4SA0JE4XB[6#L\@F*77,9,8N5?V\L+9+:;*.5UL]XU!K M%LR:!;-FP:Q9,&L6S.JY8+;/>\*[R([W^ABK2KVN7H],=U8B!L2%39+0;@GK M._Y`7RYQUV"O>M]<2IV"$ONN8)6H3*E):I6D1G3)IY.B])*<,Y$DT MS40^V7XJV8=^14A=Y+ MRPO"GY.]:!P71ECF.*:RRFCJS$`$@BW*,>EH=W7;Z5>:M)FV8^Y[ADNS>U^9 M8L6J\^2RQ/7*)$<[-GLRF:Q^A?R1%Z"XW:<*;`>Z1"P]"\MPG"/=]0V1":AS M#JG\]9XJ5AON<;%4+RO&][UT!P!0,B`&^-3RAT&%N4!B\HL^]Z+/O,:@$,D` M'@UB)'*_9*/"["#1G3\8WI/$66O&FWVOG;[1U*WC-Q[BS,5JOZ5;U'XND&^2 MO`'[JR!Y*Y72N4*]*32Q)7+I1AM.R0HZ7<[6AMA@;"K&O6^:UW,R>'#E^A/2LN`DL?$ MQ?R2>NL>+J,"#(1$];L&C7RZ4!!$#;I""6/GO3Z&V%*O]5:X1!H%+2 M(38Z4M0\S7`/K*DW?M+W@0*@E)CH=Y$:_F:N;/+)O/+\MK<+R[A'/V>!$EQ^W\GR M\IKB1U50")H`-/6[L>V'NT)!2&39-9F34$U6['A"AE.L,AC`%>V!I8R#08#*F@`.7L'ZWM''E@7XZH)^,FF`" M*F<*5`A(Y^Z45+C6^NIL7>'N;WDDX_H2B[SWQCPWN$03S]]G+XY6!.E$IG@J M'Z>RR[C71>',LU['6MH%KH!S[.AH.9PU=;FJZWR(\U9JZ][2)7W'#MF/59?( M1TM?`OJNA/._32`DJ_G,[@E-44(7#A@ M)B0^M=S14^'R^.%^ID/*1\ZJN*S8(>$'KYBFH`&*!4$,GY1^=_O1;;TT`WN, MYVYMVUF&B;QYP-(<"-"E*T."5-<,/(A%C<."1Y\%C@1=_6[0NT?V=(;;=K'" ML_\IZBWG(^3_G"3RPG$&C+35]UVK7%W3`29C-T`&'G46^MV[QY%A;QZR)(\I M:XNAQJU=&=)28XF/0V`7Q6&HV@X!2/G\\S\(^;7@3)4M,YA=.=[ZU?Y5MI-PDK=$E;V4$C&]"BZ'/LGE]N_`F3]<(_AIA?CT%[M+@[D MQ&&F)O"ZKJU*H'JT,">1F;L"N$*NS$2[U)HUWP/)H&BE/1)U/KGOH2"?GI]5 MN!YZ8?W_Y3XRA>SWX:Z)S,+P!FB,_[8=%)/=\+(-;66QV^N^<'8UM9>2U9"' M"1;?Y.*SMU(9#TQP4@E62792"5.+I!*EX2N9FT+057$8%MU&1HH+4Y3B(H=U MOFJS8[R;(ZMEHCOUR=[UQ4&I"<; M?_AV88-']HJQ7:52A8M`1I4J;V!310\3<])NB*,-SI:-,A:[W`]+5!A"GY28 MG"!R,3<[D?4#5)8+QM.RM4^N24?EX/TQY[L MV.9HG\,0["$HT)*Z#A!:M3>%]!U7C+,!:@=G7[#"C<&D0`?;9E]/`"[/12E= MOO9(%'=`OFA+\,I_F;C*E.E)@5O+(/3FR&^CA1?8`&^"5X&+QT2%V@-2T@7Y M(C+)K`!(5GC<`[[TD3I.)W5\3EU7I5)W34[1&F#FN5]$4F6R)K;"9GHEST?^\71ILF5YU]8*],=(\.[F$RP2XQEIO=^ M(64/F[_"LKH-C!!D>&H=`!H+!7RC+5HQO_SG\15N+QUDQ1*.GY>VCW!?X3$_ MW/8=TR4)FDA*I@4IPD$EO"(%44#%FN-5N6OR!"^$>?Y(KC)7TJO5MCP7=\AR M3`0CJW/>&"4S*`&+)P=6=O&:8Q78#3D/KQR6^>.RVM1.P$Y*[5FF]BCKBMK4 M79,'?E68YSY5JC9C%$ON*]O%+E*&J1*`@!C8(@+UFBK!NR+#5$G(A'-HML*= MINBK@*PH/^@`.61<[YO8GVFC4<(G!11]C9+E%]5M5(3`PE,2'S0."MCN(UD% M[#A`JG!3Y[2])%UM%$>(K/UZK@!*_,(,,#$*OP$X2;L@;T"Q&.IW%\0`+?;. M++F56S@V08KN^U)8M*9@4A`_#RB)V>6?(UB_K1A&!Z5VQU*[875%:^JNR0.[ M*LQSSX%TLJH5-44DAG$ M!Z5/52+/<1PKW'9AM_0"#_R^O\5C_)WI)(+,E.H(1S>ZCJ882B-P^O$L03?3 M0+:(1D?,WP^IX:S"+9+"4/?W;VEP]S<]3RBH)R:?>\$`6&9\S0OEVF(EA__0AIEJ%W-S%M:B$7-_%-3ZWK&#")G*O:E>H M<[Q[%U*G^B2XM9@+0 M3`":"4`S`6@F`,T$H/I!LYD`5#H!X'S:.8[2X38,CANUO[R"Z?]HYTJ+A8!X MQPD*^CF\)SF^"O9ZF9RJ=GV9C6K\W\;_;?S?QO]M_-_&_ZU^T&S\7QW]7Y'? M=!@"1:[5?ASD^T3:N<,`<2`^,9N,?H[Q,,0-FWD.;DA`@H##+2G>MH.QXP5+ M'Q7L+O;!QC2/?./*-(]\X\HTCWSCR MU0^:C2/_!AQYB/M%GS&6>ZT`%TL[#UU!/(A3+B:GGQ\>#41=,R07?),<'%X4 M/([<$HY\PEA7[9G#6MFXZ(V+WKCHC8O>N.B-BU[]H-FXZ&_`15?RS$Z'4+`W M=S*P`MTP[;SW-`*#PF9@=/7SYV%G00\/"@JF46M#U1Z^8G,;5[]Q]1M7OW'U M&U>_1295@B ML)^7MD6^4])=/$C1XRD905%-,:`@'NS4C(A<0=Y:>AS\%:"?DV]!:,^Q,+0G MP'ZY[PSJI:;:%8H`T2=-0#M_;H!6R%VB`1I[4];+RFJI> M55`(&@`TBS_12!KA!ZB+_"GRYHQBH&B@?5+I\<6[$5WGIT#!@1 M8T!6C([`J8GN@6(I1=X`=5[EG4/>?&Z'NR4\:G-!C`+UBOL.5*BH*5)2BPZZ M@4B!.!M-%=XBU$/KDXFK[[GXU_%N@1BRCI"V^F%W0;6ZIOC*V`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`16"=A9@TC6)?[K>]$F)U5WT_&$RO\1N2WG6+&1?O"&SV;\_ M&X:HH6+SY32Q`,NM25`4>14N%IL;:[?:;@P[)2Y?\9F7L'[%8/[^;%:N@JI7 ML%@-+,!>:Q(:M>[,\8@5W$R)"T+*6N1']+X\NP4THGC[%37B_=DQ7"45V[.P MH078=4V"IE:7X\UCJ].>/UGM\@R9Q;5XRXUQ?7^F*NCTBFTSWK("C+$F@5"M MZ->IL?;("GQ4F/PR?0QORK--0".*-U51(]Z?Y<)54K$A"QM:@%W7)(!J9I%> MV%QNGJ,7!P\DM,JS:FD3BK=I?A/>GT5#U5&Q/0N:68`UUR3P*K@9DH[XWNU- M^[WOJQ*CE=F,2PA6IAB_/WL5=WW5HA5R8O)@$84 M;[FB1KP_&X:KI&)K%C:T@$07-8FPLC;7T9,9<4>&]F80/5V,<,GR[!K0B.+M M6M2(]V?7<)54;-?"AA9@US4)LQJ\7+D.&>VB1P_&YJ74,"LA^^)MFNE'6UU=[M'AZ7$0[RR%A1OO]P6O#\3!BJC8BOF MM[(`0ZY)_)5!NL$:=R?/+UWF&R>):0E[D4Z[OSR0%G5ZQ/<9;5H`QUB2&"CL/^.'E M\R1Z-+XA,WFC7>(^D*0!I?B[S`:\/VN%J:)Z;Y?=R`)LN";Q4NO[[Z07INN5 ML?;\[=UUB4<,>*Q+.%B08/W^+%;6_54?(D@VKP`KK4D)A MK,1P1C[OXNV4P?O]&:I4`15;*JM]!9AJ3<*B1L&@33JA>S=W=K/W\DR5S[MX M4V7P?G^F*E5`Q:;*:E\!IEJ3V"CR>I>\Y_E7]+03OCPO2CR;)VE`.9G,60UX M?Y8+4T7%YLMM9`'7B-0D#JJ[C7['+XQI_WF*QS8R:R@Q8D+2@!(BDCD->'\V M#%-%U=')O$868,,UB7GZU2(;7*OO#]'S8#$?E'@O@8!Y\;;+8O[^[%:N@HIM MEMG``NSU$.GTS_.$[K&H3[MWT2M"9(`F9^3_OP8_8NS&VY%OV9_&WOP\-#>> MZ\VW.Z9M.Q@[7K#TT440H#!Y\7T,78$]7[Q>U<]GZ7JV\J]AW/4"_K?Y+EKAM M7"P`YS-SO&H\49NMK%1Q;FF4M6O*X0K[F*98K_92QEY5IB.>)CQAV^,:HF@0 M%<7KLO63*M8IYT$SX6/1`V?2":,&S]<"&MJ95`R9J;$(L+699[#,SG6@O4'R M=_#H?Y_?38V1L?96Q!ND]):BYKXG5&I6KVGFW""]\!#'7HFZWO?3\T49#>U- M]/>DOVKY_5[[`0PP?E4IPAA5:P_^1_+8RAAWZ M9(IR/2F\Z'JUPY98\&S`2M#6^RYPOB#1.LDU6<4'E=S8QY)=3\=+9('9=-4E0*.4;5V8).*GPUH M+/)Z7[G,E^5N=+4.B&]YM8T>]T@!.H%^VNI2L'&JUPYPH&[(!CH>"[WO$N;+ MTWJ)#.AVU+O=A:OC24[T_A(,/CD)*0`%)&H'0G!W9`.BB(W>5^CR99I$.U^# M,'Q\N)J[SBT8@KR*4N`E*M8.;A+1LX$L25SO.U\%7FDD2?0#/[F^)N\?PB@! M*GW$,QL1^51"1*1V\%/HDHS3"B$CO>\QY4M%+F7=W4=S.QS>1+\\/<+]/G%U M*10YU6L'0E`W9(,?CX7FMV_R!5I?7HZLYY=Q[^7J$8PW5B4IRF*5:H/NRCU87A/9P5(5UF*.F;EVF$.T`79$,=FH/F5>WQQ[A\ZF]XN M9G.ZN0RF8*SQ*DIQEJA8.XQ)1,^&KR1QS:]]XXNRB"QDWMMTC'7P'/U!'[Y. M5UF*,6;EVN$,T`79L,9FH/G-9GQQ.E$6/H<\=HSAV,?.`!TCEJZR%&_,RK7# M&Z`+LN&-S4#S&[?XXMR0']/;WK3;Z_4<.-0X]:0HH^O5#F!BP;-A*T%;\ZN? M^)+\PO_WVX_.W60VN?/!J&)7DX**JE8[3`G%S@8IFK3F%Q;Q!6D'&R,(AO9F MV")_#KI@4'%K2G&5K%D[:,F$SX8N!G7-[]KARW)%5I*#;O3(F9#MB^<'.GE+ MRMI2H+%KUPYLD$[(!C@.!\TO@N'+$SW#4I#GK?OHS6QN&0OR#(P]"!$I!(5$ M:H=$A2[)!D@Q(\TO,I'$B@Z?I]^QO?5:Z^^AHQ;0RZP*"^:-5ZT=\J3BYQ#$ M2Y'7_-(-0:#HP]28=B8M/(?&3Q*7-*M7E$?OTA5KAR^)Z!DC=Q/$-;\'0F`H M?>*9DC7H/DFR@M]N;NEC^2EKR\BK6KE[K3,<]6R=`''=E#GJGWY"(@T5P M-@^SM>&&9(O??5$#';*3DD\D1A3'?]I\GE2[24 M?$D?9$]='P8]1OUZ8D_:$3F`C\5#[]0=,FLB-G1+9!FW!M_QP_'@67'D$U`` M#GXL"O7$(*`S\A@"F5STSN0A$>GR<=,ES^8&$2N8KP9J*.37AV&04;^>")1V M1`[X8_'0.\6'1*"["?8J#/+;:+&.5J2)A;77:AB448$AD4NEGG@$=DH.J.1S MTCL+B$2LZ^_&=C*.^OU%C];*7Z&^?5A MP&34KR<>I1V1`PQ9/#3/!R*1R,$#_OTP$JL_[F]VQQP5)R=B&C`8,A.!6A\$N6;V> MN)-U0P[`8[#0/%F*1*!H[P@/W!L_VEA?/1K=N1KX1!1@^&-2J"<$`9V1`PK9 M7#3/L2(+<+M<;0;7HYX3S?-OZ)S7*6L#(Q'IVO4$GZ03\HA"3'#0/.^*+)ZM M&T6TD3G4_*D;A6THCGXB"L`@1!:%>@(0T!EY!"$RN128BZ7PP[O#T!L_S3P' MLPV^/2_M<$M.%[Z^+^!$KS++4H_Y*K>N.?O;G/V-#V3-V=_F["_DR].<_6W. M_C9G?]_#V=^D4\'R+N>_#.,N>D!V5Q[Q4W^2O.,U%UI'I6>A53T^F#.%/#L( M,F?(R$_O$\0PX?!_OW9W0/K1SF#+P$\NZ0V,7&@I(9='J];(A750?LCE\M/[ M"#),N)GUM#+67G\P&43O%ZDPRZ6BA-8DE5KC5-8I^2&4P4GO`\HPL;8WJ^<5 ML3C7&(2=42ID8<$_1'X^[R(W[[U?CP$\WL1(14L(L MDU"M`0OHFOS0RF:F]ZEGF&2]Y_DHF$5/^L^M#7WM1S8B2A!-$*DU/"5=DA\T MDXST/AT-D^HRP"[VFCSM#BSRW]#>M.B,87F04H(HAU2M@0KJGOS@RF.G]T%K MF&R/MU;OTE_?#G^M\)-48&634`(I1:+6X!1V1WZ@I-GH?90:)M-5O]?=8..Z MON\NNC>IP,@FH01&BD2MP2CLCOS`2+/1_&0U3*C!]<#O1M[S=.:OUO1U-]F( M*"$R0:36F)1T27ZH3#+2_'@U3*Q)M,F`79+P$?]H+W[-28E4Z!234L(HAU2M MD0KJGOSPRF.G^8EIH+\2&6+WYO'NZ)5$>$35GDR92:XQ*NB1'AS/! M2//CU4"CPZ8V[^,?J]'X:=M.&T[")Z,VBB;)U!J=TF[)EMF%CCX?RZ_S)KW76NZ/2EZ0DH MX3%&H-98%'1%?CB,,]'\'#KR>I!VJ9U-0BT2)$ZBUD@4=D>. M<1\4FP(/H(1PJ740XN0!C7G%)MSBO$QJCFGV)Q3A'Q3 MFG.*S3G%YISB>SBG>/0C.+G/-JM[8_!,'C^2#%2TT:6MON\3Y>K5*Y[IW6?L M!HAGK\Y"[V.&$GF>C5\W#PO_<1&T;M4PQZH)@UNL9CV1)A`^!Y#%J>M]&%`B M2BOZ<>>,[F=/\^C8`YT&,3T!&-I8!.H).GE7Y(`])A.]S_Q))(JNM[R;/#YV MPL[])7T,-5UE&/3HRO6$G;@+!_HDTD2A.+WNX]W3:COLTYL&Z2K# MX$97KB?1QGAZ<:-A^O8YP`[I0_M1#7'\^C#0,>K7$W?2 MCL@!>BP>>A^LDPC4MKJK*+QK=R71HO5TNU7#GX@"#(%,"O7$(*`S M)^DD(JV?K4NC-YT-'R:7:OACU83A+E:SGG@3")\#SN+4]3[T)A'%FOCX-RM< MW-_>X8%;<8SCU8;A+%&[GEB3=$(.>$MRT/MLF\Q9B,[?KUK!/!SXNQO(Z1#C M#!2`WAV+0CWQ!^B,/#P\)I<"C[45'O@1;85US3!$?G#A6BW/#6UWBMRQC8(" M(D"4V)4:"J+4LB8FI(D):6)"FIB0)B:DB0FI?M!,^$M-3(@&,2$Q#P)[%!T[ MM*=[_T5\6K1PYP[%--ID/E$;ISU#D-) M+6;W&O\RM/PM>8%E[I#M&_K^[(*H9\4^A_I;LP%0)Q9J"[P6Z!TZDUK.S?M?(R!R[AK):0)/S6C$#6=87BG\%<[Y"=U)*2?X/#BZ&]N7V> MA5<&G?*K*/)9S8!'_JT9`ZP;"S4);A/T#BY*+>^F':TVS^X>9B_KN16]RLLJ M1+2SF@23]ENS!T`'%FH,;/YZQSVE%O8JLG@BKQ\86^.F-S;R,@0!Z:QVP"+] MULQ`WGV%6@&3O=[A5^D]0M==3?%GK_>X'EWZN1;Y^]J@[_LN@G16U+-(OS7HR[NO4/PSV>L=AY9: M5O=YNWZZ&FVZ6-HG.CXM9ZI9H4]1?6NH%W9:H8"G.>L=_Y9:3"S=RWH13$;K M[<,+?7M;SE2S8IVB^M:P+NRT0K%.<]8\=7SZ64L_FK)$CQ9SLL@['\]O'G*; MTHK)9Y[6$S1/7I]:X`>+G!Q=[/?\6J-A?YO;2H^(=E:; M8-)^:P8!Z,!"K8'-7_.,^*FE71-AH]CS]M,M?M9_'EFYK?H(B6NL7G\N1>ZU\G+&/B4LUH"@_);,P-IYQ5J`RSN M!2;ZYY_,V;\A/T9F@/"3_P902P,$%`````@`N7$.005\P3'3$```U+\``!$` M'`!C>61I+3(P,3(P-C,P+GAS9%54"0`#7I4J4%Z5*E!U>`L``00E#@``!#D! M``#M75MWHL@6?C]KG?_`R5//6F-,.MTSTUG=,TLQ7H$8J%''EUG(399<"P3T MUY^J0HT7H,%V'(EY2:"J]J[]?;ON;/#K'Y%I4($"/=VVOMWV&\GS1DD7#MI1O-PO%N_GC]__^Y^O_*A6*MDW'T$5+4JB1`Q7/ M"T6H4!T+"Z"TABW-3<7RJ:GO.X_5:AB&M])&)-I(X,0J154J:[V#V)Y'"MES M>XF/O5!^BG9 MS)\IANG?4C7#H'A/=_<>[7QXPAX:"D3=M:#8459P;_K<;=RX:NJHK\@TE^C[4)W-? MV2DPM[:*(+]8WB.R8:>R\.'6AAJJZ.Z^.F(9@9BW*3R!AKY3'*>L!1ZJ^LHQ MZ_*&;LTRBN/LB>AMBD<'Y5?6W'_Y\J5*GDV>(MUJ=E"-\PB, MRMU]Y>'^!C46BB+-1;0LVR=ME*2M4QU'MU1[E802,56/T#84@.JF\,6??">- M+U^,;,LV%U58&D<_44+[Z0D([U[(X84^&O4M?ZKX.B(@Q26[9;+]\Y#? M/]2''<4_O?LKQ5\=M/8PE0VK6U[:S\GVS:EO^>$W+]L3G_)Z@:T*;:C+/PW=/I'F"LWW%`S:8*DW= M0J.6+AH;L]K?0H7F?T'7++2FE$2T&I`D>XZF<$OKVX8NZ4B5$OEU MPY9F6Y[]Y^K(;BF_X-6&[DF&[6])1+:GF>8I?O''LBV7[ M^]=]?]<$X7TM%O9I?8;:KO^R[6@#/=*_]S#2>>(%Z>OFS`_YZ=_DQ M+H^7M$",?L#+F3HR'7M_M^_8#D<_LT\4J(W>._&1H["BB08K^C[J#"5Y>,\_RMK%IKF$)%_7:#`UTJZXB6OY'$;60:ZR*^[N-:Z%<]%%;D_4R)AG%3O5SD MNV[,`1P))`!O;-24!+BB9A_UK= MCX):I>Q&2Y%8*42##7W*2@RU2PMGBZ/T&%LBRC)$\%UE+5?!297[CY6'^UM4 M]8X2XXW0Q6]"5$V]RJ:*#K;08%I1A`#$@6KBN%[ZY3*JZIBS6(=IB@K>FYS M]F7PQ0\;0`ZAX**P$=MRZYL?-L;S'8@UWA>Q9"-$KBJOXL?9+Y4)16,5]XWOD[7_%X M`B7!SX\H#:W5.[YBXK4E`C9'Q71_CB5:T)X[ZX(Z*G)#B2LEWVY\.$?%+=U` M\SJ>T^+[N"R:9'5;!J0:>0[C(-I4C-D1$H<@B.S5YCBLHLK?.PGUKY5;E@2?X*)DE>@N'(U7#I\[@@M?*KM/S=D`#0&S&2[IGNGT(:':JZ(=:&B= MQY!3`'+$R)&L,ZYY,@VX*E?(48ND3/$H@-:!/$EU)JCD>5R1:*9SA:1ZKRE\ M:N+Q#0R;'9A&/-6=A_>D>G=>Z)B*J-8W2SO.CI^NNB\DE?&7KG.F`^74RJ_( M`>R"7*,,H/5=#;5$//:>:2>56OD5.>"%QFOJH#TBZ9YC\F<*74NL^/+6-_$[ M'?M8\+TWAFUSH($)6B8$&,O!FR`YIH(Z";E7^P$-^UQCE`MUDEB98,^D MZ1".2>@!$)AF+LP',F4"3/II"P^'/,Z:6%'3:0URX4X3+1/\T3A`2U&"9*A- MG-VSO6)B98(]F#1##P]*S44<^T?"Z7-!3Q,M$WQZ25S7FW"]>..-QFB27\]% M099XF6A0R8S,^_YXU#0MHY<+_*%0F2"#.)0/_T$IK1;.'_GD\78[WZ"7J:!, M5.!8WSC`JR<(77(Q&^<;`])$RP0_K-'UC2/F@M+7EY3 M_PX$9+81C:8AL,@KN-8R/_H$T=+!)TOP07^FUI=DV*Y'^?$GR9:.`!+KUB.O MF])\&R5*O%N@"21*EXZ$^CAB<9H),!3/#/C\%"3)EHZ`@8HZ,R"/T)R0C.C8 ML8TP/PWI&B[LO.8[.%IML%`%>^>B2.4\"V=GX5,)>7J`_&K+PO.9<)P@=*"`MT@2;90"(V&:?*FZQ7Y$?!Q6`:3-%@_(\2.8G,04T5V8#>"S?P$'$J6#ORP&X0D`LMI,@W4D`MLH!)$2P>? MK'A1PXT@V0@%8\":^1E(EBX=">-Z$/&M"6>0F:[+%#A&.)`L'7C`@M7WVZ`Y M8\G.KT`+2):^/!(.?]0R"8WY`L"`))"O5J!4J.X&]OV@GHL[7LV'!_V+7S_H M03+ATP"EU)N%>4G5L\W+)433YX,SE6?X!;`^K_(DWRE,2(*&;2ITRU_!X7I2-53UJ%U1F[&\6IQ MV&Y*'BP^KB8K*2LEG&M.O"E)Z;MTQ!:FXU#!A9W6Y(-1]]`02+Z7R?(R_H>F M2GI9F(TT-:7D9-R3N3H,>\)+\+SSVM!QXN4<3)M]CHV0%UM#UF&[A4G8%R\G M"7R+AVS\;;LI#$*C,`V'"LHZ8*IDT8AZN3\F`<4O)BY1F)`T-3L#A8`;2!E( MB>.,V>YX,.9?9B_%EQJ'"DK;/I`[3?R[*L%$FBT:Q^S,,UV81IV MA,SP[J3'_N!8+EPDX4NQXX'LV`A]-OY<1\(E@LWF"WC-VU[+GZ;8]08 MYX>>)%LN]`V9#>)8?O+7H6>]17[\R=+E8B!TY3K@M*DP4NOYD>]*E0NQK$)T M)?O.L#=`K;:`OP\ERX4\/@P.:,_T>1A'KT8%>GNB].4MZFF;?#E)L?!WDVJ6 MS.B^KA&9[T?Z:S/9@.8+@-+N3]V?2.,;(HMMX7@W&2Y6@0T,G@=GIR`M3?,; M(F^)/X%//F?Q$DH2'-"GX"U!Z<4](3T:'#F>76>@L;?G3OTFZ)Z"MU35;ZC! M18WX4_.#T709FG$,ZBFX2];[AHAKDD:!,4(/+$"7D\`I>$M4^X9H6UI6@#\! MR8W#21V>9'3;T_B&R`HF+KKB\-!#?H&L!.@D7H^7D%&3M:[RPK=#Q0W.?C,LDR3'Q>LJ4S.[H)*-^ MFNHWU-!&Y#?-G-7:G9X(_<5)9LQDO6^(N'#S*S2-60^E]=V)?)*9,T7QQ078 M'@VPW90<"T0X>)C`Y)A3T):D]5]M;E^KF#-/FBJFB&[_#U!+`0(>`Q0````( M`+EQ#D$V#7E($TH``*/V`0`1`!@```````$```"D@0````!C>61I+3(P,3(P M-C,P+GAM;%54!0`#7I4J4'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`+EQ M#D'`:OEO8@X``!*X```5`!@```````$```"D@5Y*``!C>61I+3(P,3(P-C,P M7V-A;"YX;6Q55`4``UZ5*E!U>`L``00E#@``!#D!``!02P$"'@,4````"`"Y M<0Y!=L`5)ILK```9^`(`%0`8```````!````I($/60``8WED:2TR,#$R,#8S M,%]D968N>&UL550%``->E2I0=7@+``$$)0X```0Y`0``4$L!`AX#%`````@` MN7$.0==)?9R:7P``$CD&`!4`&````````0```*2!^80``&-Y9&DM,C`Q,C`V M,S!?;&%B+GAM;%54!0`#7I4J4'5X"P`!!"4.```$.0$``%!+`0(>`Q0````( M`+EQ#D$^@KKRGRT``*HW`P`5`!@```````$```"D@>+D``!C>61I+3(P,3(P M-C,P7W!R92YX;6Q55`4``UZ5*E!U>`L``00E#@``!#D!``!02P$"'@,4```` M"`"Y<0Y!!7S!,=,0``#4OP``$0`8```````!````I('0$@$`8WED:2TR,#$R M,#8S,"YX`L``00E#@``!#D!``!02P4&``````8`!@`: )`@``[B,!```` ` end XML 14 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCKHOLDERS EQUITY
6 Months Ended
Jun. 30, 2012
STOCKHOLDERS EQUITY [Text Block]

NOTE D – STOCKHOLDERS’ EQUITY

As a result of the reverse merger (see Note A item 6), the common stock of Cybrdi-Maryland has been cancelled and converted into shares of common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of Certron’s common stock to the Cybrdi shareholders. As of June 30, 2012 and December 31, 2011, the Company had 120,225,323 and 120,225,323 shares issued and outstanding, respectively.

As of June 30, 2012, the balance sheet included total equity of $4,678,647, of which $1,112,330 was for non-controlling interest, representing 20% minority interest in Chaoying Biotech and 16.67% minority interest in SD Chaoying.

On January 15, 2010, the Board of Directors adopted resolutions that authorized incentive compensation to key management of the Company for services it has provided to the Company. As set forth in the Board of Directors’ resolution dated January 15, 2010, the incentive compensation shall be paid by the issuance of 12,000,000 shares of common stock of the Company to Mr. Yanbiao Bai, Chief Executive Officer and President of the Company, and 3,300,000 shares of common stock of the Company to Ms. Xue Bu, the former Chief Financial and Operating Officer of the Company. Compensation cost of $306,000 was recorded during the first quarter of 2010 at $0.02 per share, the market price of the Company’s common stock on January 15, 2010, the grant date.

On June 30, 2011, the Company entered into a written Debt Conversion Agreement with Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd. (a related party), Shaanxi NuoQi Healthfood Co., Ltd. (a related party), and Mr. Yanbiao Bai, Chairman and CEO of the Company. In the Agreement, the Company agreed to repay a total of $605,723 (RMB3,920,000) debt due to Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd. by issuing the Company's common stock. Simultaneously upon the execution of the repayment, Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd. agreed to transfer to Mr. Yanbiao Bai the number of shares to be issued through the debt repayment. The number of shares transferred to Mr. Yanbiao Bai was further offset by a number of shares equivalent to $169,973 (RMB1,100,000) due by Shaanxi NuoQi Health Food Co., Ltd., a company wholly-controlled by Ms. Xue Bu, the spouse of Mr. Yanbiao Bai and former COO and Director of the Company, to offset its debt due to the Company. The Agreement was approved by the Company’s Board of Directors on June 30, 2011. As a result of the debt conversion and offset, the number of shares of common stock issued to Mr. Yanbiao Bai was 54,468,756 shares, which was determined based on the closing price of $0.008 per share on June 30, 2011. The share issuance for repayment of debt as agreed upon and approved was executed on August 17, 2011.

EXCEL 15 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\P-64W9C=F8U\R8V)B7S0X8C5?83-A85\X9F1D M,S0T9C`U964B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7 M;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O5]O9E]3:6=N:69I8V%N=%]!8V-O M=6YT/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/D%34T544U].87)R871I=F5?1&5T86EL M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O6QE M#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T M#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\ M8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@ M36EC'1087)T7S`U93=F-V9C7S)C8F)?-#AB M-5]A,V%A7SAF9&0S-#1F,#5E90T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO M+R]#.B\P-64W9C=F8U\R8V)B7S0X8C5?83-A85\X9F1D,S0T9C`U964O5V]R M:W-H965T'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA61I/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6)R9&DL($EN8RX\2!#96YT3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^,#`P,#`Q.3`P,CQS<&%N/CPO'0^+2TQ,BTS,3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2!6;VQU;G1A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\P-64W9C=F8U\R8V)B7S0X8C5?83-A85\X9F1D,S0T9C`U964-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#5E-V8W9F-?,F-B8E\T.&(U7V$S M86%?.&9D9#,T-&8P-65E+U=O'0O:'1M;#L@8VAA'!E;G-E M6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA"!L:6%B:6QI=&EEF5D+"!N;R!S:&%R97,@:7-S=65D(&%N9"!O=71S=&%N9&EN M9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\P-64W9C=F8U\R8V)B7S0X8C5?83-A85\X9F1D,S0T9C`U M964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#5E-V8W9F-?,F-B M8E\T.&(U7V$S86%?.&9D9#,T-&8P-65E+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%RF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XQ-3`L,#`P+#`P,#QS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!P"!E>'!E;G-E'!E;G-E'!E;G-E'!E;G-E+"!.970\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\P-64W9C=F8U\R8V)B7S0X8C5?83-A85\X9F1D M,S0T9C`U964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#5E-V8W M9F-?,F-B8E\T.&(U7V$S86%?.&9D9#,T-&8P-65E+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R2!/<&5R871I;F<@ M06-T:79I=&EE2!I;G1E6UE;G1S(&9O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G1S(&]F(&QO86X@9G)O;2!S:&%R96AO;&1E2!&:6YA;F-I M;F<@06-T:79I=&EE3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-64W9C=F8U\R8V)B7S0X8C5? M83-A85\X9F1D,S0T9C`U964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO,#5E-V8W9F-?,F-B8E\T.&(U7V$S86%?.&9D9#,T-&8P-65E+U=O'0O:'1M;#L@ M8VAA'0^/'`@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)V9O;G0M9F%M:6QY M.B!T:6UE2!A8V-O=6YT:6YG M('!R:6YC:7!L97,@9V5N97)A;&QY(&%C8V5P=&5D(&EN('1H92!5;FET960@ M4W1A=&5S(&]F($%M97)I8V$@9F]R(&%N;G5A;"!F:6YA;F-I86P@2!O9B!N;W)M86P@2!F;W(@=&AE(&9A:7(@<')E28C.#(Q M-SMS($%N;G5A;"!297!O6QE/3-$)V9O;G0M9F%M:6QY.B!T M:6UE2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@ M("`@("`@("`\8CXR+B!$97-C2!B;&%N M:R!A=61I;R!A;F0@=FED96\@8V%S2X@07,@82!R97-U;'0@;V8@=&AE6QA;F0@*")#>6)R9&D@36%R>6QA;F0B*2X@07,@82!R M97-U;'0@;V8@=&AE(&]W;F5R6QE/3-$)V9O M;G0M9F%M:6QY.B!T:6UE&D@0VAA;R!9:6YG($)I;W1E8VAN;VQO M9WD@0V\N+"!,=&0N("@F(S@R,C`[0VAA;WEI;F<@0FEO=&5C:"8C.#(R,3LI M+"!A('-I;F\M9F]R96EG;B!E<75I='D@:F]I;G0@=F5N='5R92!E&ES=&EN9R!S:&%R96AO;&1E6EN9R!":6]T96-H(&1E96UE9"!T M:&4@86-C;W5N=&EN9R!A8W%U:7)E&D@ M0VAA;WEI;F<@0F5A=71Y("9A;7`[($-O6EN9R!":6]T96-H(&%R92!R M97-E87)C:"P@;6%N=69A8W1U6QE/3-$)V9O;G0M9F%M:6QY.B!T M:6UE2!C;VUP;&5T960@ M=&AE(&UE3H@=&EM97,@;F5W(')O M;6%N+'1I;65S+'-EF4Z(#$P<'0[)SY/;B!*=6QY(#(V M("P@,C`P-RP@0VAA;WEI;F<@0FEO=&5C:"!E;G1E6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UEF5D(&EN(%-H86YD;VYG(%!R M;W9I;F-E(%`N4BY#:&EN82X@3VX@4V5P=&5M8F5R(#4L(#(P,#6EN9R!H860@8F5E;B!T6EN9R!":6]T96-H M(&9R;VT@:71S($-H:6YE6EN9R!W:6QL('!R:6UA2!F;V-U6EN9R!H860@2!C;VUP;&5T960@=&AE(&-O;G-T&-E<'0@9F]R('1H92!E>'1E'!E M8W1E9"!T;R!B92!C;VUP;&5T960@:6X@,C`Q,B!P6QE/3-$)V9O;G0M M9F%M:6QY.B!T:6UE2!!9W)E96UE;G0@=VET:"!":6]-87@L M($QT9"XL(&$@2!S='EL93TS1"=F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@("`@("`@("!/;B!!<')I;"`R.2P@,C`Q,2P@ M0VAA;WEI;F<@0FEO=&5C:"!I;G9E2`H)B,X,C(P.TE/4T-# M4"8C.#(R,3LI+"!A('=H;VQL>2UO=VYE9"!S=6)S:61I87)Y(&5S=&%B;&ES M:&5D(&]N($IU;'D@,S$L(#(P,#,L('=H;W-E(&UA:6X@8G5S:6YE2!A;F0@ M<&%T:&]L;V=Y+7)E;&%T960@'1E6EN9R!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E M;65N=',@:&%V92!B965N('!R97!AF%T:6]N(&]F(&%S2!H860@86X@86-C=6UU;&%T M960@9&5F:6-I="!O9B`D,BPW-#`L,SDP#0H@("`@("`@("`@86YD("0R+#0T M-RPV-#,-"B`@("`@("`@("!A"!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,B!A;F0@,C`Q,2P@&-E961E9"!C=7)R96YT(&%S2`D,RPR,3$L-3$U#0H@("`@("`@ M("`@86YD("0R+#DS,2PQ-S4-"B`@("`@("`@("!A="!*=6YE(#,P+"`R,#$R M(&%N9"!$96-E;6)E2!T;R!C;VYT:6YU92!A6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE2!T:')O M=6=H('-H;W)T+71E2`D,RXP#0H@("`@("`@("`@;6EL;&EO;B`H97%U M:79A;&5N="!T;R!234(Q.0T*("`@("`@("`@(&UI;&QI;VXI(&]F(&-A<&ET M86P@:7,@97AP96-T960@=&\@8F4@;F5E9&5D+B!4:&4@0V]M<&%N>2P@=&%K M:6YG(&EN=&\@86-C;W5N="!T:&4@879A:6QA8FQE(&)A;FMI;F<@9F%C:6QI M=&EE'0@='=E;'9E(&UO;G1H M2!S='EL93TS M1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@("`@("`@("`H82D@4V%L92!O9B!H;W5S M:6YG(&EN=F5N=&]R:65S.B!02!S='EL93TS1"=F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@("`@("`@("`H8BD@4F5N=&%L(&%N9"!M86YA M9V5M96YT(&9E92!R979E;G5E(&9R;VT@=&AE(&-U;'1U2!H87,@;F]T(&-O;6UE;F-E9"!C;VQL96-T M:6YG(')E;G1A;"!A;F0@;6%N86=E;65N="!F964@2!S='EL93TS1"=F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@("`@("`@("`H8RD@061D:71I;VYA;"!A9'9A;F-E M2!I;B!T:&4@8W5R2`F86UP.R!#;W-M971I8W,@1W)O=7`L('=H:6-H(&ES(&%L&EM871E;'D@)#&D@0VAA;WEI;F<@0F5A=71Y("9A;7`[ M($-O6QE/3-$)V9O;G0M9F%M:6QY M.B!T:6UE2!R97%U:7)E(&%D9&ET:6]N86P@9G5N9',@ M86YD(&UA>2!S965K('1O(')A:7-E('-U8V@@9G5N9',@=&AO=6=H('!U8FQI M8R!A;F0@<')I=F%T92!F:6YA;F-I;F=S(&]R(&9R;VT@;W1H97(@2!S='EL93TS1"=F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@("`@("`@("`\8CXT+B!52!F2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S M+'-EF4Z(#$P<'0[)SX-"B`@("`@("`@("`\8CXU+B!2 M979E;G5E(%)E8V]G;FET:6]N/"]B/@T*("`@("`@("`\+W`^#0H@("`@("`@ M(#QP(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SY2 M979E;G5E(')E<')E2!O9B!G;V]DF5D(&%S M(&EN8W5R6QE/3-$)V9O;G0M M9F%M:6QY.B!T:6UE2!S M='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-E MF4Z(#$P<'0[)SX-"B`@("`@("`@("!/;B!&96)R=6%R M>2`Q,"P@,C`P-2P@*'1H92`B0VQO2UO=VYE9"!S=6)S:61I87)Y(&]F($-E0T*("`@("`@("`@(#DS+C@E M(&]F('1H92!I6)R9&DL($EN8RX-"B`@("`@("`@/"]P/@T* M("`@("`@("`\<"!A;&EG;CTS1&IU2!A;65N M9&5D(&ET6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE M&5S(&%R92!P"!E9F9E8W1S(&]F('1R86YS86-T:6]N&5S(')E;&%T960@<')I;6%R:6QY M('1O('1H92!D:69F97)E;F-E&%B;&4@;W(@9&5D=6-T:6)L92!W:&5N('1H92!A2!C;&%I;7,@ M86=A:6YS="!U2!W:&5N(&)O=&@@;V8@=&AE(&9O;&QO=VEN9R!C;VYD:71I;VYS(&%R M92!M970Z("AI*2!I;F9O2!D:69F97)E M;G0@9G)O;2!O=7(@97-T:6UA=&5S+"!W:&EC:"!C;W5L9"!R97-U;'0@:6X@ M=&AE(&YE960@=&\@6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE2!I'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA2!S M='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-E MF4Z(#$P<'0[)SX-"B`@("`@(#QB/DY/5$4@0B`F(S@R M,3$[($%34T544SPO8CX-"B`@("`\+W`^#0H@("`@/'`@86QI9VX],T1J=7-T M:69Y('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE3H@=&EM97,@;F5W(')O;6%N M+'1I;65S+'-EF4Z(#$P<'0[)SY/=&AE2!F:6YI2!A M2!B=7-I;F5S2`R,#`V+B!!(')E;6%I;FEN M9R!B86QA;F-E(&]F(%)-0C2P@<&QA;G0@86YD(&5Q=6EP;65N="!M86EN;'D@8V]N M2P@<&QA;G0@86YD(&5Q=6EP;65N="!I2!C M;VYS:7-T960@;V8@;&%N9"!U;F1E&5D(&%S6EN M9R!W:&5N(&-O;G-T2!A="!31"!#:&%O M>6EN9RX@169F96-T:79E($IA;G5AF5D(&]V97(@:71S(&5S=&EM871E9"!L:69E(&]F#0H@("`@("`Q,`T*("`@ M("`@>65A65A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-64W M9C=F8U\R8V)B7S0X8C5?83-A85\X9F1D,S0T9C`U964-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO,#5E-V8W9F-?,F-B8E\T.&(U7V$S86%?.&9D M9#,T-&8P-65E+U=O'0O:'1M;#L@8VAA'0^/'`@ M86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX- M"B`@("`@($%S(&]F($IU;F4@,S`L(#(P,3(L('1H92!B86QA;F-E('-H965T M(&EN8VQU9&5D('1O=&%L(&QI86)I;&ET:65S(&]F("0U+#8S-2PS,#4L('=H M:6-H(&-O;G-I2!R96YE=V5D('1H:7,@2!D871E M(&]F($%U9W5S="`R,"P@,C`Q,BX@5&AE(&%D:G5S=&%B;&4@:6YT97)E6EN9R!W:71H(&$@8F]O:R!V86QU M92!O9B`D,RXQ-0T*("`@("`@;6EL;&EO;B`H97%U:79A;&5N="!T;R!234(R M,"XP,PT*("`@("`@;6EL;&EO;BD@86YD("0T+C,R#0H@("`@("!M:6QL:6]N M("AE<75I=F%L96YT('1O(%)-0C(W+C0U#0H@("`@("!M:6QL:6]N*2!AF%T M:6]N+B!4:&4@0V]M<&%N>2!C=7)R96YT;'D@:7,@:6X@<')O8V5S2!D871E(&]N($%U M9W5S="`R,"P@,C`Q,BXF(S$V,#L@061D:71I;VYA;&QY+"!T:&5R92!I&D@0VAA;WEI;F<@0F5A=71Y("9A;7`[($-O3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\P-64W9C=F8U\R8V)B7S0X8C5?83-A85\X9F1D,S0T9C`U M964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#5E-V8W9F-?,F-B M8E\T.&(U7V$S86%?.&9D9#,T-&8P-65E+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S M+'-EF4Z(#$P<'0[)SX-"B`@("`@(#QB/DY/5$4@1"`F M(S@R,3$[(%-43T-+2$],1$524R8C.#(Q-SL@15%52519/"]B/@T*("`@(#PO M<#X-"B`@("`\<"!A;&EG;CTS1&IU2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@ M("`@($%S(&]F($IU;F4@,S`L(#(P,3(L('1H92!B86QA;F-E('-H965T(&EN M8VQU9&5D('1O=&%L(&5Q=6ET>2!O9B`D-"PV-S@L-C0W+"!O9B!W:&EC:"`D M,2PQ,3(L,S,P#0H@("`@("!W87,@9F]R(&YO;BUC;VYT6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE M2`Q-2P@,C`Q,"P@=&AE($)O87)D(&]F($1I2!M86YA9V5M96YT(&]F('1H92!# M;VUP86YY(&9O2`Q-2P@,C`Q,"P@=&AE(&=R86YT(&1A=&4N M#0H@("`@/"]P/@T*("`@(#QP(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@("`@($]N($IU;F4@,S`L(#(P,3$L('1H92!# M;VUP86YY(&5N=&5R960@:6YT;R!A('=R:71T96X@1&5B="!#;VYV97)S:6]N M($%G&D@0VAA;WEI;F<@0F5A=71Y("9A;7`[ M($-O2DL M(%-H86%N>&D@3G5O46D@2&5A;'1H9F]O9"!#;RXL($QT9"X@*&$@2DL(&%N9"!-2!A('1O=&%L(&]F("0V,#4L-S(S#0H@("`@ M("`H4DU",RPY,C`L,#`P*2!D96)T(&1U92!T;R!3:&%A;GAI($-H86]Y:6YG M($)E875T>2`F86UP.R!#;W-M971I8W,@1W)O=7`@0V\N+"!,=&0N(&)Y(&ES M2`F86UP.R!#;W-M971I8W,@1W)O=7`@0V\N M+"!,=&0N(&%G2!W:&]L;'DM8V]N=')O;&QE M9"!B>2!-&5C=71E9"!O M;B!!=6=U7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'`@86QI9VX],T1J=7-T:69Y M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE"!A="!A;B!E9F9E8W1I=F4@&5S('!L=7,-"B`@("`@(#,E(&QO M8V%L(&EN8V]M92!T87AE2!D97-I9VYA=&5D(')E9VEO;B!F;W(@ M=VAI8V@@;6]R92!F879O"!R871E"!E>&5M<'1I;VXL('-I>"!Y96%R#0H@("`@("`U,"4@=&%X(')E M9'5C=&EO;B!A;F0@=&%X(&AO;&ED87D@9F]R('!R;V1U8W1I;VXM;W)I96YT M960@1DE%6EN9R!":6]T96-H(&ES(&5N=&ET;&5D('1O M(&$-"B`@("`@(#4P)2!R961U8W1I;VX@:6X@14E4(&]F('!R969E6EN9R!":6]T96-H)B,X,C$W.W,@969F96-T:79E($5) M5"!T87@@2!S='EL93TS1"=F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@("`@(%1H92!#;VUP86YY)B,X,C$W.W,@:6YC;VUE M('1A>"!E>'!E;G-E(&EN8VQU9&5S(%4N4RX@86YD(%!20R!I;F-O;64@=&%X M97,N(%1H97)E('=E&5S(&9O"!B96YE9FET M(&EN('1H92!F=71U'!E8W1E9"!T M;R!B92!G96YE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'`@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V9O;G0M M9F%M:6QY.B!T:6UE6EN9R!A="!T:&4@0F%S:6,@4&5O<&QE)W,@0V]U M2!31"!#:&%O>6EN M9R!F;W(@;F]T('!E2!A;F0@8V]M<&QE M=&5L>2!T:&4@;V)L:6=A=&EO;G,@:6X@86-C;W)D86YC92!W:71H('1H92!A M9W)E96UE;G0@2P@=&]T86QI;F<@ M)#$X."PX.#@-"B`@("`@("AE<75I=F%L96YT('1O(%)-0C$L,C`P+#`P,"DL M(&%N9"!F;W(@871T;W)N97ES)B,X,C$W.R!F965S(&%N9"!C;W-T6EN9R!C M;VYS=')U8W1I;VX@8F%S92!O9B!T:&4@(S$@86YD(",R(')E28C.#(Q-SMS(&QE9V%L(&-O=6YS96P@=&\@8V]N=&5S="!T:&4@86-T M:6]N+"!W:&EL92!C;VYC=7)R96YT;'D@<'5R6EN9R!H860@;F\@;&EA8FEL:71Y+B!(;W=E=F5R+"!T M:&4@<&QA:6YT:69F('-T:6QL(&AA2`Q-BP@,C`Q,B!A="!);G1E65T(&)E M96X@'!E;G-E2!T:&4@0V]M<&%N>28C.#(Q-SMS(&QE9V%L M(&-O=6YS96P@=&\@8F4@'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA2!S='EL93TS1"=F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z M(#$P<'0[)SX-"B`@("`@(#QB/C$N($EN=&5R:6T@1FEN86YC:6%L(%-T871E M;65N=',\+V(^#0H@("`@/"]P/@T*("`@(#QP(&%L:6=N/3-$:G5S=&EF>2!S M='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-E MF4Z(#$P<'0[)SY4:&4@=6YA=61I=&5D(&-O;G-O;&ED M871E9"!F:6YA;F-I86P@6)R9&D@26YC+B!A;F0@ M2!S='EL93TS1"=F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z M(#$P<'0[)SY4:&4@8V]N2UO=VYE9"!S=6)S:61I87)I97,@86YD(&IO:6YT('9E;G1U2!497AT($)L;V-K73PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'`@86QI9VX],T1J=7-T:69Y('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B!T:6UE2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I M;65S+'-EF4Z(#$P<'0[)SY#>6)R9&DL($EN8RX@*&8O M:R]A($-E6)R9&DF(S@R,C$[*2!W87,@:6YC;W)P;W)A M=&5D(&]N($%U9W5S="`Q+"`Q.38V+"!U;F1E6QE M/3-$)V9O;G0M9F%M:6QY.B!T:6UE2P@=&AR;W5G:"!A('=H;VQL>2UO=VYE9"!S=6)S:61I87)Y+"!A M8W%U:7)E9"!A;&P@=&AE(&]W;F5R6)R9&DL M($EN8RXL(&$@<')I=F%T96QY(&AE;&0@8V]M<&%N>2!I;F-O2!I6QE/3-$ M)V9O;G0M9F%M:6QY.B!T:6UE6)R9&D@36%R>6QA;F0@86-Q=6ER960@86X-"B`@("`@(#@P)2!I M;G1E2`R,#`P(&EN('1H92!096]P;&4G&-H86YG92!O M9@T*("`@("`@.3DE(&]F('1H92!#;VUP86YY)B,X,C$W.W,@&ES=&EN9R!S:&%R96AO;&1E6EN9R!":6]T96-H(&1E96UE9"!T:&4@86-C;W5N M=&EN9R!A8W%U:7)E6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE&D@0VAA;WEI;F<@0F5A=71Y("9A;7`[ M($-O65A2!B92!E>'1E;F1E9"!U<&]N(&UU='5A M;"!C;VYS96YT+B!4:&4@<')I;F-I<&%L(&%C=&EV:71I97,@;V8@0VAA;WEI M;F<@0FEO=&5C:"!A7,@86YD('1H M92!R96QA=&5D('-E2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SY- M;W-T(&]F('1H92!#;VUP86YY)B,X,C$W.W,@86-T:79I=&EE2!S='EL93TS1"=F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P M<'0[)SY/;B!&96)R=6%R>2`Q,"P@,C`P-2P@=&AE($-O;7!A;GD@8V]M<&QE M=&5D('1H92!M97)G97(@=VET:"!#>6)R9&D@36%R>6QA;F0@86YD(&-H86YG M960@:71S(&YA;64@=&\@0WEB2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N+'1I;65S+'-EF4Z(#$P<'0[)SY/;B!*=6QY(#(V M("P@,C`P-RP@0VAA;WEI;F<@0FEO=&5C:"!E;G1E2!O=VYE2!3:&%N9&]N9R!!9&UI;FES=')A=&EO M;B!F;W(@0VEV:6P@069F86ERF5D(')E=F5N=64@9G)O;2!S86QE2!M97)C:&%N="!T96YA;G1S(&EF('=E(&-A;B!O8G1A:6X@ M86X@97-T:6UA=&5D("0R+C@-"B`@("`@(&UI;&QI;VX@=&\@8V]M<&QE=&4@ M8V]N6EN9R!#;&EN:6-A;"!0871H;VQO9WD@*"8C.#(R,#M)3U-# M0U`F(S@R,C$[*2P@82!W:&]L;'DM;W=N960@2!E2!R97-E87)C:"!A;F0@8V]N2UR96QA=&5D(')E6EN M9R!":6]T96-H+B!(;W=E=F5R+"!#:&%O>6EN9R!":6]T96-H('=I=&AD2P@=V4@2!497AT($)L;V-K73PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'`@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)V9O;G0M9F%M:6QY.B!T:6UE6EN9R!C;VYS M;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@:&%V92!B965N('!R97!A MF%T M:6]N(&]F(&%S2!H860@86X@86-C=6UU;&%T960@9&5F:6-I="!O9B`D,BPW-#`L M,SDP#0H@("`@("!A;F0@)#(L-#0W+#8T,PT*("`@("`@87,@;V8@2G5N92`S M,"P@,C`Q,B!A;F0@1&5C96UB97(@,S$L(#(P,3$L(&EN8VQU9&EN9R!N970@ M;&]S2!T;R!C;VYT:6YU92!A2!S='EL M93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@("`@(%1H92!#;VUP86YY(&9I;F%N M8V5S(&ET2!T:')O=6=H('-H;W)T+71E M2`D,RXP#0H@("`@("!M:6QL:6]N("AE<75I=F%L96YT('1O(%)-0C$Y M#0H@("`@("!M:6QL:6]N*2!O9B!C87!I=&%L(&ES(&5X<&5C=&5D('1O(&)E M(&YE961E9"X@5&AE($-O;7!A;GDL('1A:VEN9R!I;G1O(&%C8V]U;G0@=&AE M(&%V86EL86)L92!B86YK:6YG(&9A8VEL:71I97,L(&EN=&5R;F%L(&9I;F%N M8VEA;"!R97-O=7)C92P@86YD('-U<'!O2=S(&9I;F%N8VEA M;"!C;VYD:71I;VX@86YD(&1E=&5R:6]R871I;F<@;&EQ=6ED:71Y('!O6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE'!E8W1E9"!T;R!A;6]U;G0@=&\@87!P2`D-CDS M+#`P,"X-"B`@("`\+W`^#0H@("`@/'`@86QI9VX],T1J=7-T:69Y('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B!T:6UE2`D-C4P+#`P,`T*("`@("`@ M<&5R('EE87(N($UA;F%G96UE;G0@9F5E(')E=F5N=64@=VEL;"!B92!C:&%R M9V5D('1O(&-O;6UE2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@ M("`@("AC*2!!9&1I=&EO;F%L(&%D=F%N8V5S(&9R;VT@&5C M=71I=F4@3V9F:6-E6EN9R!"96%U='D@)F%M<#L@0V]S;65T:6-S($=R M;W5P+"!W:&EC:"!I6EN M9R!"96%U='D@)F%M<#L@0V]S;65T:6-S($=R;W5P(&%D=F%N8V5D("0Q,BPV M-C`-"B`@("`@(&9O2!T;R!F:6YA;F-E(&ET2!O2!A9&1I=&EO;F%L(&9I;F%N8VEN9R!W:6QL(&YO="!B92!D:6QU=&EV M92X@5&AE(&-O;G-O;&ED871E9"!F:6YA;F-I86P@2!497AT($)L;V-K73PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'`@86QI9VX],T1J=7-T:69Y('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S M+'-EF4Z(#$P<'0[)SY4:&4@<')E<&%R871I;VX@;V8@ M9FEN86YC:6%L('-T871E;65N=',@:6X@8V]N9F]R;6ET>2!W:71H(&%C8V]U M;G1I;F<@<')I;F-I<&QE'!E;G-E2!497AT M($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'`@86QI M9VX],T1J=7-T:69Y('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE MF5D('5P;VX@=&AE(&1E;&EV97)Y(&]F(&=O;V1S('1O M(&-U2!497AT($)L;V-K73PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'`@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B!T:6UE2!S='EL93TS M1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@("`@($]N($9E8G)U87)Y(#$P+"`R,#`U M+"`H=&AE(")#;&]S:6YG($1A=&4B*2!T:&4@0V]M<&%N>2!C;&]S960@;VX@ M86X@06=R965M96YT(&%N9"!0;&%N(&]F($UE6)R9&D@+4UA6)R9&D@+2!-87)Y;&%N9"P@=VET:"!#>6)R M9&D@+2!-87)Y;&%N9"!B96EN9R!T:&4@6)R9&DM36%R>6QA;F0@:&%S M(&)E96X@8V%N8V5L;&5D(&%N9"!C;VYV97)T960@:6YT;R!T:&4@6)R9&DL($EN8RX- M"B`@("`\+W`^#0H@("`@/'`@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)V9O M;G0M9F%M:6QY.B!T:6UE2!A M;65N9&5D(&ET2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SY# M;VYC=7)R96YT('=I=&@@=&AE(&9I;&EN9R!O9B!T:&4@07)T:6-L97,@;V8@ M365R9V5R+"!A;&P@;V8@=&AE($-O;7!A;GD@=&AE;B!E>&ES=&EN9R!O9F9I M8V5R&5S(%M0;VQI8WD@5&5X="!";&]C:UT\+W1D/@T* M("`@("`@("`\=&0@8VQA2!S M='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N+'1I;65S+'-E MF4Z(#$P<'0[)SX-"B`@("`@(#QB/C6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE&5S(&-U2!D=64@<&QU2!T;R!T:&4@9&EF9F5R96YC97,@8F5T=V5E;B!T:&4@ M8F%S:7,@;V8@87-S971S(&%N9"!L:6%B:6QI=&EE"!A M"!R971U&5S(&%L2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'`@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)V9O;G0M9F%M:6QY M.B!T:6UE6QE/3-$)V9O;G0M9F%M:6QY M.B!T:6UE2!W92!A2X@ M2&]W979E2!L:71I9V%T:6]N(&%N9"]O2!E2!S M=6-H(&1I2!S='EL93TS1"=F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N+'1I;65S+'-EF4Z(#$P<'0[)SX-"B`@ M("`@(#QB/CDN(%)E8V5N="!!8V-O=6YT:6YG(%!R;VYO=6YC96UE;G1S/"]B M/@T*("`@(#PO<#X-"B`@("`\<"!A;&EG;CTS1&IU65T(&5F9F5C=&EV92P@:7,@;F]T(&%N=&EC M:7!A=&5D('1O(&AA=F4@82!M871E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A65A2!/9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(#$\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!/9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O M;&EC:65S(#<\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!/9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG M(%!O;&EC:65S(#$U/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR M-S,L-3(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!/9B!3:6=N:69I8V%N="!!8V-O M=6YT:6YG(%!O;&EC:65S(#(Q/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XV-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!/9B!3:6=N:69I8V%N="!!8V-O M=6YT:6YG(%!O;&EC:65S(#(U/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\2!/9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(#(V/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,BPV-C`\2!/9B!3:6=N:69I8V%N="!!8V-O M=6YT:6YG(%!O;&EC:65S(#(W/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XY,RXX,"4\2!/9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(#(X M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+C4V-C8T,38P.3QS M<&%N/CPO2!/9B!3:6=N:69I M8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(#,P/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XQ-3`L,#`P+#`P,#QS<&%N/CPO2!/9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S M(#,R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$\'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'1087)T7S`U93=F-V9C7S)C8F)?-#AB-5]A,V%A7SAF9&0S-#1F,#5E M90T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P-64W9C=F8U\R8V)B M7S0X8C5?83-A85\X9F1D,S0T9C`U964O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'10 M87)T7S`U93=F-V9C7S)C8F)?-#AB-5]A,V%A7SAF9&0S-#1F,#5E90T*0V]N M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P-64W9C=F8U\R8V)B7S0X8C5? M83-A85\X9F1D,S0T9C`U964O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2`R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-RPS M,C@L,C8S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2`S/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,C`L,C(U+#,R,SQS<&%N/CPO M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2`X/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XQ-BXV-R4\2`Q,3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M2`Q,CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\P-64W9C=F8U\R8V)B7S0X8C5?83-A85\X M9F1D,S0T9C`U964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#5E M-V8W9F-?,F-B8E\T.&(U7V$S86%?.&9D9#,T-&8P-65E+U=O'0O:'1M;#L@8VAA&5S(#0\+W1D/@T* M("`@("`@("`\=&0@8VQA&5S M(#4\+W1D/@T*("`@("`@("`\=&0@8VQA&5S(#8\+W1D/@T*("`@("`@("`\=&0@8VQA&5S(#<\+W1D/@T*("`@("`@("`\=&0@8VQA&5S(#@\+W1D/@T*("`@("`@("`\ M=&0@8VQA&5S(#D\+W1D/@T* M("`@("`@("`\=&0@8VQA&5S M(#$P/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$V,CQS<&%N M/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\P-64W9C=F8U\R8V)B7S0X8C5?83-A85\X M9F1D,S0T9C`U964-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#5E M-V8W9F-?,F-B8E\T.&(U7V$S86%?.&9D9#,T-&8P-65E+U=O&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T M960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA&UL;G,Z;STS1")U'1087)T7S`U93=F-V9C7S)C =8F)?-#AB-5]A,V%A7SAF9&0S-#1F,#5E92TM#0H` ` end XML 16 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
LIABILITIES
6 Months Ended
Jun. 30, 2012
LIABILITIES [Text Block]

NOTE C - LIABILITIES

As of June 30, 2012, the balance sheet included total liabilities of $5,635,305, which consisted of current liabilities of $4,795,155 and construction payable of $840,150. Included in the current liabilities was a short-term loan of $1,495,357 (equivalent to RMB9.5 million) from Changle Rural Credit Union, which is a bank located in Shandong Province of the PRC. The original term of the loan was from August 25, 2009 to August 24, 2010 with an interest rate of 7.965% per annum. In August 2011, the Company renewed this short-term loan with the same amount of $1,495,357 (equivalent to RMB9.5 million) with Changle Rural Credit Union. The term of the renewal loan started from August 31, 2011 with a maturity date of August 20, 2012. The adjustable interest rate is a rate per annum equal to the Prime Rate plus 50% of prime rate. The prime rate is based on six-month-to-one-year loan interest rate released by The People's Bank of China. The interest rate for the short-term loan was 9.465% as of June 30, 2012. This short-term loan had been secured by the Company’s land use right and construction-in-progress of SD Chaoying with a book value of $3.15 million (equivalent to RMB20.03 million) and $4.32 million (equivalent to RMB27.45 million) as of June 30, 2012, respectively. For the $3.15 million land use rights, $2.49 million was classified under construction-in-progress for the commercial property and the remaining $0.66 million was classified under intangible assets subject to amortization. The Company currently is in process of negotiating with Changle Rural Credit Union to renew the bank loan upon maturity date on August 20, 2012.  Additionally, there is another short-term loan of $157,406 (equivalent to RMB1.0 million) from Mr. Fengguo Liu, an unrelated party. Also included in the current liabilities was $1,745,801 of loans from related companies, including Xi’an Yanfeng Biotechnology Co., Ltd., Shaanxi Yanfeng Real Estate Co. Ltd, Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd and the stockholders who are also the Company’s officers. These entities were related to the Company through common ownership and principal officers. These loans are non-interest bearing and have no set repayment terms.

XML 17 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (USD $)
Jun. 30, 2012
Dec. 31, 2011
CURRENT ASSETS    
Cash and equivalents $ 495,492 $ 781,048
Accounts receivable, net 3,125 0
Inventories 921,606 1,053,038
Due from related companies 90,331 79,442
Other receivables, net and prepaid expenses 72,456 75,089
Advance to suppliers 630 832
TOTAL CURRENT ASSETS 1,583,640 1,989,449
PROPERTY, PLANT AND EQUIPMENT, NET 1,233,391 1,310,529
CONSTRUCTION IN PROGRESS 6,781,274 6,829,329
INTANGIBLE ASSETS, NET 715,647 782,215
TOTAL ASSETS 10,313,952 10,911,522
CURRENT LIABILITIES    
Short-term loan 1,652,762 1,668,282
Accounts payable 3,318 4,942
Accrued expenses 746,757 693,436
Deferred revenue 123,370 139,284
Customers deposits 86,080 188,186
Due to related parties 1,745,801 1,850,181
Deferred tax liabilities 10,197 10,293
Other payables 426,870 366,020
TOTAL CURRENT LIABILITIES 4,795,155 4,920,624
CONSTRUCTION PAYABLE 840,150 894,750
TOTAL LIABILITIES 5,635,305 5,815,374
EQUITY    
Preferred Stock, $1.00 per value, 500,000 shares authorized, no shares issued and outstanding 0 0
Common Stock, no par value, 150,000,000 shares authorized, and 120,225,323 and 120,225,323 shares issued and outstanding, respectively 4,313,614 4,313,614
Additional paid-in capital 172,308 172,308
Reserve funds 336,885 336,885
Accumulated deficit (2,740,390) (2,447,643)
Accumulated other comprehensive income 1,483,900 1,540,329
TOTAL STOCKHOLDERS' EQUITY 3,566,317 3,915,493
NONCONTROLLING INTEREST 1,112,330 1,180,655
TOTAL EQUITY 4,678,647 5,096,148
TOTAL LIABILITIES AND EQUITY $ 10,313,952 $ 10,911,522
XML 18 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2012
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Text Block]

NOTE A - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

1. Interim Financial Statements

The unaudited consolidated financial statements of Cybrdi Inc. and subsidiaries have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and pursuant to the requirements for reporting on Form 10-Q. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. However, the information included in these interim financial statements reflects all adjustments (consisting solely of normal recurring adjustments) which are, in the opinion of management, necessary for the fair presentation of the consolidated financial position and the consolidated results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full year. The consolidated balance sheet information as of December 31, 2011 was derived from the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K. These interim financial statements should be read in conjunction with that report. Certain comparative amounts have been reclassified to conform to the current period's presentation.

The consolidated financial statements include the accounts of Cybrdi, Inc. and its wholly-owned subsidiaries and joint ventures. All material intercompany balances and transactions have been eliminated.

2. Description of Business

Cybrdi, Inc. (f/k/a Certron Corporation) (the “Company” or “Cybrdi”) was incorporated on August 1, 1966, under the laws of the State of California. Until around June 2004, the Company’s business consisted of the distribution of magnetic media products, primarily blank audio and video cassettes. Due to continuing intense price competition and technological changes in the marketplace for its products, the Company lost its remaining significant customers and disposed of or wrote off its remaining inventory. As a result of these occurrences, the Company concluded that its audio and videotape businesses were no longer viable and some of its product lines were obsolete.

On February 10, 2005, the Company, through a wholly-owned subsidiary, acquired all the ownership interest in Cybrdi, Inc., a privately held company incorporated in the State of Maryland ("Cybrdi Maryland"). As a result of the ownership interests of the former shareholders of Cybrdi Maryland, for financial statement reporting purposes, the transaction was treated as a reverse acquisition, with Cybrdi Maryland deemed the accounting acquirer and Certron Corporation deemed the accounting acquiree. Historical information of the surviving company is that of Cybrdi Maryland.

Cybrdi Maryland was established in 2001 to acquire an interest in biogenetic products commercialization and related services entities in Asia. On March 5, 2003, Cybrdi Maryland acquired an 80% interest in Shaanxi Chao Ying Biotechnology Co., Ltd. (“Chaoying Biotech”), a sino-foreign equity joint venture established in July 2000 in the People's Republic of China (“PRC”), through the exchange of 99% of the Company’s shares to the existing shareholders of Chaoying Biotech. For financial statement reporting purposes, the merger was treated as a reverse acquisition, with Chaoying Biotech deemed the accounting acquirer and Cybrdi Maryland deemed the accounting acquiree.

Chaoying Biotech is a sino-foreign equity joint venture between Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd. (the “Chinese Partner”, a PRC corporation) and Immuno-Onco Genomics Inc. (the “Foreign Partner”, a USA corporation). The joint venture agreement has a 15 year operating period starting from its formation in July 2000 and it may be extended upon mutual consent. The principal activities of Chaoying Biotech are research, manufacture and sale of various high-quality tissue arrays and the related services in the PRC.

Most of the Company’s activities are conducted through Chaoying Biotech. Chaoying Biotech, with its principal operations located in China, aims to take advantage of China's abundant scientific talent, low wage rates, less stringent biogenetic regulation, and the huge genetic population as it introduces its growing list of tissue micro array products.

On February 10, 2005, the Company completed the merger with Cybrdi Maryland and changed its name to Cybrdi, Inc.

On July 26 , 2007, Chaoying Biotech entered into an acquisition agreement with its Chinese partner, which is a principal shareholder of the company, Mr. Bai, the Company’s chief executive officer and a director is also a principal of its Chinese partner.

On July 28,2007, Chaoying Biotech invested RMB15 millions (equivalent to US$1,983,078) to acquire an 83.33% equity ownership of Shandong Chaoying Culture and Entertainment Co., Ltd. (“SD Chaoying”) from its Chinese partner, SD Chaoying is a corporation organized in Shandong Province P.R.China. On September 5, 2007, Shandong Commercial government had approved this acquisition and the ownership title of SD Chaoying had been transferred to Chaoying Biotech from its Chinese partner. The future business of SD Chaoying will primarily focus on culture and entertainment, including spa activities, cosmetic and personal care, body building, gambling, catering, and lodging, etc. SD Chaoying will have a specific emphasis on casino gambling, which has been approved by Shandong Administration for Civil Affairs. As of December 31, 2009, SD Chaoying had substantially completed the construction of two residential buildings and had recognized revenue from sales of housing for 2009. The main structure of the commercial entertainment center has also been completed, except for the exterior, rooftop, the surrounding supporting projects and the community landscaping, which are expected to be completed in 2012 prior to the commencement of operations by merchant tenants if we can obtain an estimated $2.8 million to complete construction.

On March 10, 2007 the Company entered into a Sales Agency Agreement with BioMax, Ltd., a reseller located in the United States.

On April 29, 2011, Chaoying Biotech invested $154,732 (equivalent to RMB1 million) to restore the operation of the Institute of Shaanxi Chaoying Clinical Pathology (“IOSCCP”), a wholly-owned subsidiary established on July 31, 2003, whose main business includes pathology research and consulting, consulting and diagnostic clinical pathology and pathology-related research and development of new technologies, and basic training in pathology. Its sole shareholder has been Chaoying Biotech. However, Chaoying Biotech withdrew the original investment from IOSCCP in September 2007 as we believed that both internal and external conditions of IOSCCP were not mature at that time. In light of foreseeable benefits and new business opportunities for this entity, we resumed its business and re-invested $154,732 (equivalent to RMB1 million) in it in April 2011.

3. Going Concern

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred significant losses and has not demonstrated the ability to generate sufficient cash flows from operations to satisfy its liabilities and sustain operations. The Company had an accumulated deficit of $2,740,390 and $2,447,643 as of June 30, 2012 and December 31, 2011, including net losses of $292,747 and $273,526 for the six months ended June 30, 2012 and 2011, respectively. In addition, current liabilities exceeded current assets by $3,211,515 and $2,931,175 at June 30, 2012 and December 31, 2011, respectively. These matters raise substantial doubt about the Company’s ability to continue as a going concern.

The Company finances its operations primarily through short-term bank borrowings and advances from related parties and/or officers/shareholders. In order to complete the construction of SD Chaoying cultural and entertainment center, approximately $3.0 million (equivalent to RMB19 million) of capital is expected to be needed. The Company, taking into account the available banking facilities, internal financial resource, and supports from related companies, believes it has sufficient working capital to meet its present obligation for at least the next twelve months. Management is taking actions to address the company's financial condition and deteriorating liquidity position. The following sets forth management’s plans for dealing with the adverse effects of the conditions:

(a) Sale of housing inventories: Proceeds to be received from the sale of the remaining housing of the two completed residential buildings are expected to amount to approximately $693,000.

(b) Rental and management fee revenue from the cultural and entertainment center: Annual rental revenue is estimated to be approximately $650,000 per year. Management fee revenue will be charged to commercial tenants at 3% of annual gross revenue.  As of June 30, 2012, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.

(c) Additional advances from related companies and affiliates: Mr. Bai, our Chief Executive Officer, advanced $55,974 to the Company in the current period to finance operations and the costs to maintain the Company’s public status in the U.S. In addition, Shaanxi Chaoying Beauty & Cosmetics Group, which is also an affiliate, is anticipated to provide up to approximately $791,000 (equivalent to RMB5 million) of capital to support operations. Shaanxi Chaoying Beauty & Cosmetics Group advanced $12,660 for the current quarter period to the Company to finance its operations.

The Company may require additional funds and may seek to raise such funds though public and private financings or from other sources. There is no assurance that management’s plans will be realized or the additional financing will be available at all or that, if available, such financing will be obtainable on terms favorable to the Company or that any additional financing will not be dilutive. The consolidated financial statements do not include any adjustments that might result from the outcome of those uncertainties.

4. Use of Estimates:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

5. Revenue Recognition

Revenue represents the invoiced value of goods sold recognized upon the delivery of goods to customers and service income is recognized when services are provided. Deferred revenue represents the undelivered portion of invoiced value of goods sold to customers. Sales transactions not meeting all the conditions of the full accrual method are accounted for using the deposit method of accounting. Under the deposit method, all costs are capitalized as incurred, and payments received from the buyer are recorded as customer deposits.

6. Reverse Merger

On February 10, 2005, (the "Closing Date") the Company closed on an Agreement and Plan of Merger (the "Agreement") among Certron Corporation (“Certron”), a California corporation, Certron Acquisition Corp., a Maryland corporation and a wholly-owned subsidiary of Certron ("Acquisition Sub"), and Cybrdi, Inc., a Maryland corporation (“Cybrdi – Maryland”) relating to the acquisition by Certron of all of the issued and outstanding capital stock of Cybrdi -Maryland in exchange for shares of common stock of Certron that will aggregate approximately 93.8% of the issued and outstanding common stock of Certron. Pursuant to the terms of the Agreement, at the Closing Date (a) Acquisition Sub has been merged with and into Cybrdi - Maryland, with Cybrdi - Maryland being the surviving corporation, (b) the common stock of Cybrdi-Maryland has been cancelled and converted into the right to receive shares of the common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of the Certron’s common stock, and (c) each share of the common stock of Acquisition Sub has been converted in to and become one share of the common stock of Cybrdi-Maryland. The share exchange has been accounted for as a reverse merger under the purchase method of accounting. Accordingly, Cybrdi, Inc. will be treated as the continuing entity for accounting purposes and the historical financial statements presented will be those of Cybrdi, Inc.

In connection with the Agreement, on February 10, 2005, the Company amended its articles of incorporation to authorize the issuance of 150 million shares of common stock no par value and 500,000 shares of preferred stock, $1.00 par value per share, none of which are issued or outstanding.

Concurrent with the filing of the Articles of Merger, all of the Company then existing officers and directors tendered their resignation and Yanbiao Bai was appointed as its Chairman of the Board of Directors. Mr. Bai then nominated the balance of the Board of Directors.

7. Income Taxes

Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to the differences between the basis of assets and liabilities for financial and income tax reporting. The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes also are recognized for operating losses that are available to offset future income taxes.

8. Contingencies

Currently we are involved in disputes, litigation and other legal proceedings. We prosecute and defend these matters aggressively. However, there are many uncertainties associated with any litigation, and we cannot assure you that these actions or other third party claims against us will be resolved without costly litigation and/or substantial settlement charges. We record a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements and (ii) the range of loss can be reasonably estimated. However, the actual liability in any such disputes or litigation may be materially different from our estimates, which could result in the need to record additional costs.

9. Recent Accounting Pronouncements

The Company has adopted all recently issued accounting pronouncements. The adoption of the accounting pronouncements, including those not yet effective, is not anticipated to have a material effect on the financial position or results of operations of the Company.

XML 19 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 20 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
ASSETS
6 Months Ended
Jun. 30, 2012
ASSETS [Text Block]

NOTE B – ASSETS

The June 30, 2012 consolidated balance sheet included total current assets of $1,583,640 and non-current assets of $8,730,312. Of these amounts, $495,492 in cash and equivalents is planned for funding current operations and for future business expansion.

Other current assets also included accounts receivable, inventories, due from related companies, other receivables and prepaid expenses, and advance to suppliers. Inventories are mainly finished goods. Other components of inventories include raw materials, finished goods, and housing inventories. Inventories are stated at the lower of cost or market. Cost of raw materials is determined on the basis of first in first out method (“FIFO”). Finished goods are determined on the weighted average basis and are comprised of direct materials, direct labor, and an appropriate proportion of overhead.

The other primary assets included in current assets are loans to an unaffiliated company, QuanYe Security Co., Ltd (“QuanYe”), an unrelated People’s Republic of China (“PRC”) registered company located in Xian PRC. QuanYe is engaged in the pawnshop business and their primary business is offering alternative financing to small, local companies. According to the loan agreement, QuanYe had received loans from Chaoying Biotech for a total amount of RMB29.3Mill ion (equivalent to $4,652,640) since January 2006. A remaining balance of RMB7.3 million (equivalent to $1,159,190) was extended to and expired on March 24, 2008. As of June 30, 2012 and December 31, 2011, the principal balance and interest receivable for this loan had been reduced to $0, net of allowance of $94,444 and $180,258 for doubtful principal balance and interest receivable, respectively. The interest rate for these loans initially was initially 8% per year, and subsequently reduced to 5% since October 9, 2006.

Included in non-current assets are property, plant and equipment, construction-in-progress and intangible assets. Property, plant and equipment mainly consist of building, office equipments, motor vehicles, leasehold improvement, software-website, and machinery used for product manufacturing located in the People’s Republic of China (“PRC”). Depreciation on property, plant and equipment is computed using the straight-line method over the estimated useful life of the assets. The majority of the assets have estimated useful lives of 10 years. Building and office equipment have estimated useful lives of 20 and 5 years, respectively. The “construction in progress” in the amount of $6,781,274 mainly consisted of land under development and construction of the entertainment, culture, and casino facility in Shandong Province, which will be transferred to fixed assets in SD Chaoying when construction is completed. As of June 30, 2012, construction-in-progress of $4.32 million and land use rights of $3.15 million of SD Chaoying were collateralized under a short-term loan from Changle Rural Credit Union. For the $3.15 million land use rights, $2.49 million was classified under construction-in-progress for the commercial property and the remaining $0.66 million was classified under intangible assets subject to amortization. Intangible assets included a tissue chip patent at Chaoying Biotech and $0.66 million of land use rights being put in operation for the partial completed commercial property at SD Chaoying. Effective January 1, 2002, with the adoption of the accounting guidance for Goodwill and Other Intangible Assets, intangible assets with a definite life are amortized on a straight-line basis. The patent is being amortized over its estimated life of 10 years. The land use rights classified in intangible asset is being amortized over its estimated life of 36.9 years through the maturity of the land use rights for commercial use on November 6, 2047.

XML 21 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
Jun. 30, 2012
Dec. 31, 2011
Preferred Stock, Par Value Per Share $ 1.00 $ 1.00
Preferred Stock, Shares Authorized 500,000 500,000
Common Stock, Shares Authorized 150,000,000 150,000,000
Common Stock, Shares, Issued 120,225,323 120,225,323
Common Stock, Shares, Outstanding 120,225,323 120,225,323
XML 22 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
INCOME TAXES (Narrative) (Details) (USD $)
6 Months Ended
Jun. 30, 2012
Income Taxes 1 33.00%
Income Taxes 2 30.00%
Income Taxes 3 3.00%
Income Taxes 4 25.00%
Income Taxes 5 33.00%
Income Taxes 6 50.00%
Income Taxes 7 50.00%
Income Taxes 8 15.00%
Income Taxes 9 15.00%
Income Taxes 10 $ 162
XML 23 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
6 Months Ended
Jun. 30, 2012
Aug. 14, 2012
Document and Entity Information    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2012  
Trading Symbol cydi  
Entity Registrant Name Cybrdi, Inc.  
Entity Central Index Key 0000019002  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   120,225,323
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Well Known Seasoned Issuer No  
Document Fiscal Year Focus 2012  
Document Fiscal Period Focus Q2  
XML 24 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONTINGENCIES AND LITIGATION LIABILITIES (Narrative) (Details)
6 Months Ended
Jun. 30, 2012
USD ($)
days
Jun. 30, 2012
CNY
Contingencies And Litigation Liabilities 1   7,600,000
Contingencies And Litigation Liabilities 2 1,207,518  
Contingencies And Litigation Liabilities 3 12 12
Contingencies And Litigation Liabilities 4 94,444  
Contingencies And Litigation Liabilities 5   600,000
Contingencies And Litigation Liabilities 6 184,183  
Contingencies And Litigation Liabilities 7   1,170,114
Contingencies And Litigation Liabilities 8 184,183  
Contingencies And Litigation Liabilities 9   1,170,114
Contingencies And Litigation Liabilities 10 100.00% 100.00%
Contingencies And Litigation Liabilities 11 188,888  
Contingencies And Litigation Liabilities 12   1,200,000
Contingencies And Litigation Liabilities 13 15 15
Contingencies And Litigation Liabilities 14 $ 37,700  
XML 25 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Revenue        
Housing $ 0 $ 0 $ 142,200 $ 0
Commercial rental 0 0 0 0
Tissue array products 112,407 123,419 212,317 237,230
Total revenue 112,407 123,419 354,517 237,230
Cost of Sales        
Housing 0 0 123,306 0
Commercial rental 16,414 17,125 32,880 31,752
Tissue array products 65,120 102,176 144,434 189,324
Total cost of sales 81,534 119,301 300,620 221,076
Gross Profit 30,873 4,118 53,897 16,154
Operating Expenses:        
Salaries and wages 50,316 41,093 102,560 81,576
Depreciation and amortization 36,561 36,721 75,008 72,993
Professional fees 19,026 10,783 37,735 57,108
Operating tax expenses 10,985 54 27,214 125
Selling and distribution expenses 1,374 3,786 2,753 10,211
Other general and administrative expenses 24,541 25,352 54,854 51,637
Bad debt expense 0 23,226 0 68,830
Total Operating Expenses 142,803 141,015 300,124 342,480
Loss from Operations (111,930) (136,897) (246,227) (326,326)
Other Income        
Net interest expense (46,132) (1,085) (92,122) (598)
Other (expense) income, net 3,496 (14) (22,561) 229
Total Other Expense, Net (42,636) (1,099) (114,683) (369)
Loss before Income Taxes (154,566) (137,996) (360,910) (326,695)
Income Tax Expense (162) 0 (162) 0
Net loss (154,728) (137,996) (361,072) (326,695)
Net loss attributable to the noncontrolling interest (29,860) (28,160) (68,325) (53,169)
Net loss attributable to CYBRDI, INC. AND SUBSIDIARIES $ (124,868) $ (109,836) $ (292,747) $ (273,526)
Net Loss Per Common Share        
Basic and Diluted $ 0.00 $ 0.00 $ 0.00 $ 0.00
Weighted Average Number of Shares Outstanding        
Basic and Diluted 120,225,323 65,756,567 120,225,323 65,756,567
XML 26 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2012
Interim Financial Statements [Policy Text Block]

1. Interim Financial Statements

The unaudited consolidated financial statements of Cybrdi Inc. and subsidiaries have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and pursuant to the requirements for reporting on Form 10-Q. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. However, the information included in these interim financial statements reflects all adjustments (consisting solely of normal recurring adjustments) which are, in the opinion of management, necessary for the fair presentation of the consolidated financial position and the consolidated results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full year. The consolidated balance sheet information as of December 31, 2011 was derived from the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K. These interim financial statements should be read in conjunction with that report. Certain comparative amounts have been reclassified to conform to the current period's presentation.

The consolidated financial statements include the accounts of Cybrdi, Inc. and its wholly-owned subsidiaries and joint ventures. All material intercompany balances and transactions have been eliminated.

Description of Business [Policy Text Block]

2. Description of Business

Cybrdi, Inc. (f/k/a Certron Corporation) (the “Company” or “Cybrdi”) was incorporated on August 1, 1966, under the laws of the State of California. Until around June 2004, the Company’s business consisted of the distribution of magnetic media products, primarily blank audio and video cassettes. Due to continuing intense price competition and technological changes in the marketplace for its products, the Company lost its remaining significant customers and disposed of or wrote off its remaining inventory. As a result of these occurrences, the Company concluded that its audio and videotape businesses were no longer viable and some of its product lines were obsolete.

On February 10, 2005, the Company, through a wholly-owned subsidiary, acquired all the ownership interest in Cybrdi, Inc., a privately held company incorporated in the State of Maryland ("Cybrdi Maryland"). As a result of the ownership interests of the former shareholders of Cybrdi Maryland, for financial statement reporting purposes, the transaction was treated as a reverse acquisition, with Cybrdi Maryland deemed the accounting acquirer and Certron Corporation deemed the accounting acquiree. Historical information of the surviving company is that of Cybrdi Maryland.

Cybrdi Maryland was established in 2001 to acquire an interest in biogenetic products commercialization and related services entities in Asia. On March 5, 2003, Cybrdi Maryland acquired an 80% interest in Shaanxi Chao Ying Biotechnology Co., Ltd. (“Chaoying Biotech”), a sino-foreign equity joint venture established in July 2000 in the People's Republic of China (“PRC”), through the exchange of 99% of the Company’s shares to the existing shareholders of Chaoying Biotech. For financial statement reporting purposes, the merger was treated as a reverse acquisition, with Chaoying Biotech deemed the accounting acquirer and Cybrdi Maryland deemed the accounting acquiree.

Chaoying Biotech is a sino-foreign equity joint venture between Shaanxi Chaoying Beauty & Cosmetics Group Co., Ltd. (the “Chinese Partner”, a PRC corporation) and Immuno-Onco Genomics Inc. (the “Foreign Partner”, a USA corporation). The joint venture agreement has a 15 year operating period starting from its formation in July 2000 and it may be extended upon mutual consent. The principal activities of Chaoying Biotech are research, manufacture and sale of various high-quality tissue arrays and the related services in the PRC.

Most of the Company’s activities are conducted through Chaoying Biotech. Chaoying Biotech, with its principal operations located in China, aims to take advantage of China's abundant scientific talent, low wage rates, less stringent biogenetic regulation, and the huge genetic population as it introduces its growing list of tissue micro array products.

On February 10, 2005, the Company completed the merger with Cybrdi Maryland and changed its name to Cybrdi, Inc.

On July 26 , 2007, Chaoying Biotech entered into an acquisition agreement with its Chinese partner, which is a principal shareholder of the company, Mr. Bai, the Company’s chief executive officer and a director is also a principal of its Chinese partner.

On July 28,2007, Chaoying Biotech invested RMB15 millions (equivalent to US$1,983,078) to acquire an 83.33% equity ownership of Shandong Chaoying Culture and Entertainment Co., Ltd. (“SD Chaoying”) from its Chinese partner, SD Chaoying is a corporation organized in Shandong Province P.R.China. On September 5, 2007, Shandong Commercial government had approved this acquisition and the ownership title of SD Chaoying had been transferred to Chaoying Biotech from its Chinese partner. The future business of SD Chaoying will primarily focus on culture and entertainment, including spa activities, cosmetic and personal care, body building, gambling, catering, and lodging, etc. SD Chaoying will have a specific emphasis on casino gambling, which has been approved by Shandong Administration for Civil Affairs. As of December 31, 2009, SD Chaoying had substantially completed the construction of two residential buildings and had recognized revenue from sales of housing for 2009. The main structure of the commercial entertainment center has also been completed, except for the exterior, rooftop, the surrounding supporting projects and the community landscaping, which are expected to be completed in 2012 prior to the commencement of operations by merchant tenants if we can obtain an estimated $2.8 million to complete construction.

On March 10, 2007 the Company entered into a Sales Agency Agreement with BioMax, Ltd., a reseller located in the United States.

On April 29, 2011, Chaoying Biotech invested $154,732 (equivalent to RMB1 million) to restore the operation of the Institute of Shaanxi Chaoying Clinical Pathology (“IOSCCP”), a wholly-owned subsidiary established on July 31, 2003, whose main business includes pathology research and consulting, consulting and diagnostic clinical pathology and pathology-related research and development of new technologies, and basic training in pathology. Its sole shareholder has been Chaoying Biotech. However, Chaoying Biotech withdrew the original investment from IOSCCP in September 2007 as we believed that both internal and external conditions of IOSCCP were not mature at that time. In light of foreseeable benefits and new business opportunities for this entity, we resumed its business and re-invested $154,732 (equivalent to RMB1 million) in it in April 2011.

Going Concern [Policy Text Block]

3. Going Concern

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred significant losses and has not demonstrated the ability to generate sufficient cash flows from operations to satisfy its liabilities and sustain operations. The Company had an accumulated deficit of $2,740,390 and $2,447,643 as of June 30, 2012 and December 31, 2011, including net losses of $292,747 and $273,526 for the six months ended June 30, 2012 and 2011, respectively. In addition, current liabilities exceeded current assets by $3,211,515 and $2,931,175 at June 30, 2012 and December 31, 2011, respectively. These matters raise substantial doubt about the Company’s ability to continue as a going concern.

The Company finances its operations primarily through short-term bank borrowings and advances from related parties and/or officers/shareholders. In order to complete the construction of SD Chaoying cultural and entertainment center, approximately $3.0 million (equivalent to RMB19 million) of capital is expected to be needed. The Company, taking into account the available banking facilities, internal financial resource, and supports from related companies, believes it has sufficient working capital to meet its present obligation for at least the next twelve months. Management is taking actions to address the company's financial condition and deteriorating liquidity position. The following sets forth management’s plans for dealing with the adverse effects of the conditions:

(a) Sale of housing inventories: Proceeds to be received from the sale of the remaining housing of the two completed residential buildings are expected to amount to approximately $693,000.

(b) Rental and management fee revenue from the cultural and entertainment center: Annual rental revenue is estimated to be approximately $650,000 per year. Management fee revenue will be charged to commercial tenants at 3% of annual gross revenue.  As of June 30, 2012, the Company has not commenced collecting rental and management fee revenue for the culture and entertainment center.

(c) Additional advances from related companies and affiliates: Mr. Bai, our Chief Executive Officer, advanced $55,974 to the Company in the current period to finance operations and the costs to maintain the Company’s public status in the U.S. In addition, Shaanxi Chaoying Beauty & Cosmetics Group, which is also an affiliate, is anticipated to provide up to approximately $791,000 (equivalent to RMB5 million) of capital to support operations. Shaanxi Chaoying Beauty & Cosmetics Group advanced $12,660 for the current quarter period to the Company to finance its operations.

The Company may require additional funds and may seek to raise such funds though public and private financings or from other sources. There is no assurance that management’s plans will be realized or the additional financing will be available at all or that, if available, such financing will be obtainable on terms favorable to the Company or that any additional financing will not be dilutive. The consolidated financial statements do not include any adjustments that might result from the outcome of those uncertainties.

Use of Estimates [Policy Text Block]

4. Use of Estimates:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

Revenue Recognition [Policy Text Block]

5. Revenue Recognition

Revenue represents the invoiced value of goods sold recognized upon the delivery of goods to customers and service income is recognized when services are provided. Deferred revenue represents the undelivered portion of invoiced value of goods sold to customers. Sales transactions not meeting all the conditions of the full accrual method are accounted for using the deposit method of accounting. Under the deposit method, all costs are capitalized as incurred, and payments received from the buyer are recorded as customer deposits.

Reverse Merger [Policy Text Block]

6. Reverse Merger

On February 10, 2005, (the "Closing Date") the Company closed on an Agreement and Plan of Merger (the "Agreement") among Certron Corporation (“Certron”), a California corporation, Certron Acquisition Corp., a Maryland corporation and a wholly-owned subsidiary of Certron ("Acquisition Sub"), and Cybrdi, Inc., a Maryland corporation (“Cybrdi – Maryland”) relating to the acquisition by Certron of all of the issued and outstanding capital stock of Cybrdi -Maryland in exchange for shares of common stock of Certron that will aggregate approximately 93.8% of the issued and outstanding common stock of Certron. Pursuant to the terms of the Agreement, at the Closing Date (a) Acquisition Sub has been merged with and into Cybrdi - Maryland, with Cybrdi - Maryland being the surviving corporation, (b) the common stock of Cybrdi-Maryland has been cancelled and converted into the right to receive shares of the common stock of Certron at an exchange ratio of 1.566641609 per share. This resulted in the issuance of 47,328,263 shares of the Certron’s common stock, and (c) each share of the common stock of Acquisition Sub has been converted in to and become one share of the common stock of Cybrdi-Maryland. The share exchange has been accounted for as a reverse merger under the purchase method of accounting. Accordingly, Cybrdi, Inc. will be treated as the continuing entity for accounting purposes and the historical financial statements presented will be those of Cybrdi, Inc.

In connection with the Agreement, on February 10, 2005, the Company amended its articles of incorporation to authorize the issuance of 150 million shares of common stock no par value and 500,000 shares of preferred stock, $1.00 par value per share, none of which are issued or outstanding.

Concurrent with the filing of the Articles of Merger, all of the Company then existing officers and directors tendered their resignation and Yanbiao Bai was appointed as its Chairman of the Board of Directors. Mr. Bai then nominated the balance of the Board of Directors.

Income Taxes [Policy Text Block]

7. Income Taxes

Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to the differences between the basis of assets and liabilities for financial and income tax reporting. The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes also are recognized for operating losses that are available to offset future income taxes.

Contingencies [Policy Text Block]

8. Contingencies

Currently we are involved in disputes, litigation and other legal proceedings. We prosecute and defend these matters aggressively. However, there are many uncertainties associated with any litigation, and we cannot assure you that these actions or other third party claims against us will be resolved without costly litigation and/or substantial settlement charges. We record a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements and (ii) the range of loss can be reasonably estimated. However, the actual liability in any such disputes or litigation may be materially different from our estimates, which could result in the need to record additional costs.

Recent Accounting Pronouncements [Policy Text Block]

9. Recent Accounting Pronouncements

The Company has adopted all recently issued accounting pronouncements. The adoption of the accounting pronouncements, including those not yet effective, is not anticipated to have a material effect on the financial position or results of operations of the Company.

XML 27 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONTINGENCIES AND LITIGATION LIABILITIES
6 Months Ended
Jun. 30, 2012
CONTINGENCIES AND LITIGATION LIABILITIES [Text Block]

NOTE F – CONTINGENCIES AND LITIGATION LIABILITIES

On June 7, 2011, Weifang Shili Hesin Engineering Equipment Co., Ltd. (the “Plaintiff”) filed a complaint against SD Chaoying at the Basic People's Court of Changle County in Shandong Province, China, for alleged damages caused by SD Chaoying for not performing appropriately and completely the obligations in accordance with the agreement signed by both parties on April 28, 2011. Pursuant to the agreement, SD Chaoying agreed to transfer: (1) the rights of development, construction, and land of the #1 and #2 residential buildings for RMB7.6 million, or $1,207,518, and (2) the 12 unsold residential units in the #3 and #4 residential buildings at a price as agreed upon. As of June 30, 2012, the Plaintiff paid $94,444 (equivalent to RMB600,000) deposit as agreed upon, and prepaid $184,183 (equivalent to RMB1,170,114), both of which were recorded as Other Payables under current liabilities. Plaintiff was seeking for the discharge of the original agreement signed, the return of prepayment of $184,183 (equivalent to RMB1,170,114), repayment of the deposit plus 100% penalty, totaling $188,888 (equivalent to RMB1,200,000), and for attorneys’ fees and costs. The Company disputed Plaintiff’s claim for a land use right certificate of underlying construction base of the #1 and #2 residential buildings, which certificate was inseparable from other part of the land and was not specifically stated in the agreement. The Company also disputed Plaintiff’s entitlement to the amounts claimed and instructed the Company’s legal counsel to contest the action, while concurrently pursuing opportunities for reasonable settlement. The case went to trial on July 7, 2011. On November 15, 2011, the Basic People's Court of Changle County pronounced its judgment against Plaintiff and that SD Chaoying had no liability. However, the plaintiff still has a right to appeal the judgment to the Intermediate Court in Weifang City, Shandong Province, China within 15 days after receiving verdict from the court. The verdict was released by the court on March 23, 2012. An appeal was filed on April 6, 2012 by the Plaintiff after the verdict was released. The court session for the appeal was held on May 16, 2012 at Intermediate Court in Weifang City, Shandong Province, China. As of the date of this report on Form 10Q, the verdict of the appeal has not yet been released by the intermediate court in Weifang City. As of June 30, 2012, the Company has recorded an estimate of loss contingencies of $37,700 under accrued expenses, which was estimated by the Company’s legal counsel to be reasonable. The Company recorded the estimated liability and loss contingencies according to FASB ASC 450-20-25-2 under Topic 450, “Contingencies Loss Contingencies Recognition”.

XML 28 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
LIABILITIES (Narrative) (Details)
6 Months Ended
Jun. 30, 2012
USD ($)
Jun. 30, 2012
CNY
Liabilities 1 $ 5,635,305  
Liabilities 2 4,795,155  
Liabilities 3 840,150  
Liabilities 4 1,495,357  
Liabilities 5   9,500,000
Liabilities 6 7.96% 7.96%
Liabilities 7 1,495,357  
Liabilities 8   9,500,000
Liabilities 9 50.00% 50.00%
Liabilities 10 9.46% 9.46%
Liabilities 11 3,150,000  
Liabilities 12   20,030,000
Liabilities 13 4,320,000  
Liabilities 14   27,450,000
Liabilities 15 3,150,000  
Liabilities 16 2,490,000  
Liabilities 17 660,000  
Liabilities 18 157,406  
Liabilities 19   1,000,000
Liabilities 20 $ 1,745,801  
XML 29 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)
6 Months Ended
Jun. 30, 2012
USD ($)
years
Jun. 30, 2012
CNY
Basis Of Presentation And Summary Of Significant Accounting Policies 1 80.00% 80.00%
Basis Of Presentation And Summary Of Significant Accounting Policies 2 99.00% 99.00%
Basis Of Presentation And Summary Of Significant Accounting Policies 3 15 15
Basis Of Presentation And Summary Of Significant Accounting Policies 4   15,000,000
Basis Of Presentation And Summary Of Significant Accounting Policies 5 1,983,078  
Basis Of Presentation And Summary Of Significant Accounting Policies 6 83.32% 83.32%
Basis Of Presentation And Summary Of Significant Accounting Policies 7 2,800,000  
Basis Of Presentation And Summary Of Significant Accounting Policies 8 154,732  
Basis Of Presentation And Summary Of Significant Accounting Policies 9   1,000,000
Basis Of Presentation And Summary Of Significant Accounting Policies 10 154,732  
Basis Of Presentation And Summary Of Significant Accounting Policies 11   1,000,000
Basis Of Presentation And Summary Of Significant Accounting Policies 12 2,740,390  
Basis Of Presentation And Summary Of Significant Accounting Policies 13 2,447,643  
Basis Of Presentation And Summary Of Significant Accounting Policies 14 292,747  
Basis Of Presentation And Summary Of Significant Accounting Policies 15 273,526  
Basis Of Presentation And Summary Of Significant Accounting Policies 16 3,211,515  
Basis Of Presentation And Summary Of Significant Accounting Policies 17 2,931,175  
Basis Of Presentation And Summary Of Significant Accounting Policies 18 3,000,000  
Basis Of Presentation And Summary Of Significant Accounting Policies 19   19,000,000
Basis Of Presentation And Summary Of Significant Accounting Policies 20 693,000  
Basis Of Presentation And Summary Of Significant Accounting Policies 21 650,000  
Basis Of Presentation And Summary Of Significant Accounting Policies 22 3.00% 3.00%
Basis Of Presentation And Summary Of Significant Accounting Policies 23 55,974  
Basis Of Presentation And Summary Of Significant Accounting Policies 24 791,000  
Basis Of Presentation And Summary Of Significant Accounting Policies 25   5,000,000
Basis Of Presentation And Summary Of Significant Accounting Policies 26 12,660  
Basis Of Presentation And Summary Of Significant Accounting Policies 27 93.80% 93.80%
Basis Of Presentation And Summary Of Significant Accounting Policies 28 1.566641609 1.566641609
Basis Of Presentation And Summary Of Significant Accounting Policies 29 47,328,263 47,328,263
Basis Of Presentation And Summary Of Significant Accounting Policies 30 150,000,000 150,000,000
Basis Of Presentation And Summary Of Significant Accounting Policies 31 500,000 500,000
Basis Of Presentation And Summary Of Significant Accounting Policies 32 $ 1  
XML 30 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
ASSETS (Narrative) (Details)
6 Months Ended
Jun. 30, 2012
USD ($)
years
Jun. 30, 2012
CNY
Assets 1 $ 1,583,640  
Assets 2 8,730,312  
Assets 3 495,492  
Assets 4   29,300,000
Assets 5 4,652,640  
Assets 6   7,300,000
Assets 7 1,159,190  
Assets 8 0  
Assets 9 94,444  
Assets 10 180,258  
Assets 11 8.00% 8.00%
Assets 12 5.00% 5.00%
Assets 13 10 10
Assets 14 20 20
Assets 15 5 5
Assets 16 6,781,274  
Assets 17 4,320,000  
Assets 18 3,150,000  
Assets 19 3,150,000  
Assets 20 2,490,000  
Assets 21 660,000  
Assets 22 $ 660,000  
Assets 23 10 10
Assets 24 36.9 36.9
XML 31 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCKHOLDERS EQUITY (Narrative) (Details)
6 Months Ended
Jun. 30, 2012
USD ($)
Jun. 30, 2012
CNY
Stockholders Equity 1 1.566641609 1.566641609
Stockholders Equity 2 47,328,263 47,328,263
Stockholders Equity 3 120,225,323 120,225,323
Stockholders Equity 4 120,225,323 120,225,323
Stockholders Equity 5 $ 4,678,647  
Stockholders Equity 6 1,112,330  
Stockholders Equity 7 20.00% 20.00%
Stockholders Equity 8 16.67% 16.67%
Stockholders Equity 9 12,000,000 12,000,000
Stockholders Equity 10 3,300,000 3,300,000
Stockholders Equity 11 306,000  
Stockholders Equity 12 $ 0.02  
Stockholders Equity 13 605,723  
Stockholders Equity 14   3,920,000
Stockholders Equity 15 169,973  
Stockholders Equity 16   1,100,000
Stockholders Equity 17 54,468,756 54,468,756
Stockholders Equity 18 $ 0.008  
XML 32 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Loss $ (292,747) $ (273,526)
Adjustments to Reconcile Net Loss to Net Cash Provided by Operating Activities:    
Depreciation and amortization 125,081 135,345
Bad debt expense 0 68,830
Minority interest (68,325) (53,169)
Changes in Operating Assets and Liabilities:    
Accounts receivable (3,142) 0
Inventories 122,276 (15,636)
Other receivable and prepaid expenses 1,189 (3,365)
Accounts payable and other current liabilities 93,345 81,043
Deferred revenue 10,378 0
Customer deposits (100,883) 906
Net Cash Used in Operating Activities (112,828) (59,572)
CASH FLOWS FROM INVESTING ACTIVITIES    
Advance for loan to affiliated companies (5,845) (38,480)
Purchase of property, plant, and equipment (190) (46,523)
Payments for construction in progress (62,077) (87,100)
Net Cash Used in Investing Activities (68,112) (172,103)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from loans from related companies 50,635 36,710
Proceeds from shareholders/officers 104,273 122,469
Repayments of loan from shareholders/officers (253,173) 0
Net Cash (Used in) Provided by Financing Activities (98,265) 159,179
NET DECREASE IN CASH & CASH EQUIVALENTS (279,205) (72,496)
EFFECT OF EXCHANGE RATE CHANGE ON CASH & CASH EQUIVALENTS (6,351) 11,684
CASH & CASH EQUIVALENTS, BEGINNING BALANCE 781,048 585,020
CASH & CASH EQUIVALENTS, ENDING BALANCE 495,492 524,208
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION    
Interest paid 75,031 86,084
Income taxes paid $ 0 $ 0
XML 33 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
INCOME TAXES
6 Months Ended
Jun. 30, 2012
INCOME TAXES [Text Block]

NOTE E – INCOME TAXES

Under the Enterprise Income Tax (“EIT”) of the PRC, prior to 2007, Chinese enterprises are generally subject to an income tax at an effective rate of 33% ( 30% statutory income taxes plus 3% local income taxes) on income reported in the statutory financial statements after appropriate tax adjustments, unless the enterprise is located in a specially designated region for which more favorable effective tax rates are applicable. Beginning on January 1, 2008, the new EIT law has replaced the existing laws for Domestic Enterprises (“DEs”) and Foreign Invested Enterprises (“FIEs”). The new standard EIT rate of 25% will replace the 33% rate previously applicable to both DES and FIEs. The two year tax exemption, six year 50% tax reduction and tax holiday for production-oriented FIEs will be eliminated. According to the Western Developing Plan implemented by the PRC Government, Chaoying Biotech is entitled to a 50% reduction in EIT of preferential policy, but not less than 15%. As a result, Chaoying Biotech’s effective EIT tax rate has been 15% since 2008.

The Company’s income tax expense includes U.S. and PRC income taxes. There were no U.S. current taxes for the six months ended June 30, 2012 according to net loss incurred in the U.S. entity, which will not be anticipated to have any tax benefit in the future since no revenue is expected to be generated in the U.S as a result of discontinuing the U.S. operating company in Maryland in October 2007. There was $162 of PRC current income taxes accrued for the six months ended June 30, 2012 in SD Chaoying.

XML 34 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 9 232 1 false 0 0 false 8 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.cybrdi.com/taxonomy/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 102 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.cybrdi.com/taxonomy/role/BalanceSheet CONSOLIDATED BALANCE SHEETS false false R3.htm 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.cybrdi.com/taxonomy/role/BalanceSheetParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.cybrdi.com/taxonomy/role/IncomeStatement CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 105 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.cybrdi.com/taxonomy/role/CashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R6.htm 106 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.cybrdi.com/taxonomy/role/NotesToTheFinancialStatementsBasisOfPresentationAndSignificantAccountingPoliciesTextBlock BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R7.htm 107 - Disclosure - ASSETS Sheet http://www.cybrdi.com/taxonomy/role/NotesToTheFinancialStatementsAssetsTextBlock ASSETS false false R8.htm 108 - Disclosure - LIABILITIES Sheet http://www.cybrdi.com/taxonomy/role/NotesToTheFinancialStatementsLiabilitiesTextBlock LIABILITIES false false R9.htm 109 - Disclosure - STOCKHOLDERS EQUITY Sheet http://www.cybrdi.com/taxonomy/role/NotesToTheFinancialStatementsStockholdersEquityNoteDisclosureTextBlock STOCKHOLDERS EQUITY false false R10.htm 110 - Disclosure - INCOME TAXES Sheet http://www.cybrdi.com/taxonomy/role/NotesToTheFinancialStatementsIncomeTaxDisclosureTextBlock INCOME TAXES false false R11.htm 111 - Disclosure - CONTINGENCIES AND LITIGATION LIABILITIES Sheet http://www.cybrdi.com/taxonomy/role/NotesToTheFinancialStatementsLegalMattersAndContingenciesTextBlock CONTINGENCIES AND LITIGATION LIABILITIES false false R12.htm 112 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.cybrdi.com/taxonomy/role/NotesToTheFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies Summary of Significant Accounting Policies (Policies) false false R13.htm 113 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) Sheet http://www.cybrdi.com/taxonomy/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesTextBlockDetails BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) false false R14.htm 114 - Disclosure - ASSETS (Narrative) (Details) Sheet http://www.cybrdi.com/taxonomy/role/DisclosureAssetsTextBlockDetails ASSETS (Narrative) (Details) false false R15.htm 115 - Disclosure - LIABILITIES (Narrative) (Details) Sheet http://www.cybrdi.com/taxonomy/role/DisclosureLiabilitiesTextBlockDetails LIABILITIES (Narrative) (Details) false false R16.htm 116 - Disclosure - STOCKHOLDERS EQUITY (Narrative) (Details) Sheet http://www.cybrdi.com/taxonomy/role/DisclosureStockholdersEquityNoteDisclosureTextBlockDetails STOCKHOLDERS EQUITY (Narrative) (Details) false false R17.htm 117 - Disclosure - INCOME TAXES (Narrative) (Details) Sheet http://www.cybrdi.com/taxonomy/role/DisclosureIncomeTaxDisclosureTextBlockDetails INCOME TAXES (Narrative) (Details) false false R18.htm 118 - Disclosure - CONTINGENCIES AND LITIGATION LIABILITIES (Narrative) (Details) Sheet http://www.cybrdi.com/taxonomy/role/DisclosureLegalMattersAndContingenciesTextBlockDetails CONTINGENCIES AND LITIGATION LIABILITIES (Narrative) (Details) false false All Reports Book All Reports Process Flow-Through: 102 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Jun. 30, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 105 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS cydi-20120630.xml cydi-20120630.xsd cydi-20120630_cal.xml cydi-20120630_def.xml cydi-20120630_lab.xml cydi-20120630_pre.xml true true